GVF-UPDATE｜Annual 2009

GVF-UPDATE｜Annual 2009

Current and Relevant Publications on Vitamins, Carotenoids and other Health Ingredients GVF-Update | Annual 2009 | I

CONTENTS

Diese Auswahl an Publikationen aus dem Bereich der Vitamine, Mineralstoffe und sekundären Pflanzenstoffe wird von der GVF getroffen und erhebt keinen Anspruch auf Vollständigkeit.

Jedem Eintrag in PubMed ist eine Identifikationsnummer, die PubMed-ID PMID, zugeordnet. Diese Nummer dient als Suchkriterium in PubMed und ist am Ende jeder Literaturangabe aufgeführt. Æ Ahmad, S. M. et al. (2009a). Markers of innate immune function are associated with vitamin a

stores in men. JU Nutr,U 139(2), 377-385, 19091796.

Fat-SolubleU VitaminsU ...... 1

VitaminU AU ...... 1

VitaminU DU ...... 3

VitaminU EU ...... 17

VitaminU KU ...... 21

Water-SolubleU VitaminsU ...... 24

BiotinU U ...... 24

B-VitaminsU U...... 24

VitaminU B1U ...... 29

VitaminU B2U ...... 30

VitaminU B6U ...... 30

VitaminU B12U ...... 31

FolicU AcidU ...... 33

NiacinU U ...... 40

VitaminU CU ...... 41

MultivitaminsU U ...... 45

AntioxidantsU U ...... 47

CarnitineU U ...... 51

CarotenoidsU U ...... 53

CholineU U ...... 57

CoQ10U U ...... 58

GlucosamineU U ...... 59

InositolU U ...... 60

AlphaU Lipoic AcidU ...... 60

MiscellaneousU U ...... 61

MineralsU U ...... 64

PolyphenolsU U ...... 66

ProbioticsU U ...... 67

PUFAsU U ...... 67

ReservatrolU U ...... 80 GVF-Update | Annual 2009 | 1

Fat-Soluble0B Vitamins

Vitamin A

Æ Ahmad, S. M. et al. (2009a). Markers of innate immune function are associated with vitamin a stores in men. JU

Nutr,U 139(2), 377-385, 19091796.

Æ Ahmad, S. M. et al. (2009b). Vitamin A status is associated with T-cell responses in Bangladeshi men. BrU J Nutr,U 102(6), 797-802, 19747427.

Æ Al Senaidy, A. M. (2009). Serum vitamin A and beta-carotene levels in children with asthma. JU Asthma,U 46(7), 699- 702, 19728208. Æ Alpsoy, L. et al. (2009). Protective role of vitamins A, C, and E against the genotoxic damage induced by aflatoxin

B1 in cultured human lymphocytes. ToxicolU Ind Health,U 25(3), 183-188, 19482912. Æ Arlappa, N. et al. (2008). Clinical and sub-clinical vitamin A deficiency among rural pre-school children of

Maharashtra, India. AnnU Hum Biol,U 35(6), 606-614, 18958633. Æ Benn, C. S. et al. (2009). Does vitamin A supplementation interact with routine vaccinations? An analysis of the

Ghana Vitamin A Supplementation Trial. AmU J Clin Nutr,U 90(3), 629-639, 19640958. Æ Benn, C. S. et al. (2009). The effect of high-dose vitamin A supplementation administered with BCG vaccine at

birth may be modified by subsequent DTP vaccination. VaccineU ,U 27(21), 2891-2898, 19428899. Æ Bezerra, D. S. et al. (2009). Maternal supplementation with retinyl palmitate during immediate postpartum

period: potential consumption by infants. RevU Saude Publica,U 43(4), 572-579, 19547802. Æ Bystrowska, B. et al. (2009). Rapid HPLC method for the determination of vitamin A and E and cotinine

concentration in human serum in women with CIN and cervical cancer. GinekolU Pol,U 80(4), 256-262, 19507558. Æ Caire-Juvera, G. et al. (2009). Vitamin A and retinol intakes and the risk of fractures among participants of the

Women's Health Initiative Observational Study. AmU J Clin Nutr,U 89(1), 323-330, 19056568.

Æ Caminha Mde, F. et al. (2009). Vitamin A supplementation during puerperium: systematic review. RevU Saude

Publica,U 43(4), 699-706, 19547803.

Æ Colburn, J. D. et al. (2009). Corneal ulceration due to vitamin A deficiency in Zellweger syndrome. JU Aapos,U 13(3), 289-291, 19541270. Æ Custodio, V. I. et al. (2009). Vitamin A deficiency among Brazilian school-aged children in a healthy child service.

EurU J Clin Nutr,U 63(4), 485-490, 18043701. Æ Dizhoor, A. M. et al. (2008). Night blindness and the mechanism of constitutive signaling of mutant G90D

rhodopsin. JU Neurosci,U 28(45), 11662-11672, 18987202. Æ Erikstrup, C. et al. (2009). RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes.

DiabetesU Obes Metab,U 11(3), 204-212, 19215278. Æ Fujita, M. et al. (2009). Assessment of the relative dose-response test based on serum retinol-binding protein

instead of serum retinol in determining low hepatic vitamin A stores. AmU J Clin Nutr,U 90(1), 217-224, 19474143. Æ Grover, D. S. et al. (2008). Vitamin A supplementation in Cambodia: program coverage and association with

greater maternal formal education. AsiaU Pac J Clin Nutr,U 17(3), 446-450, 18818165.

Æ Hind, M. et al. (2009). Retinoid induction of alveolar regeneration: from mice to man? ThoraxU ,U 64(5), 451-457, 19401491. Æ Howe, J. A. et al. (2009). 13C natural abundance in serum retinol acts as a biomarker for increases in dietary

provitamin A. ExpU Biol Med (Maywood),U 234(2), 140-147, 19116317. Æ Johnson-Davis, K. L. et al. (2009). A rapid HPLC method used to establish pediatric reference intervals for vitamins

A and E. ClinU Chim Acta,U 405(1-2), 35-38, 19361489. GVF-Update | Annual 2009 | 2

Æ Kato, Y. et al. (2009). Trends in dietary intakes of vitamins A, C and E among Japanese men and women from 1974

to 2001. PublicU Health Nutr,U 12(9), 1343-1350, 19012802. Æ Kolusari, A. et al. (2008). Catalase activity, serum trace element and heavy metal concentrations, and vitamin A, D

and E levels in pre-eclampsia. JU Int Med Res,U 36(6), 1335-1341, 19094444. Æ Kongnyuy, E. J. et al. (2009). A systematic review of randomized controlled trials of prenatal and postnatal

vitamin A supplementation of HIV-infected women. IntU J Gynaecol Obstet,U 104(1), 5-8, 18926534. Æ Kraemer, K. et al. (2008). Are low tolerable upper intake levels for vitamin A undermining effective food

fortification efforts? NutrU Rev,U 66(9), 517-525, 18752475.

Æ Lasisi, A. O. (2009). The role of retinol in the etiology and outcome of suppurative otitis media. EurU Arch

Otorhinolaryngol,U 266(5), 647-652, 18704470.

Æ Lee, V. et al. (2008). Extent of vitamin A deficiency among rural pregnant women in Bangladesh. PublicU Health

Nutr,U 11(12), 1326-1331, 18547455. Æ Lipkin, A. C. & Lenssen, P. (2008). Hypervitaminosis a in pediatric hematopoietic stem cell patients requiring renal

replacement therapy. NutrU Clin Pract,U 23(6), 621-629, 19033221.

Æ Luo, T. et al. (2009). Integrating retinoic acid signaling with brain function. DevU Psychol,U 45(1), 139-150, 19209997. Æ Maslova, E. et al. (2009). Are vitamin A and iron deficiencies re-emerging in urban Latin America? A survey of

schoolchildren in Bogota, Colombia. FoodU Nutr Bull,U 30(2), 103-111, 19689088. Æ Melichar, B. et al. (2008). Intestinal permeability and vitamin A absorption in patients with chemotherapy-

induced diarrhea. AmU J Clin Oncol,U 31(6), 580-584, 19060591. Æ Mello-Neto, J. et al. (2009). The influence of maternal factors on the concentration of vitamin A in mature breast

milk. ClinU Nutr,U 28(2), 178-181, 19249141.

Æ Moro, J. R. et al. (2008). Vitamin effects on the immune system: vitamins A and D take centre stage. NatU Rev

Immunol,U 8(9), 685-698, 19172691.

Æ Nagl, B. et al. (2009). Urinary vitamin A excretion in very low birth weight infants. PediatrU Nephrol,U 24(1), 61-66, 18751734. Æ Pakasi, T. A. et al. (2009). Vitamin A deficiency and other factors associated with severe tuberculosis in Timor and

Rote Islands, East Nusa Tenggara Province, Indonesia. EurU J Clin Nutr,U 63(9), 1130-1135, 19471295.

Æ Poulain, S. et al. (2009). Vitamin A/retinoids signalling in the human lung. LungU Cancer,U 66(1), 1-7, 19346027. Æ Ribeiro Nogueira, C. et al. (2009). Serum concentrations of vitamin A and oxidative stress in critically ill patients

with sepsis. NutrU Hosp,U 24(3), 312-317, 19721904. Æ Ross, A. C. et al. (2009). Application of a key events dose-response analysis to nutrients: a case study with vitamin

A (retinol). CritU Rev Food Sci Nutr,U 49(8), 708-717, 19690996. Æ Sanjoaquin, M. A. & Molyneux, M. E. (2009). Malaria and vitamin A deficiency in African children: a vicious circle?

MalarU J,U 8, 134, 19534807. Æ Sarma, P. C. et al. (2009). A new approach to the assessment of marginal vitamin A deficiency in children in

suburban Guwahati, India: hydrolysis of retinoyl glucuronide to retinoic acid. BrU J Nutr,U 101(6), 794-797, 19283884. Æ Schenk, J. M. et al. (2009). Serum retinol and prostate cancer risk: a nested case-control study in the prostate,

lung, colorectal, and ovarian cancer screening trial. CancerU Epidemiol Biomarkers Prev,U 18(4), 1227-1231, 19336558. Æ Semeraro, A. et al. (2009). Evaluation of uncertainty of measurement from method validation data: an application

to the simultaneous determination of retinol and alpha-tocopherol in human serum by HPLC. JU

Chromatogr B Analyt Technol Biomed Life Sci,U 877(11-12), 1209-1215, 19332395.

Æ Sethi, S. K. et al. (2009). Vitamin A responsive night blindness in Dent's disease. PediatrU Nephrol,U 24(9), 1765-1770, 19444483. Æ Siavash, M. et al. (2008). Endemic goiter in Semirom; there is no difference in vitamin A status between goitrous

and nongoitrous children. JU Nutr Sci Vitaminol (Tokyo),U 54(6), 430-434, 19155579. GVF-Update | Annual 2009 | 3

Æ Tang, G. et al. (2009). Golden Rice is an effective source of vitamin A. AmU J Clin Nutr,U 89(6), 1776-1783, 19369372.

Æ Thielitz, A. & Gollnick, H. (2008). Topical retinoids in acne vulgaris: update on efficacy and safety. AmU J Clin

Dermatol,U 9(6), 369-381, 18973403. Æ Tucker-Samaras, S. et al. (2009). A stabilized 0.1% retinol facial moisturizer improves the appearance of

photodamaged skin in an eight-week, double-blind, vehicle-controlled study. JU Drugs Dermatol,U 8(10), 932-936, 19852122. Æ Van Loo-Bouwman, C. A. et al. (2009). Vitamin A equivalency of beta-carotene in healthy adults: limitation of the

extrinsic dual-isotope dilution technique to measure matrix effect. BrU J Nutr,U 101(12), 1837-1845, 19025719. Æ Weisse, S. et al. (2009). Investigations on topically applied vitamin A loaded amphiphilic cyclodextrin

nanocapsules. JU Nanosci Nanotechnol,U 9(1), 640-645, 19441361.

Æ Wendling, D. et al. (2009). Dysphagia and hypervitaminosis A: cervical hyperostosis. JointU Bone Spine,U 76(4), 409- 411, 19289294.

Æ Zulet, M. A. et al. (2008). Vitamin A intake is inversely related with adiposity in healthy young adults. JU Nutr Sci

Vitaminol (Tokyo),U 54(5), 347-352, 19001764.

Vitamin D

Æ Adami, S. et al. (2009). Vitamin D status and response to treatment in post-menopausal osteoporosis. OsteoporosU

Int,U 20(2), 239-244, 18551242.

Æ Agarwal, A. et al. (2009). Rickets: a cause of delayed walking in toddlers. IndianU J Pediatr,U 76(3), 269-272, 19347666. Æ Ahmadpoor, P. et al. (2009). Effect of active vitamin D on expression of co-stimulatory molecules and HLA-DR in

renal transplant recipients. ExpU Clin Transplant,U 7(2), 99-103, 19715513. Æ Ahn, J. et al. (2009). Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.

CarcinogenesisU ,U 30(5), 769-776, 19255064.

Æ Al-Atawi, M. S. et al. (2009). Epidemiology of nutritional rickets in children. SaudiU J Kidney Dis Transpl,U 20(2), 260- 265, 19237815. Æ Alfonso, B. et al. (2009). Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment.

DiabetesU Metab Res Rev,U 25(5), 417-419, 19565622. Æ Ali, F. N. et al. (2009). Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic.

PediatricsU ,U 123(3), 791-796, 19255004. Æ Almerighi, C. et al. (2009). 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and

immunomodulatory activity in human monocytes. CytokineU ,U 45(3), 190-197, 19186073. Æ Anand, S. P. & Selvaraj, P. (2009). Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7,

MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis. ClinU Immunol,U 133(1), 126-131, 19615945. Æ Andersen, R. et al. (2009). Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani

immigrants. EurU J Clin Nutr,U 63(9), 1150-1153, 19352377. Æ Andrade, J. et al. (2008). Exploration of association of 1,25-OH2D3 with augmentation index, a composite

measure of arterial stiffness. ClinU J Am Soc Nephrol,U 3(6), 1800-1806, 18922995. Æ Annweiler, C. et al. (2009). Is there an association between serum 25-hydroxyvitamin D concentration and

muscle strength among older women? Results from baseline assessment of the EPIDOS study. JU Nutr

Health Aging,U 13(2), 90-95, 19214335. Æ Araujo, A. B. et al. (2009). Serum 25-hydroxyvitamin D and bone mineral density among Hispanic men.

OsteoporosU Int,U 20(2), 245-255, 18548306. Æ Arguelles, L. M. et al. (2009). Heritability and environmental factors affecting vitamin D status in rural Chinese

adolescent twins. JU Clin Endocrinol Metab,U 94(9), 3273-3281, 19549746. GVF-Update | Annual 2009 | 4

Æ Arpadi, S. M. et al. (2009). Effect of bimonthly supplementation with oral cholecalciferol on serum 25-

hydroxyvitamin D concentrations in HIV-infected children and adolescents. PediatricsU ,U 123(1), e121-126, 19117833.

Æ Asgari, M. M. et al. (2009). A cohort study of vitamin D intake and melanoma risk. JU Invest Dermatol,U 129(7), 1675- 1680, 19194478. Æ Ashraf, A. et al. (2009). Threshold for effects of vitamin D deficiency on glucose metabolism in obese female

African-American adolescents. JU Clin Endocrinol Metab,U 94(9), 3200-3206, 19549742. Æ Avenell, A. et al. (2009). Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-

controlled trial in older people (RECORD trial, ISRCTN 51647438). AgeU Ageing,U 38(5), 606-609, 19617604. Æ Badsha, H. et al. (2009). Myalgias or non-specific muscle pain in Arab or Indo-Pakistani patients may indicate

vitamin D deficiency. ClinU Rheumatol,U 28(8), 971-973, 19277814. Æ Barna, B. P. et al. (2009). A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is

dysfunctional in patients with pulmonary alveolar proteinosis (PAP). AutoimmunityU ,U 42(1), 56-62, 18803071. Æ Bartley, J. (2008). Prevalence of vitamin D deficiency among patients attending a multidisciplinary tertiary pain

clinic. NU Z Med J,U 121(1286), 57-62, 19098948.

Æ Belostotsky, V. et al. (2008). Vitamin D deficiency in children with renal disease. ArchU Dis Child,U 93(11), 959-962, 18463127. Æ Bener, A. et al. (2009). High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children.

ActaU Diabetol,U 46(3), 183-189, 18846317. Æ Bener, A. et al. (2008). Impact of lifestyle and dietary habits on hypovitaminosis D in type 1 diabetes mellitus and

healthy children from Qatar, a sun-rich country. AnnU Nutr Metab,U 53(3-4), 215-222, 19077420. Æ Bergink, A. P. et al. (2009). Vitamin D status, bone mineral density, and the development of radiographic

osteoarthritis of the knee: The Rotterdam Study. JU Clin Rheumatol,U 15(5), 230-237, 19654490.

Æ Bertone-Johnson, E. R. (2009). Vitamin D and breast cancer. AnnU Epidemiol,U 19(7), 462-467, 19230714.

Æ Bhan, I. & Thadhani, R. (2009). Vitamin D therapy for chronic kidney disease. SeminU Nephrol,U 29(1), 85-93, 19121478.

Æ Bikle, D. (2009). Nonclassic actions of vitamin D. JU Clin Endocrinol Metab,U 94(1), 26-34, 18854395.

Æ Bikle, D. D. (2009). Vitamin D and immune function: understanding common pathways. CurrU Osteoporos Rep,U 7(2), 58-63, 19631030. Æ Billoo, A. G. et al. (2009). Comparison of oral versus injectable vitamin-D for the treatment of nutritional vitamin-

D deficiency rickets. JU Coll Physicians Surg Pak,U 19(7), 428-431, 19576150. Æ Binkley, N. et al. (2009). Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3

for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial. BoneU ,U 44(4), 639-647, 19185560. Æ Birlea, S. A. et al. (2009). New insights on therapy with vitamin D analogs targeting the intracellular pathways that

control repigmentation in human vitiligo. MedU Res Rev,U 29(3), 514-546, 19241402.

Æ Bischoff-Ferrari, H. A. & Staehelin, H. B. (2008). Importance of vitamin D and calcium at older age. IntU J Vitam Nutr

Res,U 78(6), 286-292, 19685438. Æ Bischoff-Ferrari, H. A. et al. (2008). Additive benefit of higher testosterone levels and vitamin D plus calcium

supplementation in regard to fall risk reduction among older men and women. OsteoporosU Int,U 19(9), 1307-1314, 18351428. Æ Bischoff-Ferrari, H. A. et al. (2009). Fall prevention with supplemental and active forms of vitamin D: a meta-

analysis of randomised controlled trials. BMJU ,U 339, b3692, 19797342. Æ Bischoff-Ferrari, H. A. et al. (2009). Prevention of nonvertebral fractures with oral vitamin D and dose

dependency: a meta-analysis of randomized controlled trials. ArchU Intern Med,U 169(6), 551-561, 19307517. Æ Bjorkman, M. et al. (2009). Responses of parathyroid hormone to vitamin D supplementation: a systematic review

of clinical trials. ArchU Gerontol Geriatr,U 48(2), 160-166, 18243368. GVF-Update | Annual 2009 | 5

Æ Blaney, G. P. et al. (2009). Vitamin D metabolites as clinical markers in autoimmune and chronic disease. AnnU N Y

Acad Sci,U 1173, 384-390, 19758177.

Æ Blauer, M. et al. (2009). Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. FertilU Steril,U 91(5), 1919-1925, 18423458. Æ Bodnar, L. M. et al. (2009). Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera

frozen for over 40 years. BrU J Nutr,U 101(2), 278-284, 18430263. Æ Bolland, M. J. et al. (2008). The effects of seasonal variation of 25-hydroxyvitamin D on diagnosis of vitamin D

insufficiency. NU Z Med J,U 121(1286), 63-74, 19098949. Æ Bonakdaran, S. & Varasteh, A. R. (2009). Correlation between serum 25 hydroxy vitamin D3 and laboratory risk

markers of cardiovascular diseases in type 2 diabetic patients. SaudiU Med J,U 30(4), 509-514, 19370277.

Æ Bordelon, P. et al. (2009). Recognition and management of vitamin D deficiency. AmU Fam Physician,U 80(8), 841- 846, 19835345.

Æ Bouillon, R. (2009). Vitamin D as potential baseline therapy for blood pressure control. AmU J Hypertens,U 22(8), 816, 19638953.

Æ Bowyer, L. et al. (2009). Vitamin D, PTH and calcium levels in pregnant women and their neonates. ClinU

Endocrinol (Oxf),U 70(3), 372-377, 18573121. Æ Brandi, L. (2008). 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.

DanU Med Bull,U 55(4), 186-210, 19232159.

Æ Braun-Moscovici, Y. et al. (2008). Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis. JU

Rheumatol,U 35(11), 2201-2205, 18843781.

Æ Brehm, J. M. et al. (2009). Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. AmU J

Respir Crit Care Med,U 179(9), 765-771, 19179486.

Æ Buell, J. S. et al. (2009). Vitamin D is associated with cognitive function in elders receiving home health services. JU

Gerontol A Biol Sci Med Sci,U 64(8), 888-895, 19377013. Æ Calatayud, M. et al. (2009). [Prevalence of deficient and insufficient vitamin D levels in a young healthy

population]. EndocrinolU Nutr,U 56(4), 164-169, 19627732.

Æ Cannell, J. J. et al. (2009). Athletic performance and vitamin D. MedU Sci Sports Exerc,U 41(5), 1102-1110, 19346976. Æ Cantor, T. L. (2009). Lack of evidence for administering vitamin D analogs to kidney failure patients to improve

survivability. ClinU Nephrol,U 72(2), 97-104, 19640366. Æ Carlin, A. M. et al. (2009). Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized

prospective clinical trial. SurgU Obes Relat Dis,U 5(4), 444-449, 18996761.

Æ Cashman, K. D. et al. (2008). Estimation of the dietary requirement for vitamin D in healthy adults. AmU J Clin Nutr,U 88(6), 1535-1542, 19064513. Æ Cashman, K. D. et al. (2009). Estimation of the dietary requirement for vitamin D in free-living adults >=64 y of

age. AmU J Clin Nutr,U 89(5), 1366-1374, 19297462.

Æ Cavalier, E. et al. (2009). Vitamin D: current status and perspectives. ClinU Chem Lab Med,U 47(2), 120-127, 19099529. Æ Chan, J. et al. (2009). Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians:

the Adventist Health Study-2. AmU J Clin Nutr,U 89(5), 1686S-1692S, 19339396. Æ Chan, S. P. et al. (2009). Final Declaration of the Asian Metaforum on the Role of Vitamin D and the Management

of Osteoporosis. PublicU Health Nutr,U 12(4), 578-580, 18647434. Æ Chel, V. et al. (2008). Efficacy of different doses and time intervals of oral vitamin D supplementation with or

without calcium in elderly nursing home residents. OsteoporosU Int,U 19(5), 663-671, 17874029.

Æ Chiang, K. C. & Chen, T. C. (2009). Vitamin D for the prevention and treatment of pancreatic cancer. WorldU J

Gastroenterol,U 15(27), 3349-3354, 19610135.

Æ Chlebowski, R. T. et al. (2008). Calcium plus vitamin D supplementation and the risk of breast cancer. JU Natl

Cancer Inst,U 100(22), 1581-1591, 19001601. GVF-Update | Annual 2009 | 6

Æ Chocano-Bedoya, P. & Ronnenberg, A. G. (2009). Vitamin D and tuberculosis. NutrU Rev,U 67(5), 289-293, 19386033. Æ Christensen, S. E. et al. (2008). Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone

in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. UEur J Endocrinol,U 159(6), 719- 727, 18787045.

Æ Chun, R. F. et al. (2008). Back to the future: a new look at 'old' vitamin D. JU Endocrinol,U 198(2), 261-269, 18495944.

Æ Cicarma, E. et al. (2009). Sun and sun beds: inducers of vitamin D and skin cancer. AnticancerU Res,U 29(9), 3495- 3500, 19667143. Æ Courbebaisse, M. et al. (2009). Effects of vitamin D supplementation on the calcium-phosphate balance in renal

transplant patients. KidneyU IntU, 75(6), 646-651, 18923386. Æ Coussens, A. et al. (2009). 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by

Mycobacterium tuberculosis infection. ImmunologyU ,U 127(4), 539-548, 19178594.

Æ Cozzolino, M. et al. (2009). Importance of vitamin D receptor activation in clinical practice. ContribU Nephrol,U 163, 213-218, 19494616. Æ Crew, K. D. et al. (2009). High prevalence of vitamin D deficiency despite supplementation in premenopausal

women with breast cancer undergoing adjuvant chemotherapy. JU Clin Oncol,U 27(13), 2151-2156, 19349547. Æ Cross, H. S. et al. (2009). Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for

cancer prevention. AnticancerU Res,U 29(9), 3705-3712, 19667168.

Æ Cuppari, L. et al. (2008). Vitamin D status of chronic kidney disease patients living in a sunny country. JU Ren Nutr,U 18(5), 408-414, 18721735. Æ Cuppari, L. & Garcia-Lopes, M. G. (2009). Hypovitaminosis D in chronic kidney disease patients: prevalence and

treatment. JU Ren Nutr,U 19(1), 38-43, 19121769. Æ Daly, R. M. & Nowson, C. A. (2009). Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and

serum lipid concentrations in healthy older men. EurU J Clin Nutr,U 63(8), 993-1000, 19156159.

Æ Danescu, L. G. et al. (2009). Vitamin D and diabetes mellitus. EndocrineU ,U 35(1), 11-17, 18979202.

Æ de Boer, I. H. & Kestenbaum, B. (2008). Vitamin D in chronic kidney disease: is the jury in? KidneyU Int,U 74(8), 985- 987, 18827796.

Æ De Cock, C. et al. (2008). Vitamin D inadequacy in French osteoporotic and osteopenic women. JointU Bone Spine,U 75(5), 567-572, 18722798. Æ Demirel, N. et al. (2009). Hyperparathyroidism secondary to maternal hypoparathyroidism and vitamin D

deficiency: an uncommon cause of neonatal respiratory distress. AnnU Trop Paediatr,U 29(2), 149-154, 19460269. Æ Ding, C. et al. (2009). Serum levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults: the

Tasmanian older adult cohort study. ArthritisU Rheum,U 60(5), 1381-1389, 19404958. Æ Dixon, D. et al. (2009). Calcium and vitamin D use among adults in periodontal disease maintenance

programmes. BrU Dent J,U 206(12), 627-631; discussion 617, 19557061. Æ Drueke, T. B. & Ritz, E. (2009). Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet

and/or vitamin D derivatives. ClinU J Am Soc Nephrol,U 4(1), 234-241, 19056615. Æ Dusilova-Sulkova, S. (2009). Vitamin D metabolism and vitamin D traditional and nontraditional, target organs:

implications for kidney patients. JU Ren Care,U 35 Suppl 1, 39-44, 19222730. Æ Edlich, R. et al. (2009). Modern concepts in the diagnosis and treatment of vitamin D deficiency and its clinical

consequences. JU Environ Pathol Toxicol Oncol,U 28(1), 1-4, 19392650. Æ Edlich, R. et al. (2009). Scientific documentation of the relationship of vitamin D deficiency and the development

of cancer. JU Environ Pathol Toxicol Oncol,U 28(2), 133-141, 19817700.

Æ Edlich, R. et al. (2009). Revolutionary advances in the prevention of demyelinating diseases. JU Environ Pathol

Toxicol Oncol,U 28(2), 143-152, 19817701.

Æ Egan, K. M. (2009). Vitamin D and melanoma. AnnU Epidemiol,U 19(7), 455-461, 19282200. GVF-Update | Annual 2009 | 7

Æ Ernst, B. et al. (2009). Seasonal variation in the deficiency of 25-hydroxyvitamin D(3) in mildly to extremely obese

subjects. ObesU Surg,U 19(2), 180-183, 18663544. Æ Eyles, D. et al. (2009). A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots.

ClinU Chim Acta,U 403(1-2), 145-151, 19232332. Æ Fakih, M. G. et al. (2009). Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal

cancer. IntU J Colorectal Dis,U 24(2), 219-224, 18830610.

Æ Fang, Y. et al. (2009). Vitamin D binding protein genotype and osteoporosis. CalcifU Tissue Int,U 85(2), 85-93, 19488670. Æ Farooque, A. et al. (2009). Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis.

BrU J Dermatol,U 160(2), 423-425, 18811689. Æ Faulhaber, G. A. et al. (2009). Low bone mineral density is associated with insulin resistance in bone marrow

transplant subjects. BoneU Marrow Transplant,U 43(12), 953-957, 19363530. Æ Fehmi, H. et al. (2009). Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of

vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio. ClinU

Nephrol,U 71(3), 267-275, 19281737. Æ Ferreira, G. B. et al. (2009). Proteome analysis demonstrates profound alterations in human dendritic cell nature

by TX527, an analogue of vitamin D. ProteomicsU ,U 9(14), 3752-3764, 19639594. Æ Fioletov, V. E. et al. (2009). On the relationship between erythemal and vitamin D action spectrum weighted

ultraviolet radiation. JU Photochem Photobiol BU, 95(1), 9-16, 19150601. Æ Foo, L. H. et al. (2009). Low vitamin D status has an adverse influence on bone mass, bone turnover, and muscle

strength in Chinese adolescent girls. JU Nutr,U 139(5), 1002-1007, 19321588.

Æ Gandini, S. et al. (2009). Vitamin D and skin cancer: a meta-analysis. EurU J Cancer,U 45(4), 634-641, 19008093. Æ Gannage-Yared, M. H. et al. (2009). Prevalence and predictors of vitamin D inadequacy amongst Lebanese

osteoporotic women. BrU J Nutr,U 101(4), 487-491, 18631414.

Æ Garland, C. F. et al. (2009). Vitamin D for cancer prevention: global perspective. AnnU Epidemiol,U 19(7), 468-483, 19523595. Æ Garratt, F. N. (2009). Pre-eclampsia: a challenge to public health teams worldwide to ensure that maternal diets

contain adequate levels of folic acid, n3 polyunsaturated fatty acids and vitamin D at conception. PublicU

Health,U 123(1), 95-96, 19058819. Æ Gennari, L. et al. (2009). Update on the pharmacogenetics of the vitamin D receptor and osteoporosis.

PharmacogenomicsU ,U 10(3), 417-433, 19290791. Æ Ginde, A. A. et al. (2009). Demographic differences and trends of vitamin D insufficiency in the US population,

1988-2004. ArchU Intern Med,U 169(6), 626-632, 19307527.

Æ Giovannucci, E. (2009). Vitamin D and cancer incidence in the Harvard cohorts. AnnU Epidemiol,U 19(2), 84-88, 18291673. Æ Glebocka, A. et al. (2009). New 1alpha,25-dihydroxy-19-norvitamin D(3) compounds constrained in a single A- ring conformation: synthesis of the analogues by ring-closing metathesis route and their biological

evaluation. JU Med Chem,U 52(11), 3496-3504, 19402630.

Æ Gocek, E. & Studzinski, G. P. (2009). Vitamin D and differentiation in cancer. CritU Rev Clin Lab Sci,U 46(4), 190-209, 19650715. Æ Godar, D. E. et al. (2009). Increased UVA exposures and decreased cutaneous Vitamin D(3) levels may be

responsible for the increasing incidence of melanoma. MedU Hypotheses,U 72(4), 434-443, 19155143. Æ Golan, E. et al. (2009). Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in

hemodialysis patients. ClinU J Am Soc Nephrol,U 4(8), 1374-1380, 19578003.

Æ Gonzalez, E. (2008). Vitamin D receptor ligand therapy in chronic kidney disease. ClinU Nephrol,U 70(4), 271-283, 18826852. Æ Goswami, R. et al. (2008). Presence of 25(OH) D deficiency in a rural North Indian village despite abundant

sunshine. JU Assoc Physicians India,U 56, 755-757, 19263699. GVF-Update | Annual 2009 | 8

Æ Goswami, R. et al. (2009). Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in

Asian Indians: a community-based survey. BrU J Nutr,U 102(3), 382-386, 19203420. Æ Gozdzik, A. et al. (2008). Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry

living in the Toronto area: associations with vitamin D intake and skin pigmentation. BMCU Public Health,U 8, 336, 18817578. Æ Grant, W. B. & Boucher, B. J. (2009). Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer

hypothesis. AnticancerU Res,U 29(9), 3597-3604, 19667154.

Æ Grant, W. B. & Mohr, S. B. (2009). Ecological studies of ultraviolet B, vitamin D and cancer since 2000. AnnU

Epidemiol,U 19(7), 446-454, 19269856.

Æ Gupta, D. et al. (2009). Vitamin D and prostate cancer risk: a review of the epidemiological literature. ProstateU

Cancer Prostatic Dis,U 12(3), 215-226, 19350051. Æ Haiyang, Z. & Chenggang, X. (2009). Comparison of intermittent intravenous and oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients: a meta-analysis of randomized

controlled trials. ClinU Nephrol,U 71(3), 276-285, 19281738. Æ Hanada, S. et al. (2009). Calcium-alkali syndrome due to vitamin D administration and magnesium oxide

administration. UAm J Kidney Dis,U 53(4), 711-714, 19185403. Æ Hansen, D. et al. (2009). Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised

clinical trial comparing paricalcitol and alfacalcidol. BMCU Nephrol,U 10, 28, 19778452.

Æ Hintzpeter, B. et al. (2008). Vitamin D status and health correlates among German adults. EurU J Clin Nutr,U 62(9), 1079-1089, 17538533. Æ Hobbs, R. D. et al. (2009). Severe vitamin D deficiency in Arab-American women living in Dearborn, Michigan.

EndocrU Pract,U 15(1), 35-40, 19211395.

Æ Holick, M. F. (2009). Vitamin D status: measurement, interpretation, and clinical application. AnnU Epidemiol,U 19(2), 73-78, 18329892. Æ Hollis, B. W. (2008). Assessment of vitamin D status and definition of a normal circulating range of 25-

hydroxyvitamin D. CurrU Opin Endocrinol Diabetes Obes,U 15(6), 489-494, 18971676.

Æ Holmes, V. A. et al. (2009). Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. BrU J

Nutr,U 102(6), 876-881, 19331703.

Æ Holt, S. K. et al. (2009). Vitamin D pathway gene variants and prostate cancer risk. CancerU Epidemiol Biomarkers

Prev,U 18(6), 1929-1933, 19454612.

Æ Hosl, M. & Berneburg, M. (2008). [Vitamin D and the skin]. HautarztU ,U 59(9), 737-742; quiz 743, 18688585.

Æ Hughes, D. A. & Norton, R. (2009). Vitamin D and respiratory health. ClinU Exp Immunol,U 158(1), 20-25, 19737226.

Æ Hypponen, E. et al. (2009). Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship. AllergyU ,U 64(4), 613-620, 19154546.

Æ Invernizzi, M. et al. (2009). Osteoporosis in Parkinson's disease. ParkinsonismU Relat Disord,U 15(5), 339-346, 19346153.

Æ Ishihara, J. et al. (2008). Dietary calcium, vitamin D, and the risk of colorectal cancer. AmU J Clin Nutr,U 88(6), 1576- 1583, 19064518. Æ Jakobsen, J. et al. (2009). Vitamin D status assessed by a validated HPLC method: within and between variation in

subjects supplemented with vitamin D3. ScandU J Clin Lab Invest,U 69(2), 190-197, 18942019.

Æ Janssens, W. et al. (2009). Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. AmU J

Respir Crit Care Med,U 179(8), 630-636, 19164701. Æ Jehan, F. et al. (2008). Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and

response to treatment. JU Clin Endocrinol Metab,U 93(12), 4672-4682, 18827005. Æ Jeng, L. et al. (2009). Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive

care unit with sepsis. JU Transl Med,U 7, 28, 19389235. Æ Johnson, M. A. et al. (2008). Vitamin D deficiency and insufficiency in the Georgia Older Americans Nutrition

Program. JU Nutr Elder,U 27(1-2), 29-46, 18928189. GVF-Update | Annual 2009 | 9

Æ Jorde, R. et al. (2008). Effects of vitamin D supplementation on symptoms of depression in overweight and obese

subjects: randomized double blind trial. JU Intern Med,U 264(6), 599-609, 18793245. Æ Karatekin, G. et al. (2009). Association of subclinical vitamin D deficiency in newborns with acute lower

respiratory infection and their mothers. EurU J Clin Nutr,U 63(4), 473-477, 18030309. Æ Katikaneni, R. et al. (2009). Breastfeeding does not protect against urinary tract infection in the first 3 months of

life, but vitamin D supplementation increases the risk by 76%. ClinU Pediatr (Phila),U 48(7), 750-755, 19264720. Æ Kazantzidis, A. et al. (2009). Calculations of the human vitamin D exposure from UV spectral measurements at

three European stations. PhotochemU Photobiol Sci,U 8(1), 45-51, 19247528. Æ Kazemi, A. et al. (2009). High prevalence of vitamin D deficiency among pregnant women and their newborns in

an Iranian population. JU Womens Health (Larchmt),U 18(6), 835-839, 19514825.

Æ Kelly, J. L. et al. (2009). Vitamin D and non-Hodgkin lymphoma risk in adults: a review. CancerU Invest,U 27(9), 942- 951, 19832043. Æ Kemmis, C. M. & Welsh, J. (2008). Mammary epithelial cell transformation is associated with deregulation of the

vitamin D pathway. JU Cell Biochem,U 105(4), 980-988, 18767073. Æ Khajehei, M. et al. (2009). Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of

premenstrual syndrome. IntU J Gynaecol Obstet,U 105(2), 158-161, 19232611. Æ Khazai, N. B. et al. (2009). Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients:

comparative efficacy of ergocalciferol, cholecalciferol, and UV light. JU Clin Endocrinol Metab,U 94(6), 2037- 2043, 19336509.

Æ Kilkkinen, A. et al. (2009). Vitamin D status and the risk of cardiovascular disease death. AmU J Epidemiol,U 170(8), 1032-1039, 19762371.

Æ Kilkkinen, A. et al. (2008). Vitamin D status and the risk of lung cancer: a cohort study in Finland. CancerU

Epidemiol Biomarkers Prev,U 17(11), 3274-3278, 18990771. Æ Kim, D. H. et al. (2008). Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and

Nutrition Examination Survey 2001 to 2004). AmU J Cardiol,U 102(11), 1540-1544, 19026311. Æ Kim, S. H. et al. (2009). Nargenicin enhances 1,25-dihydroxyvitamin D(3)- and all-trans retinoic acid-induced

leukemia cell differentiation via PKCbetaI/MAPK pathways. BiochemU Pharmacol,U 77(11), 1694-1701, 19428323.

Æ Kotsa, K. et al. (2009). Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. FertilU

Steril,U 92(3), 1053-1058, 18930208. Æ Kremer, R. et al. (2009). Vitamin D status and its relationship to body fat, final height, and peak bone mass in

young women. JU Clin Endocrinol Metab,U 94(1), 67-73, 18984659. Æ Kuchuk, N. O. et al. (2009). Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum

parathyroid hormone and markers of bone turnover in older persons. JU Clin Endocrinol Metab,U 94(4), 1244- 1250, 19158198. Æ Kuchuk, N. O. et al. (2009). Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal

women with osteoporosis: global perspective. JU Bone Miner Res,U 24(4), 693-701, 19049341. Æ Kull, M., Jr. et al. (2009). Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern

European country. BMCU Public Health,U 9, 22, 19152676.

Æ La Rosa, C. et al. (2009). Ganglioneuroblastoma-associated vitamin D deficiency rickets. JU Pediatr Hematol Oncol,U 31(7), 502-504, 19564745. Æ LaCroix, A. Z. et al. (2009). Calcium plus vitamin D supplementation and mortality in postmenopausal women:

the Women's Health Initiative calcium-vitamin D randomized controlled trial. JU Gerontol A Biol Sci Med Sci,U 64(5), 559-567, 19221190. Æ Lagunova, Z. et al. (2009). The dependency of vitamin D status on body mass index, gender, age and season.

AnticancerU Res,U 29(9), 3713-3720, 19667169.

Æ Lee, E. S. et al. (2009). Serum vitamin D status of Korean postmenopausal women during the winter months. AsiaU

Pac J Clin Nutr,U 18(1), 29-33, 19329392. GVF-Update | Annual 2009 | 10

Æ Lee, J. H. et al. (2008). Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?

JU Am Coll Cardiol,U 52(24), 1949-1956, 19055985.

Æ Lee, M. S. et al. (2008). Vitamin D intake and its food sources in Taiwanese. AsiaU Pac J Clin Nutr,U 17(3), 397-407, 18818159. Æ Lee, P. et al. (2009). Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index.

AmU J Med,U 122(11), 1056-1060, 19854337. Æ Lehmann, B. (2009). Role of the vitamin D3 pathway in healthy and diseased skin--facts, contradictions and

hypotheses. ExpU Dermatol,U 18(2), 97-108, 19146580. Æ Lenders, C. M. et al. (2009). Relation of body fat indexes to vitamin D status and deficiency among obese

adolescents. AmU J Clin Nutr,U 90(3), 459-467, 19640956.

Æ Levenson, C. W. & Figueiroa, S. M. (2008). Gestational vitamin D deficiency: long-term effects on the brain. NutrU

Rev,U 66(12), 726-729, 19019042. Æ Leventis, P. & Patel, S. (2008). Clinical aspects of vitamin D in the management of rheumatoid arthritis.

RheumatologyU (Oxford),U 47(11), 1617-1621, 18682414. Æ Levi, R. & Silver, J. (2009). Vitamin D supplementation after renal transplantation: how much vitamin D should we

prescribe? KidneyU Int,U 75(6), 576-578, 19247380. Æ Li-Ng, M. et al. (2009). A randomized controlled trial of vitamin D3 supplementation for the prevention of

symptomatic upper respiratory tract infections. EpidemiolU Infect,U 137(10), 1396-1404, 19296870. Æ Li, X. et al. (2009). Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with

adult-onset latent autoimmune diabetes (LADA). DiabetesU Metab Res Rev,U 25(5), 411-416, 19488999.

Æ Lim, U. et al. (2009). A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. IntU J

Cancer,U 124(4), 979-986, 19035445.

Æ Lipworth, L. et al. (2009). Dietary vitamin D and cancers of the oral cavity and esophagus. AnnU Oncol,U 20(9), 1576- 1581, 19487490. Æ Liu, E. et al. (2009). Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in

nondiabetic adults. JU Nutr,U 139(2), 329-334, 19106328.

Æ Liu, K. et al. (2009). Elevated plasma calcifediol is associated with aggressive periodontitis. JU Periodontol,U 80(7), 1114-1120, 19563291.

Æ Llewellyn, D. J. et al. (2009). Serum 25-hydroxyvitamin D concentration and cognitive impairment. JU Geriatr

Psychiatry Neurol,U 22(3), 188-195, 19073839. Æ Looker, A. C. et al. (2008). Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with

2000-2004. AmU J Clin Nutr,U 88(6), 1519-1527, 19064511. Æ Lu, L. et al. (2009). Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and

elderly Chinese individuals. DiabetesU Care,U 32(7), 1278-1283, 19366976. Æ Macedo, L. C. et al. (2008). Mutations in the vitamin D receptor gene in four patients with hereditary 1,25- dihydroxyvitamin D-resistant rickets. Arq Bras Endocrinol Metabol, 52(8), 1244-1251, 19169476. Æ Madar, A. A. et al. (2009). Effect of free vitamin D(2) drops on serum 25-hydroxyvitamin D in infants with immigrant origin: a cluster randomized controlled trial. Eur J Clin Nutr, 63(4), 478-484, 18231120. Æ Mahlay, N. F. et al. (2009). Vitamin D status before Roux-en-Y and efficacy of prophylactic and therapeutic doses

of vitamin D in patients after Roux-en-Y gastric bypass surgery. ObesU Surg,U 19(5), 590-594, 18850253.

Æ Mahmoudi, T. (2009). Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. FertilU Steril,U 92(4), 1381-1383, 19501823.

Æ Masoompour, S. M. et al. (2008). Effects of age and renal function on vitamin D status in men. ArchU Iran Med,U 11(4), 377-381, 18588368. Æ Mata-Granados, J. M. et al. (2009). Fully automatic method for the determination of fat soluble vitamins and

vitamin D metabolites in serum. ClinU Chim Acta,U 403(1-2), 126-130, 19361456. Æ McCarthy, R. et al. (2009). Relationship between vitamin D and alkaline phosphatase in very-low-birthweight

infants. ArchU Dis Child Fetal Neonatal Ed,U 94(1), F77-78, 19103781. GVF-Update | Annual 2009 | 11

Æ McCullough, M. L. et al. (2009). Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and

prostate cancer. AnnuU Rev Nutr,U 29, 111-132, 19400699. Æ Mehta, S. et al. (2009). Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and

their association with maternal vitamin D status in Tanzania. JU Infect Dis,U 200(7), 1022-1030, 19673647.

Æ Merewood, A. et al. (2009). Association between vitamin D deficiency and primary cesarean section. JU Clin

Endocrinol Metab,U 94(3), 940-945, 19106272. Æ Michos, E. D. et al. (2009). Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease

or C-reactive protein in the old order amish. CalcifU Tissue Int,U 84(3), 195-202, 19148561.

Æ Mimouni, F. B. & Shamir, R. (2009). Vitamin D requirements in the first year of life. CurrU Opin Clin Nutr Metab Care,U 12(3), 287-292, 19346937. Æ Mishra, G. et al. (2008). Dietary calcium and vitamin D intakes in childhood and throughout adulthood and

mammographic density in a British birth cohort. BrU J Cancer,U 99(9), 1539-1543, 18827811. Æ Mizoue, T. et al. (2008). Calcium, dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka Colorectal Cancer

Study. CancerU Epidemiol Biomarkers Prev,U 17(10), 2800-2807, 18843026. Æ Mocanu, V. et al. (2009). Long-term effects of giving nursing home residents bread fortified with 125 microg

(5000 IU) vitamin D(3) per daily serving. AmU J Clin Nutr,U 89(4), 1132-1137, 19244376.

Æ Mohr, S. B. (2009). A brief history of vitamin d and cancer prevention. AnnU Epidemiol,U 19(2), 79-83, 19185802. Æ Moosgaard, B. et al. (2008). Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism.

ClinU Endocrinol (Oxf),U 68(5), 707-715, 17980013. Æ Morley, R. et al. (2009). Maternal 25-hydroxyvitamin D concentration and offspring birth size: effect modification

by infant VDR genotype. EurU J Clin Nutr,U 63(6), 802-804, 19018272. Æ Moschonis, G. et al. (2009). Association between serum 25-hydroxyvitamin D levels and body composition in

postmenopausal women: the postmenopausal Health Study. MenopauseU ,U 16(4), 701-707, 19276997.

Æ Murphy, P. K. & Wagner, C. L. (2008). Vitamin D and mood disorders among women: an integrative review. JU

Midwifery Womens Health,U 53(5), 440-446, 18761297. Æ Nagao, S. et al. (2009). Spontaneous bilateral femoral neck fractures associated with a low serum level of vitamin

D in a young adult. JU Arthroplasty,U 24(2), 322 e321-324, 18534408. Æ Nagpal, J. et al. (2009). A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men.

DiabetU Med,U 26(1), 19-27, 19125756. Æ Naves-Diaz, M. et al. (2008). Oral active vitamin D is associated with improved survival in hemodialysis patients.

KidneyU Int,U 74(8), 1070-1078, 18633342. Æ Neville, L. A. & Ranganathan, S. C. (2009). Vitamin D in infants with cystic fibrosis diagnosed by newborn

screening. JU Paediatr Child Health,U 45(1-2), 36-41, 19208064. Æ Ng, K. et al. (2009). Prospective study of predictors of vitamin D status and survival in patients with colorectal

cancer. BrU J Cancer,U 101(6), 916-923, 19690551. Æ Nieves, J. W. et al. (2008). Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study.

OsteoporosU Int,U 19(5), 673-679, 17999024.

Æ Norsang, G. et al. (2009). The vitamin D status among Tibetans. PhotochemU PhotobiolU, 85(4), 1028-1031, 19508646. Æ Novakovic, B. et al. (2009). Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for

feedback autoregulation of active vitamin D levels at the fetomaternal interface. JU Biol Chem,U 284(22), 14838-14848, 19237542.

Æ Nurnberg, B. et al. (2009). Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. AnticancerU

Res,U 29(9), 3669-3674, 19667163. Æ O'Donnell, S. et al. (2008). Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic

review. AmU J Clin Nutr,U 88(6), 1528-1534, 19064512. GVF-Update | Annual 2009 | 12

Æ O'Riordan, M. N. et al. (2008). Prevalence of suboptimal vitamin D status during pregnancy. IrU Med J,U 101(8), 240, 242-243, 18990953. Æ Obineche, E. N. et al. (2008). Interrelationships between B-type natriuretic peptides and vitamin D in patients on

maintenance peritoneal dialysis. PeritU Dial Int,U 28(6), 617-621, 18981391. Æ Oh, J. et al. (2009). 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol

uptake in patients with type 2 diabetes mellitus. CirculationU ,U 120(8), 687-698, 19667238. Æ Olds, W. J. et al. (2008). In vitro model of vitamin D3 (cholecalciferol) synthesis by UV radiation: dose-response

relationships. JU Photochem Photobiol B,U 93(2), 88-93, 18755599.

Æ Orwoll, E. et al. (2009). Vitamin D deficiency in older men. JU Clin Endocrinol Metab,U 94(4), 1214-1222, 19174492. Æ Oudshoorn, C. et al. (2009). Ageing and vitamin D deficiency: effects on calcium homeostasis and considerations

for vitamin D supplementation. BrU J Nutr,U 101(11), 1597-1606, 19393111.

Æ Ozkan, B. et al. (2009). Prevalence of vitamin D deficiency rickets in the eastern part of Turkey. EurU J Pediatr,U 168(1), 95-100, 18762977.

Æ Papapetrou, P. D. et al. (2008). Severe vitamin D deficiency in the institutionalized elderly. JU Endocrinol Invest,U 31(9), 784-787, 18997490. Æ Pasch, A. et al. (2008). PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral

density in renal stone formers. NephrolU Dial Transplant,U 23(8), 2563-2570, 18398019. Æ Pasco, J. A. et al. (2009). Behavioural and physical characteristics associated with vitamin D status in women.

BoneU ,U 44(6), 1085-1091, 19264157.

Æ Patel, T. V. & Singh, A. K. (2009). Role of vitamin D in chronic kidney disease. SeminU Nephrol,U 29(2), 113-121, 19371802. Æ Paul, T. V. et al. (2008). Prevalence of osteoporosis in ambulatory postmenopausal women from a semiurban

region in Southern India: relationship to calcium nutrition and vitamin D status. EndocrU Pract,U 14(6), 665- 671, 18996783.

Æ Peersman, G. et al. (2009). Is oral vitamin D a risk factor for prosthetic loosening? ActaU Orthop Belg,U 75(1), 2-7, 19358390.

Æ Penckofer, S. et al. (2008). Vitamin D and diabetes: let the sunshine in. DiabetesU Educ,U 34(6), 939-940, 942, 944 passim, 19075078. Æ Peric, M. et al. (2009). Vitamin D analogs differentially control antimicrobial peptide/"alarmin"expression in

psoriasis. PLoSU One,U 4(7), e6340, 19623255.

Æ Peterlik, M. et al. (2009). Calcium, vitamin D and cancer. AnticancerU Res,U 29(9), 3687-3698, 19667166.

Æ Peters, B. S. et al. (2009). Prevalence of vitamin D insufficiency in Brazilian adolescents. AnnU Nutr Metab,U 54(1), 15- 21, 19194104. Æ Pfeifer, M. et al. (2009). Effects of a long-term vitamin D and calcium supplementation on falls and parameters of

muscle function in community-dwelling older individuals. OsteoporosU Int,U 20(2), 315-322, 18629569. Æ Phabphal, K. et al. (2009). Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D

status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. BoneU ,U 45(2), 232-237, 19394456.

Æ Pierrot-Deseilligny, C. (2009). Clinical implications of a possible role of vitamin D in multiple sclerosis. JU Neurol,U 256(9), 1468-1479, 19399382.

Æ Pilz, S. et al. (2009). Epidemiology of vitamin D insufficiency and cancer mortality. AnticancerU Res,U 29(9), 3699- 3704, 19667167.

Æ Poduje, S. et al. (2008). Vitamin D--the true and the false about vitamin D. UColl Antropol,U 32 Suppl 2, 159-162, 19138020.

Æ Poliquin, S. et al. (2009). Calcium and vitamin D intakes in an adult Canadian population. CanU J Diet Pract Res,U 70(1), 21-27, 19261203. Æ Proal, A. D. et al. (2009). Dysregulation of the vitamin D nuclear receptor may contribute to the higher prevalence

of some autoimmune diseases in women. AnnU N Y Acad Sci,U 1173, 252-259, 19758159. GVF-Update | Annual 2009 | 13

Æ Rabbani, A. et al. (2009). Vitamin D insufficiency among children and adolescents living in Tehran, Iran. JU Trop

Pediatr,U 55(3), 189-191, 18775944.

Æ Raghuwanshi, A. et al. (2008). Vitamin D and multiple sclerosis. JU Cell Biochem,U 105(2), 338-343, 18655192. Æ Ramagopalan, S. V. et al. (2009). Expression of the multiple sclerosis-associated MHC class II Allele HLA-

DRB1*1501 is regulated by vitamin D. PLoSU Genet,U 5(2), e1000369, 19197344. Æ Ramel, A. et al. (2009). Vitamin D deficiency and nutritional status in elderly hospitalized subjects in Iceland.

PublicU Health Nutr,U 12(7), 1001-1005, 19144240. Æ Rashidi, B. et al. (2009). The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot

study. TaiwanU J Obstet Gynecol,U 48(2), 142-147, 19574176. Æ Ray, D. et al. (2009). Predisposition to vitamin D deficiency osteomalacia and rickets in females is linked to their

25(OH)D and calcium intake rather than vitamin D receptor gene polymorphism. ClinU Endocrinol (Oxf),U 71(3), 334-340, 19094076. Æ Redman, C. et al. (2009). Role of vitamin D deficiency in continued hyperparathyroidism following

parathyroidectomy. HeadU Neck,U 31(9), 1164-1167, 19340862.

Æ Reinhold, U. et al. (2008). Circulating 25-hydroxyvitamin D concentration in German cancer patients. OncolU Rep,U 20(6), 1539-1543, 19020739. Æ Reis, J. P. et al. (2008). Differences in vitamin D status as a possible contributor to the racial disparity in peripheral

arterial disease. AmU J Clin Nutr,U 88(6), 1469-1477, 19064505. Æ Rejnmark, L. et al. (2008). Parathyroid response to vitamin D insufficiency: relations to bone, body composition

and to lifestyle characteristics. ClinU Endocrinol (Oxf),U 69(1), 29-35, 18208576. Æ Ringe, J. D. & Schacht, E. (2009). Potential of alfacalcidol for reducing increased risk of falls and fractures.

RheumatolU Int,U 29(10), 1177-1185, 19159932.

Æ Rizzoli, R. (2008). Nutrition: its role in bone health. BestU Pract Res Clin Endocrinol Metab,U 22(5), 813-829, 19028358. Æ Rockell, J. E. et al. (2008). Vitamin D insufficiency in New Zealanders during the winter is associated with higher

parathyroid hormone concentrations: implications for bone health? NU Z Med J,U 121(1286), 75-84, 19098950. Æ Rodriguez-Martin, M. et al. (2009). Randomized, double-blind clinical trial to evaluate the efficacy of topical

tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo. BrU J Dermatol,U 160(2), 409-414, 19016706.

Æ Rodriguez, M. et al. (2009). High frequency of vitamin D deficiency in ambulatory HIV-Positive patients. AIDSU Res

Hum Retroviruses,U 25(1), 9-14, 19108690. Æ Rodriguez Sangrador, M. et al. (2008). [The contribution of diet and sun exposure to the nutritional status of

vitamin D in elderly Spanish women: the five countries study (OPTIFORD Project)]. UNutr Hosp,U 23(6), 567- 576, 19132265. Æ Rohan, T. E. et al. (2009). A randomized controlled trial of calcium plus vitamin D supplementation and risk of

benign proliferative breast disease. BreastU Cancer Res Treat,U 116(2), 339-350, 18853250.

Æ Rossi, M. et al. (2009). Vitamin D intake and breast cancer risk: a case-control study in Italy. AnnU Oncol,U 20(2), 374- 378, 18711029. Æ Roth, D. E. et al. (2009). Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in

early childhood. EurU J Clin Nutr,U 63(2), 297-299, 17971825.

Æ Sadat-Ali, M. et al. (2009). Vitamin D levels in healthy men in eastern Saudi Arabia. AnnU Saudi Med,U 29(5), 378-382, 19700896. Æ Sahin, G. et al. (2008). The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss

in renal transplant patients: a prospective study. RenU Fail,U 30(10), 992-999, 19016151.

Æ Sahu, M. et al. (2009). Vitamin D replacement in pregnant women in rural north India: a pilot study. EurU J Clin

Nutr,U 63(9), 1157-1159, 19455177. GVF-Update | Annual 2009 | 14

Æ Saintonge, S. et al. (2009). Implications of a new definition of vitamin D deficiency in a multiracial us adolescent

population: the National Health and Nutrition Examination Survey III. PediatricsU ,U 123(3), 797-803, 19255005. Æ Sanchez-Abella, L. et al. (2009). Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin

D3 analogues with A-ring modifications. JU Med Chem,U 52(19), 6158-6162, 19739672.

Æ Scharla, S. (2008). Diagnosis of disorders of vitamin D-metabolism and osteomalacia. ClinU Lab,U 54(11-12), 451- 459, 19216251. Æ Schmitz, K. J. et al. (2009). Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-

hydroxyvitamin D deficient Hispanic and African Americans. AmU J Hypertens,U 22(8), 867-870, 19444222.

Æ Schwartz, G. G. (2009). Vitamin D and intervention trials in prostate cancer: from theory to therapy. AnnU

Epidemiol,U 19(2), 96-102, 18619854. Æ Seeherunvong, W. et al. (2009). Vitamin D insufficiency and deficiency in children with early chronic kidney

disease. JU Pediatr,U 154(6), 906-911 e901, 19230902. Æ Segal, E. et al. (2009). Low patient compliance--a major negative factor in achieving vitamin D adequacy in

elderly hip fracture patients supplemented with 800IU of vitamin D3 daily. ArchU Gerontol Geriatr,U 49(3), 364-367, 19147237. Æ Selvaraj, P. et al. (2009). Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and

cathelicidin in pulmonary tuberculosis. JU Clin Immunol,U 29(4), 470-478, 19219539. Æ Severo, M. et al. (2009). Development of a tool for the assessment of calcium and vitamin D intakes in clinical

settings. OsteoporosU Int,U 20(2), 231-237, 18528724.

Æ Sherman, E. M. & Svec, R. V. (2009). Barriers to vitamin D supplementation among military physicians. MilU Med,U 174(3), 302-307, 19354096. Æ Shipowick, C. D. et al. (2009). Vitamin D and depressive symptoms in women during the winter: a pilot study.

ApplU Nurs Res,U 22(3), 221-225, 19616172. Æ Shoenfeld, N. et al. (2009). The effect of melanism and vitamin D synthesis on the incidence of autoimmune

disease. NatU Clin Pract Rheumatol,U 5(2), 99-105, 19182816.

Æ Sigmon, J. R. et al. (2009). Calcitriol ointment: a review of a topical vitamin D analog for psoriasis. JU Dermatolog

Treat,U 20(4), 208-212, 19444692. Æ Silva, B. C. et al. (2008). [Prevalence of vitamin D deficiency and its correlation with PTH, biochemical bone

turnover markers and bone mineral density, among patients from ambulatories]. ArqU Bras Endocrinol

Metabol,U 52(3), 482-488, 18506273.

Æ Smith, S. M. et al. (2009). Vitamin D supplementation during Antarctic winter. AmU J Clin Nutr,U 89(4), 1092-1098, 19225122. Æ Smolders, J. et al. (2009a). Association study on two vitamin D receptor gene polymorphisms and vitamin D

metabolites in multiple sclerosis. AnnU N Y Acad Sci,U 1173, 515-520, 19758194. Æ Smolders, J. et al. (2009b). Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism

in multiple sclerosis. JU Neuroimmunol,U 207(1-2), 117-121, 19178954. Æ Smolders, J. et al. (2009). The relevance of vitamin D receptor gene polymorphisms for vitamin D research in

multiple sclerosis. AutoimmunU Rev,U 8(7), 621-626, 19393206. Æ Soliman, A. et al. (2008). An adolescent boy with thalassemia major presenting with bone pain, numbness, tetanic contractions and growth and pubertal delay: panhypopituitarism and combined vitamin D and

parathyroid defects. PediatrU Endocrinol Rev,U 6 Suppl 1, 155-157, 19337171. Æ Soni, S. S. et al. (2008). Vitamin D dependent rickets type II: late onset of disease and response to high doses of

vitamin D. SaudiU J Kidney Dis Transpl,U 19(5), 796-798, 18711299. Æ Sosa Henriquez, M. & Gomez de Tejada Romero, M. J. (2009). [Evidenced based medicine and drugs approved for

the treatment of osteoporosis. Role of calcium and vitamin D]. RevU Clin Esp,U 209(1), 25-36, 19268094.

Æ Souberbielle, J. C. et al. (2008). [Update on vitamin D and evaluation of vitamin D status]. AnnU Endocrinol (Paris),U 69(6), 501-510, 18804195. GVF-Update | Annual 2009 | 15

Æ Speeckaert, M. M. et al. (2008). Vitamin D binding protein and the need for vitamin D in hemodialysis patients. JU

Ren Nutr,U 18(5), 400-407, 18721734. Æ St Peter, W. L. et al. (2009). Effects of monthly dose and regular dosing of intravenous active vitamin D use on

mortality among patients undergoing hemodialysis. PharmacotherapyU ,U 29(2), 154-164, 19170585. Æ Stechschulte, S. A. et al. (2009). Vitamin D: bone and beyond, rationale and recommendations for

supplementation. AmU J Med,U 122(9), 793-802, 19699370. Æ Stein, E. M. et al. (2009). Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study.

ClinU Endocrinol (Oxf),U 71(2), 176-183, 19018785.

Æ Stoffman, N. & Gordon, C. M. (2009). Vitamin D and adolescents: what do we know? CurrU Opin Pediatr,U 21(4), 465- 471, 19502985.

Æ Stolzenberg-Solomon, R. Z. (2009). Vitamin D and pancreatic cancer. AnnU Epidemiol,U 19(2), 89-95, 18504144.

Æ Suhm, N. et al. (2008). Management of fragility fractures in Switzerland: results of a nationwide survey. SwissU Med

Wkly,U 138(45-46), 674-683, 18855150. Æ Sun, X. & Zemel, M. B. (2008). 1Alpha, 25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear

vitamin D receptor. IntU J Obes (Lond),U 32(8), 1305-1311, 18427562.

Æ Tachibana, S. et al. (2009). Involvement of Vitamin D receptor in the intestinal induction of human ABCB1. DrugU

Metab Dispos,U 37(8), 1604-1610, 19460946.

Æ Tai, K. et al. (2008). Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. NutritionU ,U 24(10), 950-956, 18653316.

Æ Tandeter, H. et al. (2009). Serum 25-OH vitamin D levels in patients with fibromyalgia. IsrU Med Assoc J,U 11(6), 339- 342, 19697583. Æ Tarcin, O. et al. (2009). Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic

subjects. JU Clin Endocrinol Metab,U 94(10), 4023-4030, 19584181. Æ Taskapan, H. et al. (2008). Unusually prolonged vitamin D intoxication after discontinuation of vitamin D:

possible role of primary hyperparathyroidism. IntU Urol NephrolU, 40(3), 801-805, 18528779. Æ Teichmann, J. et al. (2008). Parathormone levels and Vitamin D metabolism in female patients with various

grades of fecal elastase 1 deficiency. EurU J Med Res,U 13(12), 563-567, 19073396. Æ Thacher, T. D. et al. (2009). The effect of vitamin D2 and vitamin D3 on intestinal calcium absorption in Nigerian

children with rickets. JU Clin Endocrinol Metab,U 94(9), 3314-3321, 19567516. Æ Thieden, E. et al. (2008). Sunbed radiation provokes cutaneous vitamin D synthesis in humans--a randomized

controlled trial. PhotochemU Photobiol,U 84(6), 1487-1492, 18513233. Æ Thiem, U. et al. (2009). VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a

randomized, placebo-controlled study to evaluate the post-transplant outcome. TrialsU ,U 10, 36, 19480654. Æ Tomida, K. et al. (2009). Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone

mineral density in non-diabetic predialysis CKD patients. BoneU ,U 44(4), 678-683, 19111635.

Æ Tretli, S. et al. (2009). Association between serum 25(OH)D and death from prostate cancer. BrU J Cancer,U 100(3), 450-454, 19156140.

Æ Tseng, M. et al. (2009). Prevalence and correlates of vitamin D status in African American men. BMCU Public Health,U 9, 191, 19534831. Æ Vacca, A. et al. (2009). Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic

sclerosis. JU Rheumatol,U 36(9), 1924-1929, 19648299.

Æ Valdivielso, J. M. (2009). The physiology of vitamin D receptor activation. ContribU Nephrol,U 163, 206-212, 19494615. Æ Vieth, R. (2009a). How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation

and hydroxylase enzymology. UAnticancer Res,U 29(9), 3675-3684, 19667164.

Æ Vieth, R. (2009b). Vitamin D and cancer mini-symposium: the risk of additional vitamin D. AnnU Epidemiol,U 19(7), 441-445, 19364661. GVF-Update | Annual 2009 | 16

Æ Wagner, C. L. & Greer, F. R. (2008). Prevention of rickets and vitamin D deficiency in infants, children, and

adolescents. PediatricsU ,U 122(5), 1142-1152, 18977996.

Æ Wagner, C. L. et al. (2008). Does vitamin D make the world go 'round'? BreastfeedU Med,U 3(4), 239-250, 19086827. Æ Weaver, C. M. et al. (2008). Vitamin D status and calcium metabolism in adolescent black and white girls on a

range of controlled calcium intakes. JU Clin Endocrinol Metab,U 93(10), 3907-3914, 18682505. Æ Wehr, E. et al. (2009). Association of hypovitaminosis D with metabolic disturbances in polycystic ovary

syndrome. EurU J Endocrinol,U 161(4), 575-582, 19628650.

Æ Wei, M. Y. et al. (2008). Vitamin D and prevention of colorectal adenoma: a meta-analysis. CancerU Epidemiol

Biomarkers Prev,U 17(11), 2958-2969, 18990737. Æ Wejse, C. et al. (2009). Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized,

placebo-controlled trial. AmU J Respir Crit Care Med,U 179(9), 843-850, 19179490. Æ Wilkins, C. H. et al. (2009). Vitamin D deficiency is associated with worse cognitive performance and lower bone

density in older African Americans. JU Natl Med Assoc,U 101(4), 349-354, 19397226.

Æ Wilson, R. T. et al. (2009). Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. AmU J

Epidemiol,U 170(6), 717-729, 19651663. Æ Winters, S. J. et al. (2009). Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in

African American and white women. MetabolismU ,U 58(4), 438-442, 19303961.

Æ Wolfenden, L. L. et al. (2008). Vitamin D and bone health in adults with cystic fibrosis. ClinU Endocrinol (Oxf),U 69(3), 374-381, 18284636. Æ Wu, H. et al. (2009). The development and evaluation of a food frequency questionnaire used in assessing

vitamin D intake in a sample of healthy young Canadian adults of diverse ancestry. NutrU Res,U 29(4), 255- 261, 19410977. Æ Wu, P. W. et al. (2009). 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus

erythematosus. ArthritisU Rheum,U 61(10), 1387-1395, 19790113. Æ Xia, W. B. et al. (2009). The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low

bone mass. ActaU Pharmacol Sin,U 30(3), 372-378, 19262561. Æ Yaegashi, Y. et al. (2008). Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and

vitamin K. EurU J Epidemiol,U 23(3), 219-225, 18214692. Æ Yamshchikov, A. V. et al. (2009). Vitamin D for treatment and prevention of infectious diseases: a systematic

review of randomized controlled trials. EndocrU Pract,U 15(5), 438-449, 19491064. Æ Yavuz, B. et al. (2009). Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin

treatment: a novel pleiotropic effect of statins? CardiovascU Drugs Ther,U 23(4), 295-299, 19543962.

Æ Yoho, R. M. et al. (2009). A comparison of vitamin D levels in nondiabetic and diabetic patient populations. JU Am

Podiatr Med Assoc,U 99(1), 35-41, 19141720. Æ Young, K. A. et al. (2009). Association of plasma vitamin D levels with adiposity in Hispanic and African

Americans. JU Clin Endocrinol Metab,U 94(9), 3306-3313, 19549738.

Æ Yuk, J. M. et al. (2009). Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. CellU

Host Microbe,U 6(3), 231-243, 19748465. Æ Zehnder, D. et al. (2008). Reduction of the vitamin D hormonal system in kidney disease is associated with

increased renal inflammation. KidneyU Int,U 74(10), 1343-1353, 18784644. Æ Zella, L. A. et al. (2009). The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a

selective and prolonged induction of intestinal calcium-regulating genes. EndocrinologyU ,U 150(8), 3448- 3456, 19423758. Æ Zhang, C. et al. (2008). Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes

mellitus. PLoSU One,U 3(11), e3753, 19015731. Æ Zhou, Y. et al. (2009). Compound heterozygous mutations in the vitamin D receptor in a patient with hereditary

1,25-dihydroxyvitamin D-resistant rickets with alopecia. JU Bone Miner Res,U 24(4), 643-651, 19049339. GVF-Update | Annual 2009 | 17

Æ Zittermann, A. et al. (2009). Vitamin D supplementation enhances the beneficial effects of weight loss on

cardiovascular disease risk markers. AmU J Clin Nutr,U 89(5), 1321-1327, 19321573.

Æ Zittermann, A. & Koerfer, R. (2008). Vitamin D in the prevention and treatment of coronary heart disease. CurrU

Opin Clin Nutr Metab Care,U 11(6), 752-757, 18827580. Æ Zittermann, A. et al. (2009). Calcitriol deficiency and 1-year mortality in cardiac transplant recipients.

TransplantationU ,U 87(1), 118-124, 19136901.

Æ Zold, E. et al. (2008). Vitamin D deficiency in undifferentiated connective tissue disease. ArthritisU Res Ther,U 10(5), R123, 18928561.

Æ Zugel, U. et al. (2009). Immunomodulation by a novel, dissociated Vitamin D analogue. ExpU Dermatol,U 18(7), 619- 627, 19239489.

Vitamin E

Æ Aasheim, E. T. et al. (2009). Vitamin status after bariatric surgery: a randomized study of gastric bypass and

duodenal switch. AmU J Clin Nutr,U 90(1), 15-22, 19439456.

Æ Arnon, S. et al. (2009). Vitamin E levels during early iron supplementation in preterm infants. AmU J Perinatol,U 26(5), 387-392, 19263337. Æ Aryaeian, N. et al. (2008). Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and

blood pressure of Iranian adults with active rheumatoid arthritis. VascU Health Risk Manag,U 4(6), 1423-1432, 19337555. Æ Asha Devi, S. (2009). Aging brain: prevention of oxidative stress by vitamin E and exercise.

ScientificWorldJournalU ,U 9, 366-372, 19468659. Æ Balmer, M. L. et al. (2009). Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and

apoptosis in patients with nonalcoholic steatohepatitis. LiverU Int,U 29(8), 1184-1188, 19422479. Æ Baran, R. & Thomas, L. (2009). Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail

syndrome. JU Drugs Dermatol,U 8(3), 276-278, 19271377. Æ Belisle, S. E. et al. (2008). Cytokine response to vitamin E supplementation is dependent on pre-supplementation

cytokine levels. BiofactorsU ,U 33(3), 191-200, 19478423. Æ Belisle, S. E. et al. (2009). Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine

production in the elderly. JU Nutr,U 139(10), 1855-1860, 19710156. Æ Berdnikovs, S. et al. (2009). Isoforms of vitamin E have opposing immunoregulatory functions during

inflammation by regulating leukocyte recruitment. JU Immunol,U 182(7), 4395-4405, 19299740.

Æ Berry, D. et al. (2009). Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality. ClinU

Trials,U 6(1), 28-41, 19254931.

Æ Brigelius-Flohe, R. (2009). Vitamin E: the shrew waiting to be tamed. FreeU Radic Biol Med,U 46(5), 543-554, 19133328. Æ Cavalca, V. et al. (2009). Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age

and gender. EurU J Clin Invest,U 39(4), 267-272, 19292881.

Æ Chai, S. C. et al. (2008). The role of vitamin E in reversing bone loss. AgingU Clin Exp Res,U 20(6), 521-527, 19179835. Æ Chitra, S. & Shyamala Devi, C. S. (2008). Effect of alpha-tocopherol on pro-oxidant and antioxidant enzyme status

in radiation-treated oral squamous cell carcinoma. IndianU J Med Sci,U 62(4), 141-148, 18445980. Æ Cho, J. Y. et al. (2009). Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism

upon PXR activation. JU Lipid Res,U 50(5), 924-937, 19141872. Æ Comitato, R. et al. (2009). A novel mechanism of natural vitamin E tocotrienol activity: involvement of ERbeta

signal transduction. AmU J Physiol Endocrinol Metab,U 297(2), E427-437, 19491296. Æ Dalgard, C. et al. (2009). Supplementation with orange and blackcurrant juice, but not vitamin E, improves

inflammatory markers in patients with peripheral arterial disease. BrU J Nutr,U 101(2), 263-269, 18507878. GVF-Update | Annual 2009 | 18

Æ Das, S. et al. (2009). Oxidative stress in the brain of nicotine-induced toxicity: protective role of Andrographis

paniculata Nees and vitamin E. ApplU Physiol Nutr Metab,U 34(2), 124-135, 19370042. Æ Dong, L. F. et al. (2009). Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires

respiratory complex II. ClinU Cancer Res,U 15(5), 1593-1600, 19223492. Æ Dotan, Y. et al. (2009). Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E

does more harm than good. ArteriosclerU Thromb Vasc Biol,U 29(9), 1304-1309, 19286632.

Æ Dysken, M. W. et al. (2009). Changes in vitamin E prescribing for Alzheimer patients. AmU J Geriatr Psychiatry,U 17(7), 621-624, 19546657.

Æ Engin, K. N. (2009). Alpha-tocopherol: looking beyond an antioxidant. MolU Vis,U 15, 855-860, 19390643.

Æ Foote, J. A. et al. (2009). Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol. CancerU

Prev Res (Phila Pa),U 2(4), 394-400, 19336724.

Æ Forte, A. et al. (2008). Dietary chemoprevention of colorectal cancer. AnnU Ital Chir,U 79(4), 261-267, 19093628. Æ Freiser, H. & Jiang, Q. (2009). Optimization of the enzymatic hydrolysis and analysis of plasma conjugated

gamma-CEHC and sulfated long-chain carboxychromanols, metabolites of vitamin E. UAnal Biochem,U 388(2), 260-265, 19250920.

Æ Fukuzawa, K. (2008). Dynamics of lipid peroxidation and antioxidion of alpha-tocopherol in membranes. JU Nutr

Sci Vitaminol (Tokyo),U 54(4), 273-285, 18797148.

Æ Gagne, A. et al. (2009). Absorption, transport, and bioavailability of vitamin e and its role in pregnant women. JU

Obstet Gynaecol Can,U 31(3), 210-217, 19416566. Æ Gaziano, J. M. et al. (2009). Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians'

Health Study II randomized controlled trial. JamaU ,U 301(1), 52-62, 19066368. Æ Gerner, P. et al. (2008). Vitamin E treatment for children with chronic hepatitis B: a randomized placebo

controlled trial. WorldU J Gastroenterol,U 14(47), 7208-7213, 19084935. Æ Gerss, J. & Kopcke, W. (2009). The questionable association of vitamin E supplementation and mortality--

inconsistent results of different meta-analytic approaches. CellU Mol Biol (Noisy-le-grand),U 55 Suppl, OL1111-1120, 19267994.

Æ Ghosh, S. P. et al. (2009). Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. IntU J Radiat Biol,U 85(7), 598-606, 19557601. Æ Gill, J. K. et al. (2009). Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in

serum or urine with prostate cancer risk: the multiethnic cohort. CancerU Causes Control,U 20(7), 1161-1171, 19212706. Æ Giraud, D. W. et al. (2008). Vitamin E inadequacy observed in a group of 2- to 6-year-old children living in

Kwangju, Republic of Korea. IntU J Vitam Nutr Res,U 78(3), 148-155, 19003737. Æ Goldblum, D. et al. (2009). Dietary tocopherol supplementation after trabeculectomy and phacotrabeculectomy:

double-blind randomized placebo-controlled trial. OphthalmologicaU ,U 223(4), 228-232, 19246952. Æ Graf, R. et al. (2009). Lipophilic prodrugs of amino acids and vitamin E as osmolytes for the compensation of

hyperosmotic stress in human keratinocytes. ExpU Dermatol,U 18(4), 370-377, 19054053. Æ Grammer, T. B. et al. (2009). SOD3 R231G polymorphism associated with coronary artery disease and myocardial

infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. UFree Radic Res,U 43(7), 677-684, 19526392. Æ Guo, W. et al. (2007). Alpha-Tocopherol counteracts ritonavir-induced proinflammatory cytokines expression in

differentiated THP-1 cells. BiofactorsU ,U 31(3-4), 171-179, 18997280. Æ Gutierrez, A. D. et al. (2009). The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin

C. MetabolismU ,U 58(4), 469-478, 19303966. Æ Hahn, T. et al. (2009). Orally active alpha-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of

spontaneous murine breast cancer. MolU Cancer Ther,U 8(6), 1570-1578, 19509249. Æ Hamdy, N. M. et al. (2009). Influence of vitamin E supplementation on endothelial complications in type 2

diabetes mellitus patients who underwent coronary artery bypass graft. JU Diabetes Complications,U 23(3), 167-173, 18413198. GVF-Update | Annual 2009 | 19

Æ Hatfield, D. L. & Gladyshev, V. N. (2009). The Outcome of Selenium and Vitamin E Cancer Prevention Trial

(SELECT) reveals the need for better understanding of selenium biology. MolU Interv,U 9(1), 18-21, 19299660. Æ Helbig, D. et al. (2009). Blackcurrant seed press residue increases tocopherol concentrations in serum and stool

whilst biomarkers in stool and urine indicate increased oxidative stress in human subjects. BrU J Nutr,U 102(4), 554-562, 19302719. Æ Hemila, H. & Kaprio, J. (2008). Vitamin E supplementation may transiently increase tuberculosis risk in males who

smoke heavily and have high dietary vitamin C intake. BrU J Nutr,U 100(4), 896-902, 18279551. Æ Hemila, H. & Kaprio, J. (2009). Modification of the effect of vitamin E supplementation on the mortality of male

smokers by age and dietary vitamin C. AmU J Epidemiol,U 169(8), 946-953, 19218294. Æ Huang, P. H. et al. (2009). alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of

androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis. CarcinogenesisU ,U 30(7), 1125-1131, 19420015. Æ Huebbe, P. et al. (2009). Alpha-tocopherol transport in the lung is affected by the apoE genotype--studies in

transgenic apoE3 and apoE4 mice. IUBMBU Life,U 61(4), 453-456, 19319970. Æ Jacquemin, E. et al. (2009). Bioavailability of oral vitamin E formulations in adult volunteers and children with

chronic cholestasis or cystic fibrosis. JU Clin Pharm Ther,U 34(5), 515-522, 19744007. Æ Jiang, Q. et al. (2008). Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of

cyclooxygenases. ProcU Natl Acad Sci U S A,U 105(51), 20464-20469, 19074288. Æ Jofre-Monseny, L. et al. (2008). Influence of apolipoprotein E genotype and dietary alpha-tocopherol on redox

status and C-reactive protein levels in apolipoprotein E3 and E4 targeted replacement mice. BrU J Nutr,U 100(1), 44-53, 18179727. Æ Kang, J. H. et al. (2009). Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk

of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study. CirculationU ,U 119(21), 2772- 2780, 19451353.

Æ Kara, B. et al. (2008). Ataxia with vitamin E deficiency associated with deafness. TurkU J Pediatr,U 50(5), 471-475, 19102053. Æ Karlson, E. W. et al. (2008). Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health

Study. ArthritisU Rheum,U 59(11), 1589-1595, 18975365. Æ Khanduja, K. L. et al. (2008). Enhancement in alpha-tocopherol succinate-induced apoptosis by all-trans-retinoic

acid in primary leukemic cells: role of antioxidant defense, Bax and c-myc. MolU Cell Biochem,U 319(1-2), 133- 139, 18642056. Æ Krcmova, L. et al. (2009). HPLC method for simultaneous determination of retinoids and tocopherols in human

serum for monitoring of anticancer therapy. JU Sep Sci,U 32(15-16), 2804-2811, 19606446. Æ Kuhad, A. & Chopra, K. (2009). Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB

signaling pathway. LifeU Sci,U 84(9-10), 296-301, 19162042. Æ Kuryanova, E. V. (2009). Heart rate variability in outbred white rats upon periodical alpha-tocopherol

administration. UBull Exp Biol Med,U 147(2), 173-176, 19513414. Æ Lee, H. J. et al. (2009). Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and

activating PPAR-gamma. ClinU Cancer Res,U 15(12), 4242-4249, 19509159.

Æ Liang, D. et al. (2008). Plasma vitamins E and A and risk of bladder cancer: a case-control analysis. CancerU Causes

Control,U 19(9), 981-992, 18478342. Æ Lippman, S. M. et al. (2009). Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the

Selenium and Vitamin E Cancer Prevention Trial (SELECT). JamaU ,U 301(1), 39-51, 19066370. Æ Lloret, A. et al. (2009). Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may

even be detrimental. JU Alzheimers Dis,U 17(1), 143-149, 19494439. Æ Mafra, D. et al. (2009). Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein

concentration [LDL(-)] in haemodialysis patients. NephrolU Dial Transplant,U 24(5), 1587-1592, 19176686. Æ Marko, M. G. et al. (2009). Vitamin E reverses impaired linker for activation of T cells activation in T cells from aged

C57BL/6 mice. JU Nutr,U 139(6), 1192-1197, 19403707. GVF-Update | Annual 2009 | 20

Æ Mirbagheri, S. A. et al. (2008). Rectal administration of d-alpha tocopherol for active ulcerative colitis: a

preliminary report. WorldU J Gastroenterol,U 14(39), 5990-5995, 18932276. Æ Miwa, K. & Fujita, M. (2009). Increased oxidative stress suggested by low serum vitamin E concentrations in

patients with chronic fatigue syndrome. IntU J Cardiol,U 136(2), 238-239, 18684522. Æ Mukai, K. et al. (2008). Comparison between the free-radical-scavenging activities with vitamin E and ubiquinol in

biological systems based on their reaction rates: a research account. BiofactorsU ,U 32(1-4), 49-58, 19096100. Æ Mustacich, D. J. et al. (2009). Alpha-tocopherol modulates genes involved in hepatic xenobiotic pathways in

mice. JU Nutr Biochem,U 20(6), 469-476, 18789671. Æ Nadeem, A. et al. (2008). Effect of vitamin E supplementation with standard treatment on oxidant-antioxidant

status in chronic obstructive pulmonary disease. IndianU J Med Res,U 128(6), 705-711, 19246793.

Æ Nalbant, O. et al. (2009). Vitamin E and aerobic exercise: effects on physical performance in older adults. AgingU

Clin Exp Res,U 21(2), 111-121, 19448382. Æ Nanayakkara, P. W. et al. (2009). Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration

in mild to moderate CKD. AmU J Kidney Dis,U 53(1), 41-50, 18786751. Æ Nayeem, F. et al. (2009). Dietary beta-tocopherol and linoleic acid, serum insulin, and waist circumference predict

circulating sex hormone-binding globulin in premenopausal women. JU Nutr,U 139(6), 1135-1142, 19339706. Æ Nouri-Majalan, N. et al. (2009). Effects of allopurinol and vitamin E on renal function in patients with cardiac

coronary artery bypass grafts. VascU Health Risk Manag,U 5(2), 489-494, 19554089.

Æ Ogbonna, J. C. (2009). Microbiological production of tocopherols: current state and prospects. ApplU Microbiol

Biotechnol,U 84(2), 217-225, 19582447.

Æ Palm, M. et al. (2009). F(2)-isoprostanes, tocopherols and normal pregnancy. FreeU Radic Res,U 43(6), 546-552, 19384749. Æ Park, S. et al. (2009). Synergic effects of alpha-tocopherol and beta-carotene on tert-butylhydroperoxide-induced

HepG2 cell injury. ToxicolU Ind Health,U 25(4-5), 311-320, 19651802.

Æ Peralta, E. A. et al. (2009). Vitamin E increases biomarkers of estrogen stimulation when taken with tamoxifen. JU

Surg Res,U 153(1), 143-147, 18468636. Æ Pfeifer, W. P. et al. (2008). Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia.

ActaU Haematol,U 120(4), 225-231, 19218790. Æ Radhakrishnan, A. K. et al. (2009). Daily supplementation of tocotrienol-rich fraction or alpha-tocopherol did not

induce immunomodulatory changes in healthy human volunteers. BrU J Nutr,U 101(6), 810-815, 18702848. Æ Rizzo, M. R. et al. (2008). Evidence for anti-inflammatory effects of combined administration of vitamin E and C in

older persons with impaired fasting glucose: impact on insulin action. JU Am Coll Nutr,U 27(4), 505-511, 18978171. Æ Royer, M. C. et al. (2009). 7-ketocholesterol incorporation into sphingolipid/cholesterol-enriched (lipid raft)

domains is impaired by vitamin E: a specific role for alpha-tocopherol with consequences on cell death. JU

Biol Chem,U 284(23), 15826-15834, 19351882. Æ Sausenthaler, S. et al. (2009). Vitamin E intake in relation to allergic sensitization and IgE serum concentration.

CentU Eur J Public Health,U 17(2), 79-85, 19662825. Æ Sheridan, P. A. & Beck, M. A. (2009). The dendritic and T cell responses to herpes simplex virus-1 are modulated

by dietary vitamin E. FreeU Radic Biol Med,U 46(12), 1581-1588, 19303435. Æ Simila, M. E. et al. (2009). Glycaemic index database for the epidemiological Alpha-Tocopherol, Beta-Carotene

Cancer Prevention (ATBC) Study. BrU J Nutr,U 101(9), 1400-1405, 18814805. Æ Smedts, H. P. et al. (2009). High maternal vitamin E intake by diet or supplements is associated with congenital

heart defects in the offspring. BjogU ,U 116(3), 416-423, 19187374. Æ Stolzenberg-Solomon, R. Z. et al. (2009). Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a

cohort of male smokers. AmU J Clin Nutr,U 89(2), 584-591, 19116326. Æ Sultana, N. et al. (2008). Role of vitamin E supplementation on serum levels of copper and zinc in hemolytic

anemic patients with G6PD deficiency. MymensinghU Med J,U 17(2 Suppl), S84-90, 18946458. GVF-Update | Annual 2009 | 21

Æ Takahashi, T. et al. (2009). Effect of vitamin E treatment on progressive cognitive impairment in a patient with

adult-onset ataxia: a case report. ProgU Neuropsychopharmacol Biol Psychiatry,U 33(1), 150-152, 18773933. Æ Takeshita, K. et al. (2009). Preventive effect of alpha-tocopherol and glycyrrhizin against platelet-neutrophil

complex formation induced by hemodialysis membranes. IntU J Artif Organs,U 32(5), 282-290, 19569037.

Æ Then, S. M. et al. (2009). Is vitamin E toxic to neuron cells? CellU Mol Neurobiol,U 29(4), 485-496, 19172392.

Æ Traber, M. G. (2008). Vitamin E and K interactions--a 50-year-old problem. NutrU Rev,U 66(11), 624-629, 19019024. Æ Tsakiris, S. et al. (2009). Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum

paraoxonase 1/arylesterase activities in healthy individuals. EurU J Clin Nutr,U 63(2), 215-221, 17882129. Æ Turanek, J. et al. (2009). Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological

profile and anticancer effect against spontaneous breast carcinomas in mice. ToxicolU Appl Pharmacol,U 237(3), 249-257, 19480910. Æ Vejux, A. et al. (2009). Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are

vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. JU Nutr Biochem,U 20(1), 45-61, 18495460.

Æ Wada, S. (2009). Chemoprevention of tocotrienols: the mechanism of antiproliferative effects. ForumU Nutr,U 61, 204-216, 19367124. Æ Wali, V. B. et al. (2009). Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle

arrest in G1. ExpU Biol Med (Maywood),U 234(6), 639-650, 19359655. Æ Wang, J. S. et al. (2009). Vitamin E suppresses enhancement of factor VIII-dependent thrombin generation by

systemic hypoxia. StrokeU ,U 40(2), 656-659, 18948612. Æ Watters, J. L. et al. (2009). Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer

survival. CancerU Res,U 69(9), 3833-3841, 19383902. Æ Weber, S. U. et al. (2008). Low serum alpha-tocopherol and selenium are associated with accelerated apoptosis in

severe sepsis. BiofactorsU ,U 33(2), 107-119, 19346586. Æ Williamson, R. et al. (2008). Adverse radiation effects after radiosurgery may benefit from oral vitamin E and

pentoxifylline therapy: a pilot study. StereotactU Funct Neurosurg,U 86(6), 359-366, 18854663.

Æ Wood, L. G. et al. (2008). Oxidized vitamin E and glutathione as markers of clinical status in asthma. ClinU Nutr,U 27(4), 579-586, 18234400. Æ Xiang, J. et al. (2008). Sex and seasonal variations of plasma retinol, alpha-tocopherol, and carotenoid

concentrations in Japanese dietitians. AsianU Pac J Cancer Prev,U 9(3), 413-416, 18990012. Æ Yap, W. N. et al. (2008). Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through

multiple-signalling pathways. BrU J Cancer,U 99(11), 1832-1841, 19002171. Æ Yin, Y. et al. (2009). RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer

without overt side effects. ClinU Cancer Res,U 15(1), 190-200, 19118046. Æ Zhao, Y. et al. (2009). Vitamin E analogues as mitochondria-targeting compounds: from the bench to the

bedside? MolU Nutr Food Res,U 53(1), 129-139, 19072740. Æ Zingg, J. M. et al. (2008). Characterization of three human sec14p-like proteins: alpha-tocopherol transport

activity and expression pattern in tissues. BiochimieU ,U 90(11-12), 1703-1715, 18725265.

Vitamin K

Æ Acharya, B. R. et al. (2009). Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel

mechanism of its antiproliferative activity. BiochemistryU ,U 48(29), 6963-6974, 19527023. Æ Adame, N. & Carpenter, S. L. (2009). Closing the loophole: midwives and the administration of vitamin K in

neonates. JU Pediatr,U 154(5), 769-771, 19364563.

Æ Aiyagari, V. & Testai, F. D. (2009). Correction of coagulopathy in warfarin associated cerebral hemorrhage. UCurr

Opin Crit Care,U 15(2), 87-92, 19300085. GVF-Update | Annual 2009 | 22

Æ Akiyoshi, T. et al. (2009). The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the

mitochondria-related apoptotic pathway. CancerU Chemother Pharmacol,U 65(1), 143-150, 19449007. Æ Binkley, N. et al. (2009). Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone

turnover, density, or geometry in healthy postmenopausal North American women. JU Bone Miner Res,U 24(6), 983-991, 19113922. Æ Blostein, M. et al. (2008). The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with

factor IX. HaemophiliaU ,U 14(5), 1063-1068, 18680528.

Æ Booth, S. L. (2009). Roles for vitamin K beyond coagulation. AnnuU Rev Nutr,U 29, 89-110, 19400704.

Æ Brenner, B. et al. (2009). Vitamin K-dependent coagulation factors deficiency. SeminU Thromb Hemost,U 35(4), 439- 446, 19598072.

Æ Cashman, K. D. & O'Connor, E. (2008). Does high vitamin K1 intake protect against bone loss in later life? NutrU

Rev,U 66(9), 532-538, 18752477. Æ Cheung, A. M. et al. (2008). Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial):

a randomized controlled trial. PLoSU Med,U 5(10), e196, 18922041. Æ Ciantelli, M. et al. (2009). Late vitamin K deficiency bleeding after intramuscular prophylaxis at birth: a case

report. JU Perinatol,U 29(2), 168-169, 19177046. Æ Crosier, M. D. et al. (2009). Association of sequence variations in vitamin K epoxide reductase and gamma-

glutamyl carboxylase genes with biochemical measures of vitamin K status. JU Nutr Sci Vitaminol (Tokyo),U 55(2), 112-119, 19436136. Æ de Assis, M. C. et al. (2009). Improved oral anticoagulation after a dietary vitamin k-guided strategy: a

randomized controlled trial. CirculationU ,U 120(12), 1115-1122, 1113 p following 1122, 19738137. Æ Denas, G. et al. (2009). Effectiveness and safety of a management protocol to correct over-anticoagulation with

oral vitamin K: a retrospective study of 1,043 cases. JU Thromb Thrombolysis,U 27(3), 340-347, 18338109. Æ Dentali, F. & Crowther, M. A. (2008). Management of excessive anticoagulant effect due to vitamin K antagonists.

HematologyU Am Soc Hematol Educ Program,U 266-270, 19074094. Æ Devignes, J. et al. (2009). [A case of cutaneous and mucous haemorrhage secondary to vitamin K deficiency in

hyperemesis gravidarum]. AnnU Fr Anesth Reanim,U 28(7-8), 697-700, 19592197. Æ Fewtrell, M. S. et al. (2008). Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic

fibrosis. JU Cyst Fibros,U 7(4), 307-312, 18178136. Æ Flato, U. A. et al. (2009). Spine subdural hematoma: a rare complication associated with vitamin K antagonist

(VKA). ArqU Bras Cardiol,U 92(1), e1-3, 19219255.

Æ Gast, G. C. et al. (2009). A high menaquinone intake reduces the incidence of coronary heart disease. NutrU Metab

Cardiovasc Dis,U 19(7), 504-510, 19179058. Æ Gentric, A. et al. (2009). [Indications of vitamin K antagonists and aspirin in the atrial fibrillation of the elderly].

RevU Med Interne,U 30(8), 671-677, 19095331. Æ Harden, C. L. et al. (2009a). Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the

American Academy of Neurology and American Epilepsy Society. NeurologyU ,U 73(2), 142-149, 19398680. Æ Harden, C. L. et al. (2009b). Management issues for women with epilepsy--focus on pregnancy (an evidence- based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy

of Neurology and the American Epilepsy Society. EpilepsiaU ,U 50(5), 1247-1255, 19507305. Æ Iwamoto, J. et al. (2009). Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in

patients with neurological diseases: meta-analysis of three randomized, controlled trials. ClinU Drug

Investig,U 29(7), 471-479, 19499964. Æ Iwamoto, J. et al. (2009). High-dose vitamin K supplementation reduces fracture incidence in postmenopausal

women: a review of the literature. NutrU Res,U 29(4), 221-228, 19410972. GVF-Update | Annual 2009 | 23

Æ Koitaya, N. et al. (2009). Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal

Japanese women. JU Nutr Sci Vitaminol (Tokyo)U, 55(1), 15-21, 19352059. Æ Koos, R. et al. (2009). Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic

valve calcification. ThrombU Haemost,U 101(4), 706-713, 19350115.

Æ Krueger, T. et al. (2009). Coagulation meets calcification: the vitamin K system. IntU J Artif Organs,U 32(2), 67-74, 19363777. Æ McCann, J. C. & Ames, B. N. (2009). Vitamin K, an example of triage theory: is micronutrient inadequacy linked to

diseases of aging? AmU J Clin Nutr,U 90(4), 889-907, 19692494. Æ McDonald, M. G. et al. (2009). CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers

of the V433M variant. MolU Pharmacol,U 75(6), 1337-1346, 19297519. Æ Nimptsch, K. et al. (2009). The association between dietary vitamin K intake and serum undercarboxylated

osteocalcin is modulated by vitamin K epoxide reductase genotype. BrU J Nutr,U 101(12), 1812-1820, 19025725. Æ Presse, N. et al. (2008). Low vitamin K intakes in community-dwelling elders at an early stage of Alzheimer's

disease. JU Am Diet Assoc,U 108(12), 2095-2099, 19027415. Æ Presse, N. et al. (2009). Validation of a semi-quantitative food frequency questionnaire measuring dietary vitamin

K intake in elderly people. JU Am Diet Assoc,U 109(7), 1251-1255, 19559145.

Æ Schurgers, L. J. et al. (2008). Matrix Gla-protein: the calcification inhibitor in need of vitamin K. ThrombU Haemost,U 100(4), 593-603, 18841280.

Æ Shea, M. K. et al. (2009). Genetic and non-genetic correlates of vitamins K and D. EurU J Clin Nutr,U 63(4), 458-464, 18030310. Æ Shea, M. K. et al. (2009). Vitamin K supplementation and progression of coronary artery calcium in older men and

women. AmU J Clin Nutr,U 89(6), 1799-1807, 19386744.

Æ Shearer, M. J. (2009). Vitamin K deficiency bleeding (VKDB) in early infancy. BloodU Rev,U 23(2), 49-59, 18804903. Æ Souri, M. et al. (2009). Unique secretion mode of human protein Z: its Gla domain is responsible for inefficient,

vitamin K-dependent and warfarin-sensitive secretion. BloodU ,U 113(16), 3857-3864, 19188667.

Æ Strople, J. et al. (2009). Prevalence of subclinical vitamin K deficiency in cholestatic liver disease. JU Pediatr

Gastroenterol Nutr,U 49(1), 78-84, 19502999. Æ Titapiwatanakun, R. et al. (2009). Novel splice site mutations in the gamma glutamyl carboxylase gene in a child

with congenital combined deficiency of the vitamin K-dependent coagulation factors (VKCFD). PediatrU

Blood Cancer,U 53(1), 92-95, 19340858. Æ Van Geest-Daalderop, J. H. et al. (2009). Improvement in the regulation of the vitamin K antagonist

acenocoumarol after a standard initial dose regimen: prospective validation of a prescription model. JU

Thromb Thrombolysis,U 27(2), 207-214, 18270659.

Æ van Summeren, M. J. et al. (2008). Vitamin K status is associated with childhood bone mineral content. BrU J Nutr,U 100(4), 852-858, 18279558. Æ van Summeren, M. J. et al. (2008). Extremes in vitamin K status of bone are related to bone ultrasound properties

in children with juvenile idiopathic arthritis. ClinU Exp Rheumatol,U 26(3), 484-491, 18578975. Æ Watzka, M. et al. (2009). Polymorphisms in VKORC1 and GGCX are not major genetic determinants of vitamin K-

dependent coagulation factor activity in Western Germans. ThrombU Haemost,U 102(2), 418-420, 19652895.

Æ Weston, B. W. & Monahan, P. E. (2008). Familial deficiency of vitamin K-dependent clotting factors. HaemophiliaU ,U 14(6), 1209-1213, 19141161. Æ Yoshida, M. et al. (2008). Effect of vitamin K supplementation on insulin resistance in older men and women.

DiabetesU Care,U 31(11), 2092-2096, 18697901. Æ Yoshiji, H. et al. (2009). Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates

cumulative recurrence of hepatocellular carcinoma. JU Hepatol,U 51(2), 315-321, 19501932.

GVF-Update | Annual 2009 | 24

Water-Soluble1B Vitamins

Biotin

Æ Bakkar, R. et al. (2008). Biotin-rich intranuclear inclusions: have you checked your immunohistochemical

controls? IntU J Surg Pathol,U 16(4), 424-425, 18611941. Æ Bindu, P. S. et al. (2009). Biotin-responsive basal ganglia disease: a treatable and reversible neurological disorder

of childhood. JU Child Neurol,U 24(6), 750-752, 19491117. Æ Bogusiewicz, A. et al. (2008). Biotin accounts for less than half of all biotin and biotin metabolites in the

cerebrospinal fluid of children. AmU J Clin Nutr,U 88(5), 1291-1296, 18996865.

Æ Chedrawi, A. K. et al. (2008). Profound biotinidase deficiency in a child with predominantly spinal cord disease. JU

Child Neurol,U 23(9), 1043-1048, 18645204. Æ El-Hajj, T. I. et al. (2008). Biotin-responsive basal ganglia disease: case report and review of the literature.

NeuropediatricsU ,U 39(5), 268-271, 19294600. Æ Mock, D. M. (2009). Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic

in mice. JU Nutr,U 139(1), 154-157, 19056637.

Æ Said, H. M. (2009). Cell and molecular aspects of human intestinal biotin absorption. JU Nutr,U 139(1), 158-162, 19056639.

Æ Weber, W. et al. (2009). A biotin-triggered genetic switch in mammalian cells and mice. MetabU Eng,U 11(2), 117- 124, 19271268. Æ Yokoi, K. et al. (2009). A case of holocarboxylase synthetase deficiency with insufficient response to prenatal

biotin therapy. BrainU Dev,U 31(10), 775-778, 19201116.

Æ Zempleni, J. et al. (2009). Biotin. BiofactorsU ,U 35(1), 36-46, 19319844.

B-Vitamins

Æ Ally, M. S. et al. (2009). The relationship between gene-specific DNA methylation in leukocytes and normal

colorectal mucosa in subjects with and without colorectal tumors. CancerU Epidemiol Biomarkers Prev,U 18(3), 922-928, 19258481. Æ Almeida, L. C. et al. (2008). [Socio-demographic, lifestyle, gynecological, and obstetric predictors of serum or plasma concentrations of homocysteine, folic acid, and vitamins B12 and B6 among low-income women

in Sao Paulo, Brazil]. CadU Saude Publica,U 24(3), 587-596, 18327446. Æ Berker, B. et al. (2009). Homocysteine concentrations in follicular fluid are associated with poor oocyte and

embryo qualities in polycystic ovary syndrome patients undergoing assisted reproduction. HumU Reprod,U 24(9), 2293-2302, 19443458. Æ Bialecka, M. et al. (2009). Genetic and environmental factors for hyperhomocysteinaemia and its clinical

implications in Parkinson's disease. NeurolU Neurochir Pol,U 43(3), 272-285, 19618311. Æ Biswas, A. et al. (2009). Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian

Indians. JU Stroke Cerebrovasc Dis,U 18(2), 103-110, 19251185. Æ Borgia, G. et al. (2009). Homocysteine levels and sustained virological response to pegylated-interferon alpha2b

plus ribavirin therapy for chronic hepatitis C: a prospective study. LiverU Int,U 29(2), 248-252, 18662278. Æ Boxmeer, J. C. et al. (2008). Homocysteine metabolism in the pre-ovulatory follicle during ovarian stimulation.

HumU Reprod,U 23(11), 2570-2576, 18664470. Æ Brady, C. B. et al. (2009). Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study.

AmU J Kidney Dis,U 54(3), 440-449, 19628319.

Æ Cakmak, S. K. et al. (2009). Homocysteine, vitamin B12 and folic acid levels in psoriasis patients. JU Eur Acad

Dermatol Venereol,U 23(3), 300-303, 19207655. GVF-Update | Annual 2009 | 25

Æ Camicioli, R. M. et al. (2009). Homocysteine is not associated with global motor or cognitive measures in

nondemented older Parkinson's disease patients. MovU Disord,U 24(2), 176-182, 18951534. Æ Carmichael, S. L. et al. (2009). Nutrient pathways and neural tube defects: a semi-Bayesian hierarchical analysis.

EpidemiologyU ,U 20(1), 67-73, 19234400. Æ Casais, P. et al. (2009). Pilot study of homocysteine and cysteine in patients with thrombosis in different vascular

sites. Epidemiology and response to folate. ThrombU Res,U 123(4), 592-596, 18511109. Æ Cascalheira, J. F. et al. (2009). Serum homocysteine: interplay with other circulating and genetic factors in

association to Alzheimer's type dementia. ClinU Biochem,U 42(9), 783-790, 19232336. Æ Castro, L. & Goldani, L. Z. (2009). Iron, folate and vitamin B12 parameters in HIV-1 infected patients with anaemia

in southern Brazil. TropU Doct,U 39(2), 83-85, 19299288. Æ de Vogel, S. et al. (2008). Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal

cancer. JU Nutr,U 138(12), 2372-2378, 19022960. Æ del Rio Garcia, C. et al. (2009). Maternal MTHFR 677C>T genotype and dietary intake of folate and vitamin B(12):

their impact on child neurodevelopment. NutrU Neurosci,U 12(1), 13-20, 19178787. Æ Dhonukshe-Rutten, R. A. et al. (2009). Dietary intake and status of folate and vitamin B12 and their association

with homocysteine and cardiovascular disease in European populations. EurU J Clin Nutr,U 63(1), 18-30, 17851461.

Æ Dias, V. V. et al. (2009). Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. JU

Affect Disord,U 113(3), 285-290, 18579214. Æ Ducros, V. et al. (2009). Zinc supplementation does not alter plasma homocysteine, vitamin B12 and red blood

cell folate concentrations in French elderly subjects. JU Trace Elem Med Biol,U 23(1), 15-20, 19203712. Æ Eussen, S. J. et al. (2008). Changes in markers of cobalamin status after cessation of oral B-vitamin supplements in

elderly people with mild cobalamin deficiency. EurU J Clin Nutr,U 62(10), 1248-1251, 17609694. Æ Felkner, M. et al. (2009). Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border

population. BirthU Defects Res A Clin Mol TeratolU, 85(6), 574-581, 19180649. Æ Figueiredo, J. C. et al. (2009). Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle

characteristics and dietary and genetic factors. CancerU Epidemiol Biomarkers Prev,U 18(4), 1041-1049, 19336559. Æ Figueiredo, J. C. et al. (2008). Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial

of aspirin use and folic acid supplementation. CancerU Epidemiol Biomarkers Prev,U 17(8), 2136-2145, 18708408. Æ Galvan-Portillo, M. V. et al. (2009). Gastric cancer in relation to the intake of nutrients involved in one-carbon

metabolism among MTHFR 677 TT carriers. EurU J Nutr,U 48(5), 269-276, 19288150. Æ Ganji, V. & Kafai, M. R. (2009). Demographic, lifestyle, and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-

2004. JU Nutr,U 139(2), 345-352, 19106325. Æ Garza, A. F. et al. (2008). A pilot study of the effect of diclofenac with B vitamins for the treatment of acute pain

following lower-limb fracture and surgery. ProcU West Pharmacol Soc,U 51, 70-72, 19544682. Æ Gibson, A. et al. (2008). Alcohol increases homocysteine and reduces B vitamin concentration in healthy male

volunteers--a randomized, crossover intervention study. QjmU ,U 101(11), 881-887, 18790817. Æ Guven, M. A. et al. (2009). Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and

vitamin B12 levels with the severity of preeclampsia and fetal birth weight. HypertensU Pregnancy,U 28(2), 190-200, 19437229. Æ Hadithi, M. et al. (2009). Effect of B vitamin supplementation on plasma homocysteine levels in celiac disease.

WorldU J Gastroenterol,U 15(8), 955-960, 19248194. Æ Heinz, J. et al. (2009). Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a

meta-analysis. AmU J Kidney Dis,U 54(3), 478-489, 19359080. Æ Hengstermann, S. et al. (2008). Total serum homocysteine levels do not identify cognitive dysfunction in

multimorbid elderly patients. JU Nutr Health Aging,U 12(6), 411-416, 18548180. GVF-Update | Annual 2009 | 26

Æ Hengstermann, S. et al. (2009). [Does an association between increased homocystein levels and cognitive

dysfunction also exist in multimorbid geriatric patients]. ZU Gerontol Geriatr,U 42(2), 131-136, 18535757. Æ Hoey, L. et al. (2009). Studies of biomarker responses to intervention with vitamin B-12: a systematic review of

randomized controlled trials. AmU J Clin Nutr,U 89(6), 1981S-1996S, 19403638. Æ Holstein, J. H. et al. (2009). Low serum folate and vitamin B-6 are associated with an altered cancellous bone

structure in humans. AmU J Clin Nutr,U 90(5), 1440-1445, 19759168. Æ Horvath, B. et al. (2009). Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with

vascular diseases. ClinU Hemorheol Microcirc,U 42(1), 19-28, 19363237.

Æ Hure, A. et al. (2009). Diet and pregnancy status in Australian women. PublicU Health Nutr,U 12(6), 853-861, 18647425.

Æ Idzior-Walus, B. et al. (2008). Total plasma homocysteine correlates in women with gestational diabetes. UArch

Gynecol Obstet,U 278(4), 309-313, 18236055. Æ Johansson, M. et al. (2009). One-carbon metabolism and prostate cancer risk: prospective investigation of seven

circulating B vitamins and metabolites. CancerU Epidemiol Biomarkers Prev,U 18(5), 1538-1543, 19423531. Æ Joo, J. G. (2009). Recent perspectives on the genetic background of neural tube defects with special regard to

iniencephaly. ExpertU Rev Mol Diagn,U 9(3), 281-293, 19379086. Æ Joubert, L. M. & Manore, M. M. (2008). The role of physical activity level and B-vitamin status on blood

homocysteine levels. MedU Sci Sports Exerc,U 40(11), 1923-1931, 18845970.

Æ Kalita, J. et al. (2009). Relationship of homocysteine with other risk factors and outcome of ischemic stroke. ClinU

Neurol Neurosurg,U 111(4), 364-367, 19185985. Æ Kamphuis, M. H. et al. (2008). Dietary intake of B(6-9-12) vitamins, serum homocysteine levels and their

association with depressive symptoms: the Zutphen Elderly Study. EurU J Clin Nutr,U 62(8), 939-945, 17538543. Æ Kang, J. H. et al. (2008). A trial of B vitamins and cognitive function among women at high risk of cardiovascular

disease. AmU J Clin Nutr,U 88(6), 1602-1610, 19064521. Æ Kasiman, K. et al. (2009). Ethnicity does not affect the homocysteine-lowering effect of B-vitamin therapy in

Singaporean stroke patients. StrokeU ,U 40(6), 2209-2211, 19372453.

Æ Kasperzyk, J. L. et al. (2009). One-carbon metabolism-related nutrients and prostate cancer survival. AmU J Clin

Nutr,U 90(3), 561-569, 19571228.

Æ Keith, M. E. et al. (2009). B-vitamin deficiency in hospitalized patients with heart failure. JU Am Diet Assoc,U 109(8), 1406-1410, 19631047. Æ Khandanpour, N. et al. (2009). Homocysteine and peripheral arterial disease: systematic review and meta-

analysis. EurU J Vasc Endovasc Surg,U 38(3), 316-322, 19560951. Æ Knoops, K. T. et al. (2009). Do dietary patterns in older men influence change in homocysteine through folate

fortification? The Normative Aging Study. PublicU Health Nutr,U 12(10), 1760-1766, 19105862. Æ Kocer, B. et al. (2009). Serum vitamin B12, folate, and homocysteine levels and their association with clinical and

electrophysiological parameters in multiple sclerosis. JU Clin Neurosci,U 16(3), 399-403, 19153046. Æ Kuwata, Y. et al. (2009). Serious adverse drug reaction in a woman with hyperemesis gravidarum after first

exposure to vitamin B complex containing vitamins B1, B6 and B12. JU Obstet Gynaecol Res,U 35(4), 790-793, 19751344. Æ Lanska, D. J. (2009). Chapter 30 Historical aspects of the major neurological vitamin deficiency disorders: the

water-soluble B vitamins. HandbU Clin Neurol,U 95, 445-476, 19892133. Æ Le Marchand, L. et al. (2009). Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study.

CancerU Epidemiol Biomarkers Prev,U 18(8), 2195-2201, 19661077. Æ Li, L. et al. (2008). Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in

patients with Alzheimer disease. DementU Geriatr Cogn Disord,U 26(4), 384-390, 18931498. GVF-Update | Annual 2009 | 27

Æ Lin, C. C. & Yin, M. C. (2009). Vitamins B depletion, lower iron status and decreased antioxidative defense in

patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin. ClinU Nutr,U 28(1), 34-38, 19042060. Æ Ma, E. et al. (2009). Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related

enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMCU Cancer,U 9, 122, 19389261. Æ Mager, A. et al. (2009). Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with

coronary artery disease. AmU J Cardiol,U 104(6), 745-749, 19733705. Æ Mandal, S. M. et al. (2009). Rapid determination of vitamin B2 and B12 in human urine by isocratic liquid

chromatography. AnalU Chim Acta,U 640(1-2), 110-113, 19362629. Æ Massi Lindsey, L. L. et al. (2009). Developing effective campaign messages to prevent neural tube defects: a

qualitative assessment of women's reactions to advertising concepts. JU Health Commun,U 14(2), 131-159, 19283538. Æ Matte, C. et al. (2009). Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in

brain and blood of rats: protective effect of folic acid. NeurochemU Int,U 54(1), 7-13, 18983880.

Æ Mooney, S. et al. (2009). Vitamin B6: a long known compound of surprising complexity. MoleculesU ,U 14(1), 329- 351, 19145213.

Æ Nacci, A. et al. (2008). Plasma homocysteine, folate, and vitamin B12 levels in patients with laryngeal cancer. ArchU

Otolaryngol Head Neck Surg,U 134(12), 1328-1333, 19075131. Æ Nenseter, M. S. et al. (2009). Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of

treatment with B-vitamins. StrokeU ,U 40(1), 241-247, 19008470. Æ Ng, T. P. et al. (2009). Folate, vitamin B12, homocysteine, and depressive symptoms in a population sample of

older Chinese adults. JU Am Geriatr Soc,U 57(5), 871-876, 19484842.

Æ Oncel, C. et al. (2009). Association between cholesterols, homocysteine and silent brain infarcts. InternU Med J,U 39(3), 150-155, 19383063. Æ Petronijevic, N. D. et al. (2008). Plasma homocysteine levels in young male patients in the exacerbation and

remission phase of schizophrenia. ProgU Neuropsychopharmacol Biol Psychiatry,U 32(8), 1921-1926, 18824063. Æ Pinto, E. et al. (2009). Dietary intake and nutritional adequacy prior to conception and during pregnancy: a

follow-up study in the north of Portugal. PublicU Health Nutr,U 12(7), 922-931, 18752697. Æ Potter, K. et al. (2009). Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-

controlled trial. CerebrovascU Dis,U 27(3), 259-265, 19202330. Æ Ratan, S. K. et al. (2008). Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents

and the affected neonates with neural tube defect and their matched controls. PediatrU Surg Int,U 24(7), 803- 808, 18463884.

Æ Righetti, M. (2009). Protective effect of vitamin B therapy on bone and cardiovascular disease. RecentU Pat

Cardiovasc Drug Discov,U 4(1), 37-44, 19149705. Æ Rodriguez-Oroz, M. C. et al. (2009). Homocysteine and cognitive impairment in Parkinson's disease: a

biochemical, neuroimaging, and genetic study. MovU Disord,U 24(10), 1437-1444, 19452554.

Æ Sanchez-Moreno, C. et al. (2009). Stroke: roles of B vitamins, homocysteine and antioxidants. NutrU Res Rev,U 22(1), 49-67, 19555518. Æ Sanchez-Villegas, A. et al. (2009). Association between folate, vitamin B(6) and vitamin B(12) intake and

depression in the SUN cohort study. JU Hum Nutr Diet,U 22(2), 122-133, 19175490. Æ Saposnik, G. et al. (2009). Homocysteine-lowering therapy and stroke risk, severity, and disability: additional

findings from the HOPE 2 trial. StrokeU ,U 40(4), 1365-1372, 19228852. Æ Sawula, W. et al. (2009). Homocysteine level and metabolism in ischemic stroke in the population of Northern

Poland. ClinU Biochem,U 42(6), 442-447, 19166826. GVF-Update | Annual 2009 | 28

Æ Scambi, C. et al. (2009). Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-

MTHF and vitamin B12 supplementation: a single arm trial. PLoSU One,U 4(3), e4782, 19277125. Æ Selhub, J. et al. (2009). Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and

biochemical indicators of vitamin B-12 deficiency. AmU J Clin Nutr,U 89(2), 702S-706S, 19141696. Æ Shargorodsky, M. et al. (2009). Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic

patients: which of them is really important in atherogenesis? DiabetesU Metab Res Rev,U 25(1), 70-75, 19065546. Æ Shrubsole, M. J. et al. (2009). Dietary B vitamin and methionine intakes and plasma folate are not associated with

colorectal cancer risk in Chinese women. CancerU Epidemiol Biomarkers Prev,U 18(3), 1003-1006, 19240230. Æ Shuaibi, A. M. et al. (2008). Validation of a food choice map with a 3-day food record and serum values to assess

folate and vitamin B-12 intake in college-aged women. JU Am Diet Assoc,U 108(12), 2041-2050, 19027407. Æ Siuda, J. et al. (2009). From mild cognitive impairment to Alzheimer's disease - influence of homocysteine,

vitamin B12 and folate on cognition over time: results from one-year follow-up. NeurolU Neurochir Pol,U 43(4), 321-329, 19742390. Æ Smedts, H. P. et al. (2008). Maternal intake of fat, riboflavin and nicotinamide and the risk of having offspring with

congenital heart defects. EurU J Nutr,U 47(7), 357-365, 18779918. Æ Song, Y. et al. (2009). Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2

diabetes in women: a randomized, controlled trial. DiabetesU ,U 58(8), 1921-1928, 19491213. Æ Stopper, H. et al. (2008). Reduction of the genomic damage level in haemodialysis patients by folic acid and

vitamin B12 supplementation. NephrolU Dial Transplant,U 23(10), 3272-3279, 18469307. Æ Takimoto, H. & Tamura, T. (2006). Increasing trend of spina bifida and decreasing birth weight in relation to

declining body-mass index of young women in Japan. MedU Hypotheses,U 67(5), 1023-1026, 16831522. Æ Tanaka, T. et al. (2009). Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine

blood concentrations. AmU J Hum Genet,U 84(4), 477-482, 19303062. Æ Tangney, C. C. et al. (2009). Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline.

NeurologyU ,U 72(4), 361-367, 19171834. Æ Tassino, M. et al. (2009). Homocysteine (Hcy) and cognitive performance in a population sample of elderly

Brazilians. ArchU Gerontol Geriatr,U 48(2), 142-145, 18221800. Æ Thomas, N. E. et al. (2008). Homocyst(e)ine, folate, and vitamin B12 status in a cohort of Welsh young people

aged 12-13 years old. ResU Sports Med,U 16(4), 233-243, 19089745. Æ Tsai, M. Y. et al. (2009). Polygenic association with total homocysteine in the post-folic acid fortification era: the

CARDIA study. MolU Genet Metab,U 98(1-2), 181-186, 19577940.

Æ Van Dam, F. & Van Gool, W. A. (2009). Hyperhomocysteinemia and Alzheimer's disease: A systematic review. ArchU

Gerontol Geriatr,U 48(3), 425-430, 18479766.

Æ Varela-Moreiras, G. et al. (2009). Cobalamin, folic acid, and homocysteine. NutrU Rev,U 67 Suppl 1, S69-72, 19453682. Æ Venta, R. et al. (2009). Plasma vitamins, amino acids, and renal function in postexercise hyperhomocysteinemia.

MedU Sci Sports Exerc,U 41(8), 1645-1651, 19568194. Æ Viswanathan, A. et al. (2009). Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke

Prevention (VISP) trial. NeurologyU ,U 72(3), 268-272, 19153374. Æ Vu, T. T. et al. (2009). Folate and vitamin B12 status of women of reproductive age living in Hanoi City and Hai

Duong Province of Vietnam. PublicU Health Nutr,U 12(7), 941-946, 18752693.

Æ Weinstein, S. J. et al. (2008). One-carbon metabolism biomarkers and risk of colon and rectal cancers. CancerU

Epidemiol Biomarkers Prev,U 17(11), 3233-3240, 18990766.

Æ Wright, A. D. et al. (2008). Homocysteine, folates, and the eye. EyeU ,U 22(8), 989-993, 18064053.

Æ Xu, X. & Chen, J. (2009). One-carbon metabolism and breast cancer: an epidemiological perspective. JU Genet

Genomics,U 36(4), 203-214, 19376481. GVF-Update | Annual 2009 | 29

Æ Zeisel, S. H. (2009). Importance of methyl donors during reproduction. AmU J Clin Nutr,U 89(2), 673S-677S, 19116320. Æ Zengin, E. et al. (2009). Clinical manifestations of infants with nutritional vitamin B deficiency due to maternal

dietary deficiency. ActaU Paediatr,U 98(1), 98-102, 18945280. Æ Zhang, T. et al. (2009). Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects

in the offspring in a high-risk area of China. PublicU Health Nutr,U 12(5), 680-686, 18547453. Æ Zoccolella, S. et al. (2009). Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease

dementia. MovU Disord,U 24(7), 1028-1033, 19353704.

Vitamin B1

Æ Agyei-Owusu, K. & Leeper, F. J. (2009). Thiamin diphosphate in biological chemistry: analogues of thiamin

diphosphate in studies of enzymes and riboswitches. FebsU J,U 276(11), 2905-2916, 19490097.

Æ Ba, A. (2008). Metabolic and structural role of thiamine in nervous tissues. CellU Mol Neurobiol,U 28(7), 923-931, 18642074. Æ Bautista-Hernandez, V. M. et al. (2008). Effect of thiamine pyrophosphate on levels of serum lactate, maximum

oxygen consumption and heart rate in athletes performing aerobic activity. JU Int Med Res,U 36(6), 1220- 1226, 19094430. Æ Bettendorff, L. & Wins, P. (2009). Thiamin diphosphate in biological chemistry: new aspects of thiamin

metabolism, especially triphosphate derivatives acting other than as cofactors. FebsU J,U 276(11), 2917-2925, 19490098.

Æ Borgna-Pignatti, C. et al. (2009). Thiamine-responsive megaloblastic anemia syndrome: long term follow-up. JU

Pediatr,U 155(2), 295-297, 19619756.

Æ Fattal-Valevski, A. et al. (2009). Delayed language development due to infantile thiamine deficiency. DevU Med

Child Neurol,U 51(8), 629-634, 19191836. Æ Francini-Pesenti, F. et al. (2009). Wernicke's syndrome during parenteral feeding: not an unusual complication.

NutritionU ,U 25(2), 142-146, 18929463.

Æ Ganesh, R. et al. (2009). Thiamine responsive megaloblastic anemia syndrome. IndianU J Pediatr,U 76(3), 313-314, 19347672.

Æ Jurgenson, C. T. et al. (2009). The structural and biochemical foundations of thiamin biosynthesis. AnnuU Rev

Biochem,U 78, 569-603, 19348578. Æ Korner, R. W. et al. (2009). Determination of thiamin diphosphate in whole blood samples by high-performance

liquid chromatography--a method suitable for pediatric diagnostics. JU Chromatogr B Analyt Technol

Biomed Life Sci,U 877(20-21), 1882-1886, 19487165. Æ Masumoto, K. et al. (2009). Need for thiamine in peripheral parenteral nutrition after abdominal surgery in

children. JPENU J Parenter Enteral Nutr,U 33(4), 417-422, 19342609.

Æ Mathews, L. et al. (2009). Thiamine responsive megaloblastic anemia. IndianU Pediatr,U 46(2), 172-174, 19242038. Æ Naeem, M. A. et al. (2008). A rare case of thiamine-responsive megaloblastic anaemia syndrome: a disorder of

high-affinity thiamine transport. JU Ayub Med Coll Abbottabad,U 20(3), 146-148, 19610542. Æ Ogihara, T. et al. (2009). Use of thiamine in the treatment of post-electroconvulsive therapy delirium.

PharmacopsychiatryU ,U 42(1), 36-37, 19153946. Æ Onal, H. et al. (2009). Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing

deafness. TurkU J Pediatr,U 51(3), 301-304, 19817279. Æ Rabbani, N. et al. (2009). High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a

randomised, double-blind placebo-controlled pilot study. DiabetologiaU ,U 52(2), 208-212, 19057893. Æ Tasevska, N. et al. (2008). Twenty-four-hour urinary thiamine as a biomarker for the assessment of thiamine

intake. EurU J Clin Nutr,U 62(9), 1139-1147, 17565356. GVF-Update | Annual 2009 | 30

Æ Tinsa, F. et al. (2009). Unusual case of thiamine responsive megaloblastic anemia. TunisU Med,U 87(2), 159-163, 19522453. Æ Wong, C. Y. et al. (2008). Daily intake of thiamine correlates with the circulating level of endothelial progenitor

cells and the endothelial function in patients with type II diabetes. MolU Nutr Food Res,U 52(12), 1421-1427, 18925614. Æ Yesilkaya, E. et al. (2009). A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive

megaloblastic anemia syndrome. JU Trop Pediatr,U 55(4), 265-267, 18614593.

Vitamin B2

Æ Apelt, N. et al. (2009). ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular

risk in the obese. MetabolismU ,U 58(10), 1415-1423, 19570551.

Æ Condo, M. et al. (2009). Riboflavin prophylaxis in pediatric and adolescent migraine. JU Headache Pain,U 10(5), 361- 365, 19649688. Æ Di Lorenzo, C. et al. (2009). Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in

migraineurs. NeurologyU ,U 72(18), 1588-1594, 19414726. Æ Hill, M. H. et al. (2009). Study Protocol: randomised controlled trial to investigate the functional significance of

marginal riboflavin status in young women in the UK (RIBOFEM). BMCU Public Health,U 9, 90, 19323801.

Æ Hoey, L. et al. (2009). Studies of biomarker responses to intervention with riboflavin: a systematic review. AmU J

Clin Nutr,U 89(6), 1960S-1980S, 19403631. Æ Hoyer, A. et al. (2009). [Collagen cross-linking with riboflavin and UVA light in keratoconus. Results from

Dresden]. OphthalmologeU ,U 106(2), 133-140, 18604541. Æ Law, L. K. et al. (2009). Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple

acyl-CoA dehydrogenase deficiency. ClinU Chim Acta,U 404(2), 95-99, 19265687.

Æ Yazdanpanah, B. et al. (2009). Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. NatureU ,U 460(7259), 1159-1163, 19641494.

Vitamin B6

Æ Basura, G. J. et al. (2009). Clinical features and the management of pyridoxine-dependent and pyridoxine-

responsive seizures: review of 63 North American cases submitted to a patient registry. EurU J Pediatr,U 168(6), 697-704, 18762976. Æ Czeizel, A. E. et al. (2004). Oral pyridoxine during pregnancy : potential protective effect for cardiovascular

malformations. UDrugs R D,U 5(5), 259-269, 15357625. Æ Garcia-Lopez, R. et al. (2009). New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of

magnesium and vitamin B6. TrialsU ,U 10, 16, 19284553.

Æ Koul, R. (2009). Pyridoxine-dependent seizures: 10-year follow-up of eight cases. NeurolU India,U 57(4), 460-463, 19770548. Æ Lamers, Y. et al. (2009). Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate

without affecting red blood cell or plasma glutathione concentrations in healthy men and women. AmU J

Clin Nutr,U 90(2), 336-343, 19515736.

Æ Lee, J. E. et al. (2009). Prospective study of plasma vitamin B6 and risk of colorectal cancer in men. CancerU

Epidemiol Biomarkers Prev,U 18(4), 1197-1202, 19336555. Æ Major, P. et al. (2008). Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side

effects in children: preliminary results. EpilepsyU Behav,U 13(3), 557-559, 18647662. GVF-Update | Annual 2009 | 31

Æ Marszall, M. L. et al. (2009). Application of the high-performance liquid chromatography method with

coulometric detection for determination of vitamin B(6) in human plasma and serum. JU Chromatogr B

Analyt Technol Biomed Life Sci,U 877(27), 3151-3158, 19733133. Æ Matarese, L. E. et al. (2009). Pyridoxal-5'-phosphate deficiency after intestinal and multivisceral transplantation.

AmU J Clin Nutr,U 89(1), 204-209, 19056562.

Æ Merete, C. et al. (2008). Vitamin B6 is associated with depressive symptomatology in Massachusetts elders. JU Am

Coll Nutr,U 27(3), 421-427, 18838531.

Æ Page, J. H. et al. (2009). Plasma vitamin B(6) and risk of myocardial infarction in women. CirculationU ,U 120(8), 649- 655, 19667235.

Æ Plecko, B. & Stockler, S. (2009). Vitamin B6 dependent seizures. CanU J Neurol Sci,U 36 Suppl 2, S73-77, 19760909. Æ Rodriguez-Rodriguez, E. et al. (2008). Vitamin B6 status improves in overweight/obese women following a

hypocaloric diet rich in breakfast cereals, and may help in maintaining fat-free mass. IntU J Obes (Lond),U 32(10), 1552-1558, 18679411.

Æ Tan, P. C. et al. (2009). A placebo-controlled trial of oral pyridoxine in hyperemesis gravidarum. GynecolU Obstet

Invest,U 67(3), 151-157, 19077388. Æ Valle-Morales, L. et al. (2009). Epileptic status refractory to conventional treatment caused by vitamin B6

deficiency. JU Perinatol,U 29(3), 252-253, 19240731. Æ You, Q. et al. (2009). Vitamin B6 points PC6 injection during acupuncture can relieve nausea and vomiting in

patients with ovarian cancer. IntU J Gynecol Cancer,U 19(4), 567-571, 19509551.

Vitamin B12

Æ Allen, L. H. (2009). How common is vitamin B-12 deficiency? AmU J Clin Nutr,U 89(2), 693S-696S, 19116323.

Æ Andres, E. et al. (2008). Update on oral cyanocobalamin (vitamin B12) treatment in elderly patients. DrugsU Aging,U 25(11), 927-932, 18947260. Æ Arsenault, J. E. et al. (2009). Provision of a school snack is associated with vitamin B-12 status, linear growth, and

morbidity in children from Bogota, Colombia. UJ Nutr,U 139(9), 1744-1750, 19587125. Æ Bhate, V. et al. (2008). Vitamin B12 status of pregnant Indian women and cognitive function in their 9-year-old

children. FoodU Nutr Bull,U 29(4), 249-254, 19227049.

Æ Birch, C. S. et al. (2009). A novel role for vitamin B(12): Cobalamins are intracellular antioxidants in vitro. FreeU

Radic Biol Med,U 47(2), 184-188, 19409980. Æ Bozkurt, N. et al. (2009). The relationship of homocyteine, B12 and folic acid with the bone mineral density of the

femur and lumbar spine in Turkish postmenopausal women. ArchU Gynecol Obstet,U 280(3), 381-387, 19151987. Æ Chiu, Y. W. et al. (2009). Pharmacological dose of vitamin B12 is as effective as low-dose folinic acid in correcting

hyperhomocysteinemia of hemodialysis patients. RenU Fail,U 31(4), 278-283, 19462276.

Æ Dali-Youcef, N. & Andres, E. (2009). An update on cobalamin deficiency in adults. QjmU ,U 102(1), 17-28, 18990719.

Æ de Lau, L. M. et al. (2009). Plasma vitamin B12 status and cerebral white-matter lesions. JU Neurol Neurosurg

Psychiatry,U 80(2), 149-157, 18977824. Æ den Elzen, W. P. et al. (2008). Vitamin B12 and folate and the risk of anemia in old age: the Leiden 85-Plus Study.

ArchU Intern Med,U 168(20), 2238-2244, 19001201.

Æ El Otmani, H. et al. (2009). [Cobalamin deficiency: neurological aspects in 27 cases]. RevU Neurol (Paris),U 165(3), 263-267, 19056098. Æ Elmadfa, I. & Singer, I. (2009). Vitamin B-12 and homocysteine status among vegetarians: a global perspective.

AmU J Clin Nutr,U 89(5), 1693S-1698S, 19357223. Æ Feng, L. et al. (2009). Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living

older adults: evidence of a gene-micronutrient interaction. AmU J Clin Nutr,U 89(4), 1263-1268, 19244370. GVF-Update | Annual 2009 | 32

Æ Green, R. (2009). Is it time for vitamin B-12 fortification? What are the questions? AmU J Clin Nutr,U 89(2), 712S-716S, 19141694. Æ Gulcan, E. et al. (2008). Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even

when vitamin B12 levels are normal. AmU J Med Sci,U 336(5), 379-382, 19011392. Æ Hardlei, T. F. & Nexo, E. (2009). A new principle for measurement of cobalamin and corrinoids, used for studies of

cobalamin analogs on serum haptocorrin. ClinU Chem,U 55(5), 1002-1010, 19299543. Æ James, S. J. et al. (2009). Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in

children with autism. AmU J Clin Nutr,U 89(1), 425-430, 19056591.

Æ Januchowski, R. (2009). Evaluation of topical vitamin B(12) for the treatment of childhood eczema. JU Altern

Complement Med,U 15(4), 387-389, 19368512. Æ Kifle, L. et al. (2009). Deprivation of folate and B12 increases neurodegeneration beyond that accompanying

deprivation of either vitamin alone. JU Alzheimers Dis,U 16(3), 533-540, 19276548.

Æ Li, F. et al. (2009). Vitamin B(12) and birth defects. MolU Genet Metab,U 98(1-2), 166-172, 19586788. Æ Lin, Y. T. et al. (2009). Regular vitamin B12 supplementation among older Chinese men in a veterans care home in

Taiwan. ArchU Gerontol Geriatr,U 49(1), 186-189, 18775574. Æ Loewy, A. D. et al. (2009). Epigenetic modification of the gene for the vitamin B(12) chaperone MMACHC can

result in increased tumorigenicity and methionine dependence. MolU Genet Metab,U 96(4), 261-267, 19200761.

Æ Malik, Z. A. et al. (2009). Elevated levels of vitamin B12 and folate in vertically infected children with HIV-1. AidsU ,U 23(3), 403-407, 19114857. Æ Miousse, I. R. et al. (2009). Clinical and molecular heterogeneity in patients with the cblD inborn error of

cobalamin metabolism. JU Pediatr,U 154(4), 551-556, 19058814. Æ Molloy, A. M. et al. (2009). Maternal vitamin B12 status and risk of neural tube defects in a population with high

neural tube defect prevalence and no folic Acid fortification. PediatricsU ,U 123(3), 917-923, 19255021.

Æ Oral or intramuscular vitamin B12? (2009). DrugU Ther Bull,U 47(2), 19-21, 19193702. Æ Petrus, A. K. et al. (2009). Exploring the implications of vitamin B12 conjugation to insulin on insulin receptor

binding. ChemMedChemU ,U 4(3), 421-426, 19101970. Æ Pieters, B. et al. (2009). Periventricular white matter lucencies relate to low vitamin B12 levels in patients with

small vessel stroke. StrokeU ,U 40(5), 1623-1626, 19286604.

Æ Pontes, H. A. et al. (2009). Oral manifestations of vitamin B12 deficiency: a case report. JU Can Dent Assoc,U 75(7), 533-537, 19744365. Æ Quadros, E. V. et al. (2009). The protein and the gene encoding the receptor for the cellular uptake of

transcobalamin-bound cobalamin. BloodU ,U 113(1), 186-192, 18779389.

Æ Roed, C. et al. (2009). [Severe vitamin B12 deficiency in infants breastfed by vegans]. UgeskrU Laeger,U 171(43), 3099-3101, 19852900.

Æ Rufenacht, P. et al. (2008). [Vitamin B12 deficiency: a challenging diagnosis and treatment]. RevU Med Suisse,U 4(175), 2212-2214, 2216-2217, 19024576.

Æ Rush, E. C. et al. (2009). Dietary patterns and vitamin B(12) status of migrant Indian preadolescent girls. EurU J Clin

Nutr,U 63(4), 585-587, 18091765. Æ Scalabrino, G. (2009). The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous

system: Lessons learned from its deficiency. ProgU Neurobiol,U 88(3), 203-220, 19394404.

Æ Smith, A. D. & Refsum, H. (2009). Vitamin B-12 and cognition in the elderly. AmU J Clin Nutr,U 89(2), 707S-711S, 19116332. Æ Sturm, I. et al. (2008). [Thromboembolic events, abortions and a sick infant--unusual presentation of a vitamin

deficiency]. InternistU (Berl),U 49(12), 1507-1511, 18815762.

Æ Thompson, M. D. et al. (2009). Vitamin B-12 and neural tube defects: the Canadian experience. AmU J Clin Nutr,U 89(2), 697S-701S, 19116334.

Æ Turner, M. R. & Talbot, K. (2009). Functional vitamin B12 deficiency. PractU Neurol,U 9(1), 37-41, 19151237. GVF-Update | Annual 2009 | 33

Æ Valayannopoulos, V. et al. (2009). Multiple OXPHOS deficiency in the liver of a patient with CblA methylmalonic

aciduria sensitive to vitamin B(12). JU Inherit Metab Dis,U 32(2), 159-162, 19277894. Æ Vogiatzoglou, A. et al. (2009). Dietary sources of vitamin B-12 and their association with plasma vitamin B-12

concentrations in the general population: the Hordaland Homocysteine Study. AmU J Clin Nutr,U 89(4), 1078- 1087, 19190073.

Æ Weinberg, J. B. et al. (2009). Inhibition of nitric oxide synthase by cobalamins and cobinamides. FreeU Radic Biol

Med,U 46(12), 1626-1632, 19328848.

Folic Acid

Æ Al-Tahan, J. et al. (2008). Methylenetetrahydrofolate reductase 677CT polymorphism and cobalamin, folate, and

homocysteine status in Spanish adolescents. AnnU Nutr Metab,U 52(4), 315-321, 18714149. Æ Antoniades, C. et al. (2009). Homocysteine and coronary atherosclerosis: from folate fortification to the recent

clinical trials. EurU Heart J,U 30(1), 6-15, 19029125. Æ Astorg, P. et al. (2008). Association of folate intake with the occurrence of depressive episodes in middle-aged

French men and women. BrU J Nutr,U 100(1), 183-187, 18062830. Æ Aufreiter, S. et al. (2009). Folate is absorbed across the colon of adults: evidence from cecal infusion of (13)C-

labeled [6S]-5-formyltetrahydrofolic acid. AmU J Clin Nutr,U 90(1), 116-123, 19439459. Æ Aydin, M. et al. (2009). Association of genetic variants in Methylenetetrahydrofolate Reductase and Paraoxonase-

1 genes with homocysteine, folate and vitamin B12 in coronary artery disease. MolU Cell Biochem,U 325(1-2), 199-208, 19219535.

Æ Bachmann, C. G. et al. (2008). Homocysteine in restless legs syndrome. SleepU Med,U 9(4), 388-392, 17900981. Æ Baggott, J. E. & Morgan, S. L. (2009). Methotrexate catabolism to 7-hydroxymethotrexate in rheumatoid arthritis

alters drug efficacy and retention and is reduced by folic acid supplementation. UArthritis Rheum,U 60(8), 2257-2261, 19644884. Æ Bakker, D. J. et al. (2009). Controlled study on folate status following folic acid supplementation and

discontinuation in women of child-bearing age. AnnU Clin Biochem,U 46(Pt 3), 231-234, 19342442.

Æ Bar-Oz, B. et al. (2008). Folate fortification and supplementation--are we there yet? ReprodU Toxicol,U 25(4), 408- 412, 18550330. Æ Barbosa, P. R. et al. (2008). Association between decreased vitamin levels and MTHFR, MTR and MTRR gene

polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. EurU

J Clin Nutr,U 62(8), 1010-1021, 17522601.

Æ Bazzano, L. A. (2009). Folic acid supplementation and cardiovascular disease: the state of the art. AmU J Med Sci,U 338(1), 48-49, 19593104. Æ Beaudin, A. E. & Stover, P. J. (2009). Insights into metabolic mechanisms underlying folate-responsive neural tube

defects: a minireview. BirthU Defects Res A Clin Mol Teratol,U 85(4), 274-284, 19180567.

Æ Bermejo, L. M. et al. (2009). Dietary strategies for improving folate status in institutionalized elderly persons. BrU J

Nutr,U 101(11), 1611-1615, 19537306. Æ Biselli, J. M. et al. (2009). Double aneuploidy (48,XXY,+21) of maternal origin in a child born to a 13-year-old

mother: evaluation of the maternal folate metabolism. GenetU Couns,U 20(3), 225-234, 19852428. Æ Bistulfi, G. et al. (2009). Polyamine biosynthesis impacts cellular folate requirements necessary to maintain S-

adenosylmethionine and nucleotide pools. FasebU J,U 23(9), 2888-2897, 19417083. Æ Bjorklund, N. K. & Gordon, R. (2006). A hypothesis linking low folate intake to neural tube defects due to failure of

post-translation methylations of the cytoskeleton. IntU J Dev Biol,U 50(2-3), 135-141, 16479482.

Æ Blom, H. J. (2009). Folic acid, methylation and neural tube closure in humans. BirthU Defects Res A Clin Mol Teratol,U 85(4), 295-302, 19301298. Æ Bognar, M. et al. (2008). Improper supplementation habits of folic acid intake by Hungarian pregnant women:

improper recommendations. JU Am Coll Nutr,U 27(4), 499-504, 18978170. GVF-Update | Annual 2009 | 34

Æ Bostom, A. G. et al. (2009). Baseline characteristics of participants in the Folic Acid for Vascular Outcome

Reduction in Transplantation (FAVORIT) Trial. AmU J Kidney Dis,U 53(1), 121-128, 19022547. Æ Bower, C. et al. (2009). Neural tube defects in Australia: trends in encephaloceles and other neural tube defects

before and after promotion of folic acid supplementation and voluntary food fortification. UBirth Defects

Res A Clin Mol Teratol,U 85(4), 269-273, 19180646.

Æ Boxmeer, J. C. et al. (2009). Low folate in seminal plasma is associated with increased sperm DNA damage. FertilU

Steril,U 92(2), 548-556, 18722602. Æ Brough, L. et al. (2009). Social and ethnic differences in folic acid use preconception and during early pregnancy

in the UK: effect on maternal folate status. JU Hum Nutr Diet,U 22(2), 100-107, 19226351. Æ Bukowski, R. et al. (2009). Preconceptional folate supplementation and the risk of spontaneous preterm birth: a

cohort study. PLoSU Med,U 6(5), e1000061, 19434228. Æ Casey, G. J. et al. (2009). A free weekly iron-folic acid supplementation and regular deworming program is

associated with improved hemoglobin and iron status indicators in Vietnamese women. BMCU Public

Health,U 9, 261, 19630954. Æ Chan, A. C. et al. (2008). Folate awareness and the prevalence of neural tube defects in South Australia, 1966-

2007. MedU J Aust,U 189(10), 566-569, 19012555. Æ Cole, P. D. et al. (2009). Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic

leukemia. PediatrU Neurol,U 40(1), 34-41, 19068252.

Æ Connelly-Frost, A. et al. (2009). Selenium, folate, and colon cancer. NutrU Cancer,U 61(2), 165-178, 19235033. Æ Coppede, F. (2009). The complex relationship between folate/homocysteine metabolism and risk of Down

syndrome. MutatU Res,U 682(1), 54-70, 19524060. Æ Czeizel, A. E. (2009). Periconceptional folic acid and multivitamin supplementation for the prevention of neural

tube defects and other congenital abnormalities. BirthU Defects Res A Clin Mol Teratol,U 85(4), 260-268, 19161162.

Æ Dary, O. (2009). Nutritional interpretation of folic acid interventions. NutrU Rev,U 67(4), 235-244, 19335717.

Æ De Wals, P. et al. (2008). Spina bifida before and after folic acid fortification in Canada. BirthU Defects Res A Clin

Mol Teratol,U 82(9), 622-626, 18655127. Æ Dhillon, V. et al. (2009). Effect of common polymorphisms in folate uptake and metabolism genes on frequency

of micronucleated lymphocytes in a South Australian cohort. UMutat Res,U 665(1-2), 1-6, 19427504. Æ dos Santos, E. F. et al. (2009). Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia

in Parkinson's disease. MetabU Brain Dis,U 24(2), 257-269, 19294496. Æ du Plessis, L. et al. (2008). What has happened with neural tube defects and womens' understanding of folate in

Victoria since 1998? MedU J Aust,U 189(10), 570-574, 19012556.

Æ Duffy, C. M. et al. (2009). Alcohol and folate intake and breast cancer risk in the WHI Observational Study. BreastU

Cancer Res Treat,U 116(3), 551-562, 18785003. Æ Ericson, U. et al. (2009). Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer

risk in women from the Malmo Diet and Cancer cohort. CancerU Epidemiol Biomarkers Prev,U 18(4), 1101- 1110, 19336565. Æ Figueiredo, J. C. et al. (2008). Colorectal adenomas in a randomized folate trial: the role of baseline dietary and

circulating folate levels. CancerU Epidemiol Biomarkers Prev,U 17(10), 2625-2631, 18843003.

Æ Flynn, M. A. et al. (2008). Session 1: Public health nutrition. Folic acid food fortification: the Irish experience. ProcU

Nutr Soc,U 67(4), 381-389, 18847514. Æ Franke, C. et al. (2008). Dietary intake of natural sources of docosahexaenoic acid and folate in pregnant women

of three European cohorts. AnnU Nutr Metab,U 53(3-4), 167-174, 19001784.

Æ Gallagher, R. C. et al. (2009). Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. AnnU

Neurol,U 65(5), 550-556, 19142996. Æ Ganji, V. & Kafai, M. R. (2009). Hemoglobin and hematocrit values are higher and prevalence of anemia is lower in

the post-folic acid fortification period than in the pre-folic acid fortification period in US adults. AmU J Clin

Nutr,U 89(1), 363-371, 19056553. GVF-Update | Annual 2009 | 35

Æ Garcia, A. A. et al. (2008). Long-term effects of folic acid fortification and B-vitamin supplementation on total

folate, homocysteine, methylmalonic acid and cobalamin in older adults. CanU J Public Health,U 99(5), 428- 433, 19009931.

Æ Garikapaty, V. P. et al. (2008). Folic acid consumption among Missouri women in the periconceptional period. MoU

Med,U 105(6), 504-509, 19052012.

Æ Gordon, N. (2009). Cerebral folate deficiency. DevU Med Child Neurol,U 51(3), 180-182, 19260931. Æ Greene, N. D. et al. (2009). Understanding the causes and prevention of neural tube defects: Insights from the

splotch mouse model. BirthU Defects Res A Clin Mol Teratol,U 85(4), 322-330, 19180568.

Æ Grosse, S. D. et al. (2008). Economic evaluation of a neural tube defect recurrence-prevention program. AmU J Prev

Med,U 35(6), 572-577, 18845415. Æ Guerreiro, C. S. et al. (2008). Risk of colorectal cancer associated with the C677T polymorphism in 5,10- methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor

nutrients. AmU J Clin Nutr,U 88(5), 1413-1418, 18996879. Æ Guo, H. et al. (2009). Influence of folic acid on plasma homocysteine levels & arterial endothelial function in

patients with unstable angina. IndianU J Med Res,U 129(3), 279-284, 19491420.

Æ Haberg, S. E. et al. (2009). Folic acid supplements in pregnancy and early childhood respiratory health. UArch Dis

Child,U 94(3), 180-184, 19052032. Æ Hamner, H. C. et al. (2009). Predicted contribution of folic acid fortification of corn masa flour to the usual folic

acid intake for the US population: National Health and Nutrition Examination Survey 2001-2004. AmU J Clin

Nutr,U 89(1), 305-315, 19056605. Æ Hannisdal, R. et al. (2009). Analytical recovery of folate degradation products formed in human serum and

plasma at room temperature. JU Nutr,U 139(7), 1415-1418, 19458027. Æ Hannisdal, R. et al. (2009). Liquid chromatography-tandem mass spectrometry analysis of folate and folate

catabolites in human serum. ClinU Chem,U 55(6), 1147-1154, 19359539. Æ Harris, M. J. (2009). Insights into prevention of human neural tube defects by folic acid arising from consideration

of mouse mutants. BirthU Defects Res A Clin Mol Teratol,U 85(4), 331-339, 19117321. Æ Hennessy-Priest, K. et al. (2009). Folic acid food fortification prevents inadequate folate intake among

preschoolers from Ontario. PublicU Health Nutr,U 12(9), 1548-1555, 19200405. Æ Hervouet, E. et al. (2009). Folate supplementation limits the aggressiveness of glioma via the remethylation of

DNA repeats element and genes governing apoptosis and proliferation. ClinU Cancer Res,U 15(10), 3519- 3529, 19451595. Æ Heseker, H. B. et al. (2009). Not all cases of neural-tube defect can be prevented by increasing the intake of folic

acid. BrU J Nutr,U 102(2), 173-180, 19079944. Æ Hirsch, S. et al. (2008). Methylation status in healthy subjects with normal and high serum folate concentration.

NutritionU ,U 24(11-12), 1103-1109, 18653314. Æ Hoey, L. et al. (2009). Laying hens can convert high doses of folic acid added to the feed into natural folates in

eggs providing a novel source of food folate. BrU J Nutr,U 101(2), 206-212, 18570689. Æ Houghton, L. A. et al. (2009). Unmetabolized folic acid and total folate concentrations in breast milk are

unaffected by low-dose folate supplements. AmU J Clin Nutr,U 89(1), 216-220, 19056550.

Æ Imasa, M. S. et al. (2009). Folic acid-based intervention in non-ST elevation acute coronary syndromes. AsianU

Cardiovasc Thorac Ann,U 17(1), 13-21, 19515873. Æ Ionescu-Ittu, R. et al. (2009). Prevalence of severe congenital heart disease after folic acid fortification of grain

products: time trend analysis in Quebec, Canada. BmjU ,U 338, b1673, 19436079. Æ Iqbal, M. P. et al. (2009). Folic acid and vitamin B6 deficiencies related hyperhomocysteinemia in apparently

healthy Pakistani adults; is mass micronutrient supplementation indicated in this population? JU Coll

Physicians Surg Pak,U 19(5), 308-312, 19409165. Æ Jaszewski, R. et al. (2008). Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized

chemoprevention trial. WorldU J Gastroenterol,U 14(28), 4492-4498, 18680228. GVF-Update | Annual 2009 | 36

Æ Kageyama, M. et al. (2008). Relationship between genetic polymorphism, serum folate and homocysteine in

Alzheimer's disease. AsiaU Pac J Public Health,U 20 Suppl, 111-117, 19533869. Æ Kalimuthu, P. & John, S. A. (2009). Selective electrochemical sensor for folic acid at physiological pH using

ultrathin electropolymerized film of functionalized thiadiazole modified glassy carbon electrode. BiosensU

Bioelectron,U 24(12), 3575-3580, 19523810. Æ Kalmbach, R. D. et al. (2008). A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with

increased unmetabolized folic acid in plasma and decreased red blood cell folate. JU Nutr,U 138(12), 2323- 2327, 19022952. Æ Kaskel, F. J. & Bamgbola, O. F. (2008). Validation of a composite scoring scheme in the diagnosis of folate

deficiency in a pediatric and adolescent dialysis cohort. JU Ren Nutr,U 18(5), 430-439, 18721738. Æ Keszei, A. P. et al. (2009). Dietary folate and folate vitamers and the risk of pancreatic cancer in the Netherlands

cohort study. CancerU Epidemiol Biomarkers Prev,U 18(6), 1785-1791, 19505911. Æ Khambalia, A. et al. (2009). Periconceptional iron and folate status is inadequate among married, nulliparous

women in rural Bangladesh. JU Nutr,U 139(6), 1179-1184, 19403710. Æ Khandanpour, N. et al. (2009). Randomized clinical trial of folate supplementation in patients with peripheral

arterial disease. BrU J Surg,U 96(9), 990-998, 19672935. Æ Kim, H. A. & Lim, H. S. (2008). Dietary folate intake, blood folate status, and urinary folate catabolite excretion in

Korean women of childbearing age. JU Nutr Sci Vitaminol (Tokyo),U 54(4), 291-297, 18797150.

Æ Kim, J. et al. (2009). Folate intake and the risk of colorectal cancer in a Korean population. UEur J Clin Nutr,U 63(9), 1057-1064, 19550429. Æ Kim, K. C. et al. (2009). DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic

development and aging. JU Nutr Biochem,U 19733471.

Æ Kim, Y. I. (2009). Role of the MTHFR polymorphisms in cancer risk modification and treatment. FutureU Oncol,U 5(4), 523-542, 19450180.

Æ Kondo, A. et al. (2009). Neural tube defects: prevalence, etiology and prevention. IntU J Urol,U 16(1), 49-57, 19120526. Æ Kordas, K. et al. (2009). Methylenetetrahydrofolate reductase ( MTHFR) C677T, A1298C and G1793A genotypes,

and the relationship between maternal folate intake, tibia lead and infant size at birth. BrU J Nutr,U 102(6), 907-914, 19338708. Æ Laftah, A. H. et al. (2009). Haem and folate transport by proton-coupled folate transporter/haem carrier protein 1

(SLC46A1). BrU J Nutr,U 101(8), 1150-1156, 18782461. Æ Larsson, S. C. et al. (2008). Folate intake and risk of breast cancer by estrogen and progesterone receptor status in

a Swedish cohort. CancerU Epidemiol Biomarkers Prev,U 17(12), 3444-3449, 19064560. Æ Lasry, I. et al. (2009). Hereditary folate malabsorption: a positively charged amino acid at position 113 of the

proton-coupled folate transporter (PCFT/SLC46A1) is required for folic acid binding. BiochemU Biophys Res

Commun,U 386(3), 426-431, 19508863. Æ Lawrence, M. A. et al. (2009). Examination of selected national policies towards mandatory folic acid fortification.

NutrU Rev,U 67 Suppl 1, S73-78, 19453684.

Æ Leamon, C. P. (2008). Folate-targeted drug strategies for the treatment of cancer. CurrU Opin Investig Drugs,U 9(12), 1277-1286, 19037834. Æ Lee, L. K. et al. (2009). Serum folate concentration, cognitive impairment, and DNA damage among elderly

individuals in Malaysia. NutrU Res,U 29(5), 327-334, 19555814.

Æ Leeming, R. J. & Lucock, M. (2009). Autism: Is there a folate connection? UJ Inherit Metab Dis,U 32(3), 400-402, 19277892. Æ Lewis, S. J. et al. (2009). Body composition at age 9 years, maternal folate intake during pregnancy and

methyltetrahydrofolate reductase (MTHFR) C677T genotype. BrU J Nutr,U 102(4), 493-496, 19660149. Æ Lopreato, F. R. et al. (2008). Relationships between gene polymorphisms of folate-related proteins and vitamins

and metabolites in pregnant women and neonates. ClinU Chim Acta,U 398(1-2), 134-139, 18823966. GVF-Update | Annual 2009 | 37

Æ Low, P. S. & Kularatne, S. A. (2009). Folate-targeted therapeutic and imaging agents for cancer. CurrU Opin Chem

Biol,U 13(3), 256-262, 19419901. Æ Malouf, R. & Grimley Evans, J. (2008). Folic acid with or without vitamin B12 for the prevention and treatment of

healthy elderly and demented people. CochraneU Database Syst Rev,U (4), CD004514, 18843658. Æ Manizheh, S. M. et al. (2009). Comparison study on the effect of prenatal administration of high dose and low

dose folic acid. SaudiU Med J,U 30(1), 88-97, 19139780.

Æ Mason, J. B. (2009). Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. NutrU Rev,U 67(4), 206-212, 19335714. Æ Matsui, E. C. & Matsui, W. (2009). Higher serum folate levels are associated with a lower risk of atopy and wheeze.

JU Allergy Clin Immunol,U 123(6), 1253-1259 e1252, 19409604. Æ Mills, J. L. & Carter, T. C. (2009). Invited commentary: Preventing neural tube defects and more via food

fortification? AmU J Epidemiol,U 169(1), 18-21; discussion 22-13, 18953060.

Æ Mills, J. L. et al. (2008). Folate-related gene polymorphisms as risk factors for cleft lip and cleft palate. BirthU

Defects Res A Clin Mol Teratol,U 82(9), 636-643, 18661527. Æ Mohammad, N. S. et al. (2009). Aberrations in folate metabolic pathway and altered susceptibility to autism.

PsychiatrU Genet,U 19(4), 171-176, 19440165. Æ Mosley, B. S. et al. (2009). Neural tube defects and maternal folate intake among pregnancies conceived after

folic acid fortification in the United States. AmU J Epidemiol,U 169(1), 9-17, 18953063. Æ Nafar, M. et al. (2009). Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized,

placebo-controlled clinical trial. ExpU Clin Transplant,U 7(1), 33-39, 19364310.

Æ Ng, X. et al. (2009). Folate nutritional genetics and risk for hypertension in an elderly population sample. JU

Nutrigenet Nutrigenomics,U 2(1), 1-8, 19776634. Æ Nguyen, P. et al. (2008). Comparing folic acid pharmacokinetics among women of childbearing age: single dose

ingestion of 1.1 versus 5 MG folic acid. CanU J Clin Pharmacol,U 15(2), e314-322, 18711224. Æ Nishitani, N. et al. (2009). Folic acid-induced anaphylaxis showing cross-reactivity with methotrexate: a case

report and review of the literature. IntU J Dermatol,U 48(5), 522-524, 19416386.

Æ Ntaios, G. et al. (2009). Is there a beneficial effect of folic acid on carotid intima-media thickness? IntU J Cardiol,U 135(2), 260-261, 18584901. Æ Oakley, G. P., Jr. (2009). The scientific basis for eliminating folic acid-preventable spina bifida: a modern miracle

from epidemiology. AnnU Epidemiol,U 19(4), 226-230, 19344858. Æ Onat, A. et al. (2008). Serum folate is associated with coronary heart disease independently of homocysteine in

Turkish men. ClinU Nutr,U 27(5), 732-739, 18694616. Æ Ormond, G. et al. (2009). Endocrine disruptors in the workplace, hair spray, folate supplementation, and risk of

hypospadias: case-control study. EnvironU Health Perspect,U 117(2), 303-307, 19270804. Æ Ortega, R. M. et al. (2009). Folate status in young overweight and obese women: changes associated with weight

reduction and increased folate intake. JU Nutr Sci Vitaminol (Tokyo),U 55(2), 149-155, 19436141.

Æ Pacheco, S. S. et al. (2009). Effects of folic acid fortification on the prevalence of neural tube defects. RevU Saude

Publica,U 43(4), 565-571, 19488664. Æ Parrott, R. et al. (2009). Pregnancy intentions and folic acid supplementation exemplars: findings from the

Central Pennsylvania Women's Health Study. JU Health Commun,U 14(4), 366-383, 19466648.

Æ Patterson, D. (2008). Folate metabolism and the risk of Down syndrome. DownsU Syndr Res Pract,U 12(2), 93-97, 19026278. Æ Paul, L. et al. (2009). Telomere length in peripheral blood mononuclear cells is associated with folate status in

men. JU Nutr,U 139(7), 1273-1278, 19458030. Æ Paulik, E. et al. (2009). Preconceptional and prenatal predictors of folic acid intake in Hungarian pregnant

women. EurU J Obstet Gynecol Reprod Biol,U 145(1), 49-52, 19411131. Æ Pittschieler, S. et al. (2008). Spontaneous abortion and the prophylactic effect of folic acid supplementation in

epileptic women undergoing antiepileptic therapy. JU Neurol,U 255(12), 1926-1931, 18677647. GVF-Update | Annual 2009 | 38

Æ Piyathilake, C. J. et al. (2009). Lower risk of cervical intraepithelial neoplasia in women with high plasma folate

and sufficient vitamin B12 in the post-folic acid fortification era. CancerU Prev Res (Phila Pa),U 2(7), 658-664, 19542191. Æ Poretti, A. et al. (2008). Neural tube defects in Switzerland from 2001 to 2007: are periconceptual folic acid

recommendations being followed? SwissU Med Wkly,U 138(41-42), 608-613, 18941947. Æ Prey, S. & Paul, C. (2009). Effect of folic or folinic acid supplementation on methotrexate-associated safety and

efficacy in inflammatory disease: a systematic review. BrU J Dermatol,U 160(3), 622-628, 18945303. Æ Resler, G. et al. (2008). Effect of folic acid combined with fluoxetine in patients with major depression on plasma

homocysteine and vitamin B12, and serotonin levels in lymphocytes. NeuroimmunomodulationU ,U 15(3), 145-152, 18716414. Æ Robitaille, J. et al. (2009). Does the MTHFR 677C-->T variant affect the Recommended Dietary Allowance for

folate in the US population? AmU J Clin Nutr,U 89(4), 1269-1273, 19225123. Æ Rose, R. F. et al. (2009). Narrowband ultraviolet B phototherapy does not influence serum and red cell folate

levels in patients with psoriasis. JU Am Acad Dermatol,U 61(2), 259-262, 19493587. Æ Salerno, P. et al. (2008). [Folic acid and congenital malformation: scientific evidence and public health strategies].

AnnU Ig,U 20(6), 519-530, 19238877. Æ Samaniego Vaesken, M. L. et al. (2009). [Folic acid fortified foods available in Spain: types of products, level of

fortification and target population groups]. NutrU Hosp,U 24(4), 459-466, 19721926. Æ Santos-Reboucas, C. B. et al. (2008). The impact of folate pathway polymorphisms combined to nutritional

deficiency as a maternal predisposition factor for Down syndrome. DisU Markers,U 25(3), 149-157, 19096127.

Æ Sauer, J. et al. (2009). Too much folate: a risk factor for cancer and cardiovascular disease? CurrU Opin Clin Nutr

Metab Care,U 12(1), 30-36, 19057184.

Æ Saussele, T. (2008). [Supplementation with folic acid before and during pregnancy]. MedU Monatsschr Pharm,U 31(12), 469-472, 19133595. Æ Schernhammer, E. S. et al. (2008). A prospective study of dietary folate and vitamin B and colon cancer according

to microsatellite instability and KRAS mutational status. CancerU Epidemiol Biomarkers Prev,U 17(10), 2895- 2898, 18843035. Æ Schwarz, E. B. et al. (2008). Computerized counseling for folate knowledge and use: a randomized controlled trial.

AmU J Prev Med,U 35(6), 568-571, 19000845. Æ Sen, A. & Kanani, S. J. (2009). Impact of iron-folic acid supplementation on cognitive abilities of school girls in

Vadodara. IndianU Pediatr,U 46(2), 137-143, 19242031. Æ Shaw, G. M. et al. (2009). 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects.

BMCU Med Genet,U 10, 49, 19493349. Æ Shuaibi, A. M. et al. (2008). Folate status of young Canadian women after folic acid fortification of grain products.

JU Am Diet Assoc,U 108(12), 2090-2094, 19027414. Æ Sohn, K. J. et al. (2009). The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific

cancer risk modification. IntU J Cancer,U 124(9), 1999-2005, 19123462. Æ Stea, T. H. et al. (2009). Association between folate intake from different food sources in Norway and

homocysteine status in a dietary intervention among young male adults. BrU J Nutr,U 102(6), 899-906, 19331705. Æ Steck, S. E. et al. (2008). Polymorphisms in methionine synthase, methionine synthase reductase and serine

hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk. JU Nutrigenet Nutrigenomics,U 1(4), 196-204, 19776626. Æ Steinfeld, R. et al. (2009). Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable

neurodegenerative disorder associated with disturbed myelin metabolism. UAm J Hum Genet,U 85(3), 354- 363, 19732866. Æ Stewart, C. P. et al. (2009). Antenatal supplementation with folic acid + iron + zinc improves linear growth and

reduces peripheral adiposity in school-age children in rural Nepal. AmU J Clin Nutr,U 90(1), 132-140, 19474130. GVF-Update | Annual 2009 | 39

Æ Stockley, L. & Lund, V. (2008). Use of folic acid supplements, particularly by low-income and young women: a

series of systematic reviews to inform public health policy in the UK. PublicU Health Nutr,U 11(8), 807-821, 18457601. Æ Sweeney, M. R. et al. (2009). Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic

acid fortification. Implications for further mandatory fortification? BMCU Public Health,U 9, 295, 19689788. Æ Tam, C. et al. (2009). Periconceptional folic acid supplementation: a new indication for therapeutic drug

monitoring. TherU Drug Monit,U 31(3), 319-326, 19349928.

Æ Tamim, H. et al. (2009). Preconceptional folic acid supplement use in Lebanon. PublicU Health Nutr,U 12(5), 687-692, 18616852. Æ Tazhibayev, S. et al. (2008). Evaluation of the potential effectiveness of wheat flour and salt fortification programs

in five Central Asian countries and Mongolia, 2002-2007. FoodU Nutr Bull,U 29(4), 255-265, 19227050. Æ Temudo, T. et al. (2009). Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and

effects of treatment. BrainU Dev,U 31(1), 46-51, 18572337. Æ Tochihara, Y. et al. (2008). Effects of pre- vs. intra-dialysis folic acid on arterial wave reflections and endothelial

function in patients with end-stage renal disease. BrU J Clin Pharmacol,U 66(5), 717-722, 18754845.

Æ Ulrich, C. M. et al. (2008). Modeling folate, one-carbon metabolism, and DNA methylation. UNutr Rev,U 66 Suppl 1, S27-30, 18673484. Æ Unal, E. S. et al. (2009). The functional roles of the His247 and His281 residues in folate and proton translocation

mediated by the human proton-coupled folate transporter SLC46A1. JU Biol Chem,U 284(26), 17846-17857, 19389703. Æ Van Guelpen, B. et al. (2009). Plasma folate and total homocysteine levels are associated with the risk of

myocardial infarction, independently of each other and of renal function. JU Intern Med,U 266(2), 182-195, 19298497. Æ Vidal, J. S. et al. (2008). Homocysteine, folate and cognition in a large community-based sample of elderly

people--the 3C Dijon Study. NeuroepidemiologyU ,U 30(4), 207-214, 18424901.

Æ Vieira, A. R. et al. (2008). Reduced folate carrier 1 (RFC1) is associated with cleft of the lip only. BrazU J Med Biol Res,U 41(8), 689-693, 18797703. Æ Vir, S. C. et al. (2008). Weekly iron and folic acid supplementation with counseling reduces anemia in adolescent

girls: a large-scale effectiveness study in Uttar Pradesh, India. FoodU Nutr Bull,U 29(3), 186-194, 18947031.

Æ Wani, N. A. et al. (2008). Folate status in various pathophysiological conditions. IUBMBU Life,U 60(12), 834-842, 18942083. Æ Weger, W. et al. (2008). The methylenetetrahydrofolate reductase 677C>T gene polymorphism is not associated

with chronic plaque psoriasis. ExpU Dermatol,U 17(9), 748-751, 18355300. Æ Weggemans, R. M. et al. (2009). Toward an optimal use of folic acid: an advisory report of the Health Council of

the Netherlands. EurU J Clin Nutr,U 63(8), 1034-1036, 19209186. Æ Weng, L. C. et al. (2008). Is ischemic stroke risk related to folate status or other nutrients correlated with folate

intake? StrokeU ,U 39(12), 3152-3158, 18988909. Æ Yang, Q. et al. (2009). Serum folate and cancer mortality among U.S. adults: findings from the Third National

Health and Nutritional Examination Survey linked mortality file. CancerU Epidemiol Biomarkers Prev,U 18(5), 1439-1447, 19423522.

Æ Yasuda, S. et al. (2008). Placental folate transport during pregnancy. BiosciU Biotechnol Biochem,U 72(9), 2277-2284, 18776693.

Æ Yuasa, H. et al. (2009). Molecular and functional characteristics of proton-coupled folate transporter. JU Pharm Sci,U 98(5), 1608-1616, 18823045. Æ Zabala, R. et al. (2008). [Folic acid for neural tube defects prevention: consumption and information in fertil-age

women in Centro Cuyo Region]. ArchU Argent Pediatr,U 106(4), 295-301, 18766275. Æ Zappitelli, M. et al. (2009). Continuous renal replacement therapy amino acid, trace metal and folate clearance in

critically ill children. IntensiveU Care Med,U 35(4), 698-706, 19183946. GVF-Update | Annual 2009 | 40

Æ Zhao, Y. et al. (2009). Plasma folate status and dietary folate intake among Chinese women of childbearing age.

MaternU Child Nutr,U 5(2), 104-116, 19292745.

Niacin

Æ Alves, J. D. et al. (2008). Influence of the timing of low-dose aspirin on tolerability of prolonged-release nicotinic acid in patients at elevated cardiovascular risk. Curr Med Res Opin, 24(10), 2815-2820, 18755055. Æ Bays, H. E. et al. (2009). Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: a post hoc analysis of a 24-week, placebo-controlled trial in dyslipidemic patients. Clin Ther, 31(1), 115-122, 19243712. Æ Bays, H. E. & Rader, D. J. (2009). Does nicotinic acid (niacin) lower blood pressure? Int J Clin Pract, 63(1), 151- 159, 19054161. Æ Digby, J. E. et al. (2009). Nicotinic acid and the prevention of coronary artery disease. Curr Opin Lipidol, 20(4), 321-326, 19494772. Æ Farmer, J. A. (2009). Nicotinic acid: a new look at an old drug. Curr Atheroscler Rep, 11(2), 87-92, 19228480. Æ Ganji, S. H. et al. (2009). Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis, 202(1), 68-75, 18550065. Æ Hoskin, P. J. et al. (2009). Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial. Radiother Oncol, 91(1), 120-125, 18992952. Æ Kamanna, V. S. et al. (2009). Niacin: an old drug rejuvenated. Curr Atheroscler Rep, 11(1), 45-51, 19080727. Æ Kang, H. T. & Hwang, E. S. (2009). Nicotinamide enhances mitochondria quality through autophagy activation in human cells. Aging Cell, 8(4), 426-438, 19473119. Æ Kawata, A. K. et al. (2009). Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy. Clin Drug Investig, 29(4), 215-229, 19301936. Æ Keener, A. & Sanossian, N. (2008). Niacin for stroke prevention: evidence and rationale. CNS Neurosci Ther, 14(4), 287-294, 19040554. Æ Kirkland, J. B. (2009). Niacin status and treatment-related leukemogenesis. Mol Cancer Ther, 8(4), 725-732, 19372544. Æ Koch-Nolte, F. et al. (2009). Emerging roles of NAD+ and its metabolites in cell signaling. Sci Signal, 2(57), mr1, 19211509. Æ Lauring, B. et al. (2009). A comparison of the pharmacokinetics of two different formulations of extended- release niacin. Curr Med Res Opin, 25(1), 15-22, 19210135. Æ Lee, J. M. et al. (2009). Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol, 54(19), 1787-1794, 19874992. Æ Lee, J. Y. et al. (2009). Nicotinamide reduces dopamine in postnatal hypothalamus and causes dopamine- deficient phenotype. Neurosci Lett, 461(2), 163-166, 19539713. Æ Maccubbin, D. et al. (2008). Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia. Int J Clin Pract, 62(12), 1959-1970, 19166443. Æ Maccubbin, D. et al. (2009). Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease. Am J Cardiol, 104(1), 74-81, 19576324. Æ Paolini, J. F. et al. (2008). Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: results from a randomised placebo-controlled clinical trial. Int J Clin Pract, 62(6), 896-904, 18410350. GVF-Update | Annual 2009 | 41

Æ Papaliodis, D. et al. (2008). Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model. J Pharmacol Exp Ther, 327(3), 665-672, 18784348. Æ Peoples, M. C. et al. (2008). Assessment of matrix effects and determination of niacin in human plasma using liquid-liquid extraction and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr, 22(11), 1272-1278, 18651588. Æ Plaisance, E. P. et al. (2009). Niacin stimulates adiponectin secretion through the GPR109A receptor. Am J Physiol Endocrinol Metab, 296(3), E549-558, 19141678. Æ Poldermans, D. et al. (2008). Prolonged-release nicotinic acid in patients with atherosclerotic disease in the Netherlands. Eur Surg Res, 41(4), 313-318, 18799884. Æ Robinson, J. G. (2009). Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin. Vasc Health Risk Manag, 5(1), 31-43, 19436666. Æ Thakkar, R. B. et al. (2009). Acetylsalicylic acid reduces niacin extended-release-induced flushing in patients with dyslipidemia. Am J Cardiovasc Drugs, 9(2), 69-79, 19331435. Æ Warnholtz, A. et al. (2009). Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study. Atherosclerosis, 204(1), 216-221, 18822413.

Vitamin C

Æ Aguirre, R. & May, J. M. (2008). Inflammation in the vascular bed: importance of vitamin C. PharmacolU Ther,U 119(1), 96-103, 18582947. Æ Aly, H. et al. (2009). Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized

controlled trial. JU Perinatol,U 29(6), 438-443, 19242485. Æ Bachi, B. (2008). [Natural or synthetic vitamin C? A new substance's precarious status behind the scenes of World

War II]. NtmU ,U 16(4), 445-470, 19579835.

Æ Baron, J. H. (2009). Sailors' scurvy before and after James Lind--a reassessment. NutrU Rev,U 67(6), 315-332, 19519673. Æ Beck, R. et al. (2009). Menadione reduction by pharmacological doses of ascorbate induces an oxidative stress

that kills breast cancer cells. IntU J Toxicol,U 28(1), 33-42, 19482829.

Æ Biesalski, H. K. (2008). Parenteral ascorbic acid in haemodialysis patients. CurrU Opin Clin Nutr Metab Care,U 11(6), 741-746, 18827578.

Æ Block, G. et al. (2009). Vitamin C treatment reduces elevated C-reactive protein. FreeU Radic Biol Med,U 46(1), 70-77, 18952164. Æ Bozzato, A. et al. (2009). Salivary simulation with ascorbic acid enhances sonographic diagnosis of obstructive

sialadenitis. JU Clin Ultrasound,U 37(6), 329-332, 19444900. Æ Bozzato, A. et al. (2009). [Vitamin C as contrast agent in diagnosis of salivary duct obstruction].

LaryngorhinootologieU ,U 88(5), 290-292, 19408219. Æ Brinkevich, S. D. & Shadyro, O. I. (2008). The effects of ascorbic acid on homolytic processes involving alpha-

hydroxyl-containing carbon-centered radicals. BioorgU Med Chem Lett,U 18(24), 6448-6450, 18986808. Æ Burns, J. et al. (2009). Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-

blind, placebo-controlled, safety and efficacy trial. LancetU Neurol,U 8(6), 537-544, 19427269.

Æ Bursali, A. et al. (2009). A case of infantile scurvy treated only with vitamin C: a forgotten disease. ActaU Orthop

Belg,U 75(3), 428-430, 19681335.

Æ Cahill, L. et al. (2009). Vitamin C deficiency in a population of young Canadian adults. AmU J Epidemiol,U 170(4), 464-471, 19596710. GVF-Update | Annual 2009 | 42

Æ Cascalheira, J. F. et al. (2008). Serum homocysteine: relationship with circulating levels of cortisol and ascorbate.

AnnU Nutr Metab,U 53(1), 67-74, 18827476. Æ Castro, M. A. et al. (2009). A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic

acid. JU Neurochem,U 110(2), 423-440, 19457103. Æ Castro, T. et al. (2008). Differential distribution of the Sodium-vitamin C cotransporter-1 along the proximal

tubule of the mouse and human kidney. KidneyU Int,U 74(10), 1278-1286, 18614995. Æ Chang, J. E. et al. (2009). Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid

malignancies: a Wisconsin Oncology Network study. HematolU Oncol,U 27(1), 11-16, 18668698. Æ Chen, J. Y. et al. (2009). Plasma vitamin C is lower in postherpetic neuralgia patients and administration of

vitamin C reduces spontaneous pain but not brush-evoked pain. ClinU J Pain,U 25(7), 562-569, 19692796. Æ Chi, X. & May, J. M. (2009). Oxidized lipoprotein induces the macrophage ascorbate transporter (SVCT2):

protection by intracellular ascorbate against oxidant stress and apoptosis. ArchU Biochem Biophys,U 485(2), 174-182, 19254685.

Æ Cho, D. Y. et al. (2009). Effect of L-ascorbate on chloride transport in freshly excised sinonasal epithelia. AmU J

Rhinol Allergy,U 23(3), 294-299, 19490804. Æ Choi, H. I. et al. (2009). Design and efficient synthesis of novel ascorbyl conjugated peptide with high collagen

biosynthesis stimulating effects. BioorgU Med Chem Lett,U 19(7), 2079-2082, 19268583. Æ Cooper, C. E. et al. (2008). Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic

protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC). BiochimU Biophys Acta,U 1784(10), 1415-1420, 18457681. Æ Costanzi, E. et al. (2008). Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients.

NeurochemU Res,U 33(12), 2510-2515, 18046644. Æ Davidsson, L. et al. (2009). Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations

>105 g/L in young Bangladeshi children. AmU J Clin Nutr,U 89(6), 1815-1820, 19403640.

Æ Deruelle, F. & Baron, B. (2008). Vitamin C: is supplementation necessary for optimal health? JU Altern Complement

Med,U 14(10), 1291-1298, 19032072. Æ Ferron-Celma, I. et al. (2009). Effect of vitamin C administration on neutrophil apoptosis in septic patients after

abdominal surgery. JU Surg Res,U 153(2), 224-230, 18952228.

Æ Forman, J. P. et al. (2009). Fructose and vitamin C intake do not influence risk for developing hypertension. JU Am

Soc Nephrol,U 20(4), 863-871, 19144761. Æ Frikke-Schmidt, H. & Lykkesfeldt, J. (2009). Role of marginal vitamin C deficiency in atherogenesis: in vivo models

and clinical studies. BasicU Clin Pharmacol Toxicol,U 104(6), 419-433, 19489786.

Æ Gan, R. et al. (2008). Vitamin C deficiency in a university teaching hospital. JU Am Coll Nutr,U 27(3), 428-433, 18838532.

Æ Gao, X. et al. (2008). Vitamin C intake and serum uric acid concentration in men. JU Rheumatol,U 35(9), 1853-1858, 18464304. Æ Griffiths, H. R. et al. (2009). In vivo vitamin C supplementation increases phosphoinositol transfer protein

expression in peripheral blood mononuclear cells from healthy individuals. BrU J Nutr,U 101(10), 1432-1439, 18947437.

Æ Grober, U. (2009). [Vitamin C in complementary oncology--update 2009]. MedU Monatsschr Pharm,U 32(7), 263-267, 19731754. Æ Haftek, M. et al. (2008). Clinical, biometric and structural evaluation of the long-term effects of a topical

treatment with ascorbic acid and madecassoside in photoaged human skin. ExpU Dermatol,U 17(11), 946- 952, 18503551.

Æ Heaney, M. L. et al. (2008). Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. CancerU Res,U 68(19), 8031-8038, 18829561. Æ Heimer, K. A. et al. (2009). Examining the evidence for the use of vitamin C in the prophylaxis and treatment of

the common cold. JU Am Acad Nurse Pract,U 21(5), 295-300, 19432914. GVF-Update | Annual 2009 | 43

Æ Higasa, S. et al. (2008). Genetic polymorphisms of xenobiotic enzymes affect human vitamin C excretion. AsiaU Pac

J Public Health,U 20 Suppl, 70-79, 19533864.

Æ Hwang, S. W. et al. (2009). Clinical efficacy of 25% L-ascorbic acid (C'ensil) in the treatment of melasma. JU Cutan

Med Surg,U 13(2), 74-81, 19298775. Æ Jalal, D. et al. (2009). Comparative study of plasma ascorbic acid levels in senile cataract patients and in normal

individuals. CurrU Eye Res,U 34(2), 118-122, 19219683. Æ Jaxa-Chamiec, T. et al. (2009). Effects of vitamins C and E on the outcome after acute myocardial infarction in

diabetics: a retrospective, hypothesis-generating analysis from the MIVIT study. CardiologyU ,U 112(3), 219- 223, 18698138. Æ Jin, F. et al. (2009). Effects of ascorbic acid, phytic acid and tannic acid on iron bioavailability from reconstituted

ferritin measured by an in vitro digestion-Caco-2 cell model. BrU J Nutr,U 101(7), 972-981, 18755051. Æ Kaboli, S. A. et al. (2009). Effect of addition of vitamin C to clarithromycin-amoxicillin-omeprazol triple regimen

on Helicobacter pylori eradication. ActaU Gastroenterol Belg,U 72(2), 222-224, 19637777. Æ Kalimuthu, P. & John, S. A. (2009). Simultaneous determination of epinephrine, uric acid and xanthine in the presence of ascorbic acid using an ultrathin polymer film of 5-amino-1,3,4-thiadiazole-2-thiol modified

electrode. AnalU Chim Acta,U 647(1), 97-103, 19576392. Æ Kasahara, E. et al. (2009). Dynamic aspects of ascorbic acid metabolism in the circulation: analysis by ascorbate

oxidase with a prolonged in vivo half-life. BiochemU J,U 421(2), 293-299, 19385947. Æ Kaya, F. et al. (2008). Ascorbic acid is a regulator of the intracellular cAMP concentration: old molecule, new

functions? FEBSU Lett,U 582(25-26), 3614-3618, 18835269. Æ Kayan, M. et al. (2009). Effects of Vitamins C and E Combination on Element Levels in Blood of Smoker and

Nonsmoker Radiology X-Ray Technicians. BiolU Trace Elem Res,U 19789845. Æ Kirby, B. S. et al. (2009). Endothelium-dependent vasodilatation and exercise hyperaemia in ageing humans:

impact of acute ascorbic acid administration. JU Physiol,U 587(Pt 9), 1989-2003, 19307300. Æ Klemmensen, A. et al. (2009). Intake of vitamin C and E in pregnancy and risk of pre-eclampsia: prospective study

among 57 346 women. BjogU ,U 116(7), 964-974, 19522799.

Æ Komabayashi, T. et al. (2009). Root dentin body moisture changes caused by ascorbic acid. JU Dent,U 37(6), 475-479, 19346052. Æ Krukoski, D. W. et al. (2009). Effect of vitamin C, deferoxamine, quercetin and rutin against tert-butyl

hydroperoxide oxidative damage in human erythrocytes. HematologyU ,U 14(3), 168-172, 19490763.

Æ Kumar, V. & Choudhury, P. (2009). Scurvy-a forgotten disease with an unusual presentation. TropU Doct,U 39(3), 190-192, 19535768. Æ Kunes, J. P. et al. (2009). Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human

plasma. NutrU Res,U 29(2), 114-122, 19285602. Æ Li, Y. et al. (2008). Restoration of vitamin C synthesis in transgenic Gulo-/- mice by helper-dependent adenovirus-

based expression of gulonolactone oxidase. HumU Gene Ther,U 19(12), 1349-1358, 18764764. Æ Low, M. et al. (2009). The ascorbic acid transporter SVCT2 is expressed in slow-twitch skeletal muscle fibres.

HistochemU Cell Biol,U 131(5), 565-574, 19125272.

Æ Marti, N. et al. (2009). Vitamin C and the role of citrus juices as functional food. NatU Prod Commun,U 4(5), 677-700, 19445318. Æ May, J. M. et al. (2009). Transfer of ascorbic acid across the vascular endothelium: mechanism and self-regulation.

AmU J Physiol Cell Physiol,U 297(1), C169-178, 19419995. Æ Miranda, C. L. et al. (2009). Ascorbic acid promotes detoxification and elimination of 4-hydroxy-2(E)-nonenal in

human monocytic THP-1 cells. ChemU Res Toxicol,U 22(5), 863-874, 19326901. Æ Moyad, M. A. et al. (2009). Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a

preliminary and novel clinical urologic finding. UrolU Nurs,U 29(2), 95-102, 19507407. Æ Nakamura, S. & Oku, T. (2009). Bioavailability of 2-O-alpha-D-glucopyranosyl-L-ascorbic acid as ascorbic acid in

healthy humans. NutritionU ,U 25(6), 686-691, 19230615. GVF-Update | Annual 2009 | 44

Æ Nalame, N. et al. (2009). Loss of L-ascorbic acid in commercial drinking milk caused by milk processing and

storage times. SoutheastU Asian J Trop Med Public Health,U 40(4), 848-851, 19842423. Æ Ngoan le, T. et al. (2008). Development of a semi-quantitative food frequency questionnaire for dietary studies--

focus on vitamin C intake. AsianU Pac J Cancer Prev,U 9(3), 427-432, 18990015. Æ Odermarsky, M. et al. (2009). Poor vitamin C status is associated with increased carotid intima-media thickness, decreased microvascular function, and delayed myocardial repolarization in young patients with type 1

diabetes. AmU J Clin Nutr,U 90(2), 447-452, 19553299. Æ Ohno, S. et al. (2009). High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced

cancer. AnticancerU Res,U 29(3), 809-815, 19414313. Æ Ohshima, H. et al. (2009). Effects of vitamin C on dark circles of the lower eyelids: quantitative evaluation using

image analysis and echogram. SkinU Res Technol,U 15(2), 214-217, 19626722. Æ Ortwerth, B. J. et al. (2009). Tryptophan metabolites from young human lenses and the photooxidation of

ascorbic acid by UVA light. InvestU Ophthalmol Vis Sci,U 50(7), 3311-3319, 19264899. Æ Paixao, T. R. et al. (2008). Continuous monitoring of ascorbate transport through neuroblastoma cells with a

ruthenium oxide hexacyanoferrate modified microelectrode. AnalystU ,U 133(11), 1605-1610, 18936840.

Æ Perrone, G. et al. (2009). Ascorbic acid inhibits antitumor activity of bortezomib in vivo. LeukemiaU ,U 23(9), 1679- 1686, 19369963.

Æ Rivas, C. I. et al. (2008). Vitamin C transporters. JU Physiol Biochem,U 64(4), 357-375, 19391462.

Æ Rizvi, S. I. et al. (2009). Ascorbate recycling by erythrocytes during aging in humans. RejuvenationU Res,U 12(1), 3-6, 19072252. Æ Rodrigo, R. et al. (2009). Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial

fibrillation. IntU J Cardiol,U 19446899. Æ Rossi, S. et al. (2008). Chitosan ascorbate: a chitosan salt with improved penetration enhancement properties.

PharmU Dev Technol,U 13(6), 513-521, 18720244. Æ Roussel, A. M. et al. (2009). EDTA chelation therapy, without added vitamin C, decreases oxidative DNA damage

and lipid peroxidation. AlternU Med Rev,U 14(1), 56-61, 19364193. Æ Rozman, B. et al. (2009). Temperature-sensitive microemulsion gel: an effective topical delivery system for

simultaneous delivery of vitamins C and E. AAPSU PharmSciTech,U 10(1), 54-61, 19148763.

Æ Sahni, S. et al. (2008). High vitamin C intake is associated with lower 4-year bone loss in elderly men. JU Nutr,U 138(10), 1931-1938, 18806103.

Æ Sasazuki, S. et al. (2008). Protective effect of vitamin C on oxidative stress: a randomized controlled trial. IntU J

Vitam Nutr Res,U 78(3), 121-128, 19003734. Æ Shahrbanoo, K. & Taziki, O. (2008). Effect of intravenous ascorbic acid in hemodialysis patients with anemia and

hyperferritinemia. SaudiU J Kidney Dis Transpl,U 19(6), 933-936, 18974579.

Æ Shimada, Y. et al. (2009). Effects of ascorbic acid on gingival melanin pigmentation in vitro and in vivo. JU

Periodontol,U 80(2), 317-323, 19186973. Æ Shui, Y. B. et al. (2009). The gel state of the vitreous and ascorbate-dependent oxygen consumption: relationship

to the etiology of nuclear cataracts. ArchU Ophthalmol,U 127(4), 475-482, 19365028. Æ Sirover, W. D. et al. (2008). Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with

anemia and abnormal iron homeostasis: a preliminary study. RenU Fail,U 30(9), 884-889, 18925528. Æ Song, Y. et al. (2009). Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at

high risk of cardiovascular disease: a randomized controlled trial. AmU J Clin Nutr,U 90(2), 429-437, 19491386. Æ Tessier, D. M. et al. (2009). Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers

in elderly subjects with type 2 diabetes. ArchU Gerontol Geriatr,U 48(1), 67-72, 18077012. Æ Toth, C. (2009). Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult

Charcot-Marie-Tooth 1A patients. ActaU Neurol Scand,U 120(2), 134-138, 19154534. GVF-Update | Annual 2009 | 45

Æ Tsujimura, M. et al. (2008). Vitamin C activity of dehydroascorbic acid in humans--association between changes

in the blood vitamin C concentration or urinary excretion after oral loading. JU Nutr Sci Vitaminol (Tokyo),U 54(4), 315-320, 18797154. Æ Valachova, K. et al. (2009). Degradation of high-molar-mass hyaluronan by ascorbate plus cupric ions: effects of

D-penicillamine addition. ChemU Biodivers,U 6(3), 389-395, 19319875. Æ Velho, A. M. & Jarvis, S. M. (2009). Topological studies of hSVCT1, the human sodium-dependent vitamin C

transporter and the influence of N-glycosylation on its intracellular targeting. UExp Cell Res,U 315(13), 2312- 2321, 19379732. Æ Verlinde, P. H. et al. (2008). L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-

methyltetrahydrofolic acid in healthy men. EurU J Clin Nutr,U 62(10), 1224-1230, 17622258.

Æ Verrax, J. & Calderon, P. B. (2008). The controversial place of vitamin C in cancer treatment. BiochemU Pharmacol,U 76(12), 1644-1652, 18938145. Æ Villar, J. et al. (2009). World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from

developing countries. BjogU ,U 116(6), 780-788, 19432566. Æ Wagner, A. E. et al. (2008). Free radical scavenging and antioxidant activity of ascorbigen versus ascorbic acid:

studies in vitro and in cultured human keratinocytes. JU Agric Food Chem,U 56(24), 11694-11699, 19053372.

Æ Wagner, A. E. & Rimbach, G. (2009). Ascorbigen: chemistry, occurrence, and biologic properties. ClinU Dermatol,U 27(2), 217-224, 19168003. Æ Wang, X. et al. (2009). Ascorbate-apatite composite and ascorbate-FGF-2-apatite composite layers formed on

external fixation rods and their effects on cell activity in vitro. ActaU Biomater,U 5(7), 2647-2656, 19375998.

Æ Weigert, G. et al. (2009). Effects of vitamin C on hyperoxia-induced reduction of retinal blood flow. MicrovascU Res,U 77(3), 256-259, 19159632. Æ Weiser, B. et al. (2009). Ascorbic acid enhances adipogenesis of bone marrow-derived mesenchymal stromal

cells. CellsU Tissues Organs,U 189(6), 373-381, 18769022. Æ Willmott, N. S. & Bryan, R. A. (2008). Case report: scurvy in an epileptic child on a ketogenic diet with oral

complications. UEur Arch Paediatr Dent,U 9(3), 148-152, 18793598. Æ Wilson, J. X. (2009). Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in

endothelium. BiofactorsU ,U 35(1), 5-13, 19319840. Æ Wright, M. E. et al. (2009). Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric

cancer in Poland. EurU J Cancer,U 45(10), 1824-1830, 19243932. Æ Xiao, L. et al. (2009). Cytoprotective effects of the lipoidic-liquiform pro-vitamin C tetra-isopalmitoyl-ascorbate (VC-IP) against ultraviolet-A ray-induced injuries in human skin cells together with collagen retention,

MMP inhibition and p53 gene repression. JU Cell Biochem,U 106(4), 589-598, 19165821. Æ Zetterstrom, R. (2009). Nobel Prize 1937 to Albert von Szent-Gyorgyi: identification of vitamin C as the anti-

scorbutic factor. ActaU Paediatr,U 98(5), 915-919, 19239412.

28B

Multivitamins2B

Æ Albanes, D. (2009). Vitamin supplements and cancer prevention: where do randomized controlled trials stand?

JU Natl Cancer Inst,U 101(1), 2-4, 19116387.

Æ Bonjour, J. P. et al. (2009). Minerals and vitamins in bone health: the potential value of dietary enhancement. BrU

J Nutr,U 101(11), 1581-1596, 19335926. Æ Catov, J. M. et al. (2009). Association of periconceptional multivitamin use with reduced risk of preeclampsia

among normal-weight women in the Danish National Birth Cohort. AmU J Epidemiol,U 169(11), 1304-1311, 19372217. GVF-Update | Annual 2009 | 46

Æ Chen, P. et al. (2009). Single-laboratory validation of a high-performance liquid chromatographic-diode array detector-fluorescence detector/mass spectrometric method for simultaneous determination of water-

soluble vitamins in multivitamin dietary tablets. JU AOAC Int,U 92(2), 680-687, 19485230. Æ Gao, P. et al. (2008). Unexpected antitumorigenic effect of fenbendazole when combined with supplementary

vitamins. JU Am Assoc Lab Anim Sci,U 47(6), 37-40, 19049251. Æ Garcia-Guerra, A. et al. (2009). Prenatal multiple micronutrient supplementation impact on biochemical

indicators during pregnancy and postpartum. SaludU Publica Mex,U 51(4), 327-335, 19668928. Æ George, G. C. et al. (2009). Diet- and body size-related attitudes and behaviors associated with vitamin

supplement use in a representative sample of fourth-grade students in Texas. JU Nutr Educ Behav,U 41(2), 95-102, 19304254. Æ Gill, S. K. et al. (2009). The effectiveness of discontinuing iron-containing prenatal multivitamins on reducing

the severity of nausea and vomiting of pregnancy. JU Obstet Gynaecol,U 29(1), 13-16, 19280488. Æ Gosney, M. A. et al. (2008). Effect of micronutrient supplementation on mood in nursing home residents.

GerontologyU ,U 54(5), 292-299, 18463429. Æ Hamer, D. H. et al. (2009). Micronutrient deficiencies are associated with impaired immune response and

higher burden of respiratory infections in elderly Ecuadorians. JU Nutr,U 139(1), 113-119, 19056665.

Æ Hamrick, I. & Counts, S. H. (2008). Vitamin and mineral supplements. PrimU Care,U 35(4), 729-747, 18928827. Æ Handog, E. B. et al. (2009). A randomized, double-blind, placebo-controlled trial of oral procyanidin with

vitamins A, C, E for melasma among Filipino women. IntU J Dermatol,U 48(8), 896-901, 19659873.

Æ Hasan, R. et al. (2009). Self-reported vitamin supplementation in early pregnancy and risk of miscarriage. AmU J

Epidemiol,U 169(11), 1312-1318, 19372214. Æ Haugen, M. et al. (2008). Dietary supplements contribute substantially to the total nutrient intake in pregnant

Norwegian women. AnnU Nutr Metab,U 52(4), 272-280, 18645244.

Æ Honarbakhsh, S. & Schachter, M. (2009). Vitamins and cardiovascular disease. BrU J Nutr,U 101(8), 1113-1131, 18826726. Æ Klein, G. L. et al. (2009). Standard multivitamin supplementation does not improve vitamin D insufficiency after

burns. JU Bone Miner Metab,U 27(4), 502-506, 19291356. Æ Lea, R. et al. (2009). The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-

lowering and migraine disability. PharmacogenetU Genomics,U 19(6), 422-428, 19384265. Æ Mandic, M. L. et al. (2008). Intake of vitamins among clinically healthy adults from continental Croatia

estimated by 24-h recall. IntU J Food Sci Nutr,U 59(6), 457-464, 19086335. Æ Maraini, G. et al. (2009). Effects of multivitamin/mineral supplementation on plasma levels of nutrients. Report

No. 4 of the Italian-American clinical trial of nutritional supplements and age-related cataract. AnnU Ist

Super Sanita,U 45(2), 119-127, 19636163.

Æ Maughan, R. J. et al. (2007). The use of dietary supplements by athletes. JU Sports Sci,U 25 Suppl 1, S103-113, 18049988.

Æ Najm, W. & Lie, D. (2008). Dietary supplements commonly used for prevention. PrimU Care,U 35(4), 749-767, 18928828. Æ Paliakov, E. M. et al. (2009). Rapid quantitative determination of fat-soluble vitamins and coenzyme Q-10 in

human serum by reversed phase ultra-high pressure liquid chromatography with UV detection. JU

Chromatogr B Analyt Technol Biomed Life Sci,U 877(1-2), 89-94, 19041283. Æ Qiao, Y. L. et al. (2009). Total and cancer mortality after supplementation with vitamins and minerals: follow-up

of the Linxian General Population Nutrition Intervention Trial. JU Natl Cancer Inst,U 101(7), 507-518, 19318634. Æ Ramakrishnan, U. et al. (2009). Multiple micronutrient supplementation during early childhood increases child

size at 2 y of age only among high compliers. AmU J Clin Nutr,U 89(4), 1125-1131, 19225121. Æ Remington, R. et al. (2009). Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage

Alzheimer's disease: a placebo-controlled pilot study. AmU J Alzheimers Dis Other Demen,U 24(1), 27-33, 19056706. GVF-Update | Annual 2009 | 47

Æ Roberfroid, D. et al. (2008). Effects of maternal multiple micronutrient supplementation on fetal growth: a

double-blind randomized controlled trial in rural Burkina Faso. AmU J Clin Nutr,U 88(5), 1330-1340, 18996870. Æ Robson, P. J. et al. (2008). Sociodemographic, health and lifestyle characteristics reported by discrete groups of

adult dietary supplement users in Alberta, Canada: findings from The Tomorrow Project. PublicU Health

Nutr,U 11(12), 1238-1247, 18457599. Æ Shaikh, U. et al. (2009). Vitamin and mineral supplement use by children and adolescents in the 1999-2004 National Health and Nutrition Examination Survey: relationship with nutrition, food security, physical

activity, and health care access. ArchU Pediatr Adolesc Med,U 163(2), 150-157, 19188647. Æ Six, J. et al. (2008). [Dietary supplement use among adolescents in Germany. Results of EsKiMo].

BundesgesundheitsblattU Gesundheitsforschung Gesundheitsschutz,U 51(10), 1202-1209, 18985414. Æ Stephensen, C. B. & Livingston, K. A. (2009). Vitamin supplements and vaccines: maximize benefits, evaluate

potential risks. AmU J Clin Nutr,U 90(3), 457-458, 19640957. Æ Suleiman, A. A. et al. (2008). Prevalence of vitamin-mineral supplement use among Jordan University students.

SaudiU Med J,U 29(9), 1326-1331, 18813421. Æ Sullivan, K. M. et al. (2009). Multivitamin use in pregnant and nonpregnant women: results from the Behavioral

Risk Factor Surveillance System. PublicU Health Rep,U 124(3), 384-390, 19445414.

Æ Symington, A. (2008). South African court bans promotion of vitamin treatments as cures for AIDS. HIVU AIDS

Policy Law Rev,U 13(2-3), 43-44, 19297753. Æ Touvier, M. et al. (2009). Dietary patterns associated with vitamin/mineral supplement use and smoking among

women of the E3N-EPIC cohort. EurU J Clin Nutr,U 63(1), 39-47, 17882135. Æ Venkateswaran, V. et al. (2009). A combination of micronutrients is beneficial in reducing the incidence of

prostate cancer and increasing survival in the Lady transgenic model. CancerU Prev Res (Phila Pa),U 2(5), 473-483, 19401531. Æ Wang, C. et al. (2009). Effects of supplementation with multivitamin and mineral on blood pressure and C-

reactive protein in obese Chinese women with increased cardiovascular disease risk. AsiaU Pac J Clin Nutr,U 18(1), 121-130, 19329405. Æ Webb, A. L. et al. (2009). Effect of vitamin supplementation on breast milk concentrations of retinol,

carotenoids and tocopherols in HIV-infected Tanzanian women. EurU J Clin Nutr,U 63(3), 332-339, 17940544.

Æ Wehby, G. L. et al. (2009). Predictors of multivitamin use during pregnancy in Brazil. IntU J Public Health,U 54(2), 78-87, 19296054.

Æ Wright, C. I. et al. (2009). Acute autonomic effects of vitamins and fats in male smokers. EurU J Clin Nutr,U 63(2), 246-252, 17895912.

Æ Xu, Q. et al. (2009). Multivitamin use and telomere length in women. AmU J Clin Nutr,U 89(6), 1857-1863, 19279081. Æ Zeng, L. et al. (2008). Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled

trial. BmjU ,U 337, a2001, 18996930. Æ Zhang, Y. et al. (2009). Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study.

CancerU Causes Control,U 20(5), 691-698, 19093214.

Antioxidants3B

Æ Akinloye, O. et al. (2009). Changes in antioxidant status and lipid peroxidation in Nigerian patients with prostate

carcinoma. PolU Arch Med Wewn,U 119(9), 526-532, 19776696. GVF-Update | Annual 2009 | 48

Æ Akkus, S. et al. (2009). Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients

with fibromyalgia. CellU Biochem Funct,U 27(4), 181-185, 19319826. Æ Allen, S. et al. (2009). Association between antioxidant vitamins and asthma outcome measures: systematic

review and meta-analysis. ThoraxU ,U 64(7), 610-619, 19406861. Æ Alpsoy, L. et al. (2009). The antioxidant effects of vitamin A, C, and E on aflatoxin B1-induced oxidative stress in

human lymphocytes. ToxicolU Ind Health,U 25(2), 121-127, 19458134.

Æ Antioxidants: not for prevention. (2009). PrescrireU Int,U 18(99), 34, 19391300. Æ Asgari, M. M. et al. (2009). Antioxidant supplementation and risk of incident melanomas: results of a large

prospective cohort study. ArchU Dermatol,U 145(8), 879-882, 19687417. Æ Bae, S. C. et al. (2009). Effects of antioxidant supplements intervention on the level of plasma inflammatory

molecules and disease severity of rheumatoid arthritis patients. JU Am Coll Nutr,U 28(1), 56-62, 19571161. Æ Baillie, J. K. et al. (2009). Oral antioxidant supplementation does not prevent acute mountain sickness: double

blind, randomized placebo-controlled trial. QJMU ,U 102(5), 341-348, 19273551. Æ Bandera, E. V. et al. (2009). Antioxidant vitamins and the risk of endometrial cancer: a dose-response meta-

analysis. CancerU Causes Control,U 20(5), 699-711, 19083131. Æ Bayiroglu, F. et al. (2009). Altered antioxidant status and increased lipid peroxidation in children with acute

gastroenteritis admitted to a pediatric emergency service. JU Emerg Med,U 36(3), 227-231, 18164165. Æ Bjelakovic, G. et al. (2008). Systematic review: primary and secondary prevention of gastrointestinal cancers with

antioxidant supplements. AlimentU Pharmacol Ther,U 28(6), 689-703, 19145725. Æ Braskett, M. & Riedl, M. A. (2009). Novel antioxidant approaches to the treatment of upper airway inflammation.

CurrU Opin Allergy Clin Immunol,U 19935060.

Æ Briasoulis, A. et al. (2009). The oxidative stress menace to coronary vasculature: any place for antioxidants? CurrU

Pharm Des,U 15(26), 3078-3090, 19754382. Æ Calabrese, V. et al. (2009). Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases.

FrontU Biosci,U 14, 376-397, 19273073. Æ Chen, K. et al. (2009). Antioxidant vitamin status during pregnancy in relation to cognitive development in the

first two years of life. EarlyU Hum Dev,U 85(7), 421-427, 19286336. Æ Czernichow, S. et al. (2009). Effects of long-term antioxidant supplementation and association of serum

antioxidant concentrations with risk of metabolic syndrome in adults. UAm J Clin NutrU, 90(2), 329-335, 19491388. Æ De Rosa, S. et al. Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease:

Does the Actual Knowledge Justify a Clinical Approach? CurrU Vasc Pharmacol,U 19758111. Æ Di Giacomo, C. et al. (2009). Oxidative and antioxidant status in plasma of runners: effect of oral supplementation

with natural antioxidants. JU Med Food,U 12(1), 145-150, 19298208.

Æ Elgoweini, M. & Nour El Din, N. (2009). Response of vitiligo to narrowband ultraviolet B and oral antioxidants. JU

Clin Pharmacol,U 49(7), 852-855, 19553407. Æ Evans, J. (2008). Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review

and meta-analysis. EyeU ,U 22(6), 751-760, 18425071.

Æ Ferreira, I. C. et al. (2009). Antioxidants in wild mushrooms. CurrU Med Chem,U 16(12), 1543-1560, 19355906.

Æ Getoff, N. (2009). Vitamin free radicals and their anticancer action. Review. InU Vivo,U 23(4), 599-611, 19567396.

Æ Gieseg, S. P. et al. (2009). Macrophage antioxidant protection within atherosclerotic plaques. FrontU Biosci,U 14, 1230-1246, 19273127. Æ Goldfarb, A. H. et al. (2009). Protein and antioxidants in an isocaloric carbohydrate drink: effect on plasma

oxidative-stress markers and IL-6. IntU J Sport Nutr Exerc Metab,U 19(2), 115-126, 19478337. Æ Greenlee, H. et al. (2009). Use of antioxidant supplements during breast cancer treatment: a comprehensive

review. BreastU Cancer Res Treat,U 115(3), 437-452, 18839308. Æ Hadley, M. et al. (2009). Antioxidant effect on urinary excretion of malondialdehyde in non-athletes during

aerobic training. IntU J Vitam Nutr Res,U 79(1), 5-13, 19838998. GVF-Update | Annual 2009 | 49

Æ Heistad, D. D. et al. (2009). Novel aspects of oxidative stress in cardiovascular diseases. CircU J,U 73(2), 201-207, 19110503. Æ Hengstermann, S. et al. (2008). Altered status of antioxidant vitamins and fatty acids in patients with inactive

inflammatory bowel disease. ClinU Nutr,U 27(4), 571-578, 18316141. Æ Isaksson, C. et al. (2009). The impact of urban environment on oxidative damage (TBARS) and antioxidant

systems in lungs and liver of great tits, Parus major. EnvironU Res,U 109(1), 46-50, 19054507.

Æ Jain, A. et al. (2009). Antioxidant status and smoking habits: relationship with diet. SingaporeU Med J,U 50(6), 624- 627, 19551318. Æ Janicki-Deverts, D. et al. (2009). Socioeconomic status, antioxidant micronutrients, and correlates of oxidative

damage: the Coronary Artery Risk Development in Young Adults (CARDIA) study. PsychosomU Med,U 71(5), 541-548, 19414620. Æ Johansson, C. et al. (2008). Down-regulation of oxidative DNA lesions in human mononuclear cells after

antioxidant supplementation correlates to increase of gamma-tocopherol. IntU J Vitam Nutr Res,U 78(4-5), 183-194, 19326341.

Æ Johnson, E. J. (2009). Age-related macular degeneration and antioxidant vitamins: recent findings. CurrU Opin Clin

Nutr Metab Care,U 19841580.

Æ Joshi, S. R. et al. (2008). High maternal plasma antioxidant concentrations associated with preterm delivery. AnnU

Nutr Metab,U 53(3-4), 276-282, 19141991. Æ Kamgar, M. et al. (2009). Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients

with end-stage renal disease. JU Natl Med Assoc,U 101(4), 336-344, 19397224. Æ Katsiki, N. & Manes, C. (2009). Is there a role for supplemented antioxidants in the prevention of atherosclerosis?

ClinU Nutr,U 28(1), 3-9, 19042058. Æ Kelvin, E. A. et al. (2009). Modulation of the effect of prenatal PAH exposure on PAH-DNA adducts in cord blood

by plasma antioxidants. CancerU Epidemiol Biomarkers Prev,U 18(8), 2262-2268, 19661084. Æ Kontek, R. et al. (2009). Genotoxicity of irinotecan and its modulation by vitamins A, C and E in human

lymphocytes from healthy individuals and cancer patients. ToxicolU In Vitro,U 19853651. Æ Krajcovicova-Kudlackova, M. et al. (2009). Plasma concentrations of selected antioxidants in autistic children and

adolescents. BratislU Lek Listy,U 110(4), 247-250, 19507654. Æ Kramer, M. S. et al. (2009). Antioxidant vitamins, long-chain Fatty acids, and spontaneous preterm birth.

EpidemiologyU ,U 20(5), 707-713, 19568173. Æ Kurahashi, N. et al. (2009). Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of

hepatocellular carcinoma: a prospective cohort study in Japan. BrU J Cancer,U 100(1), 181-184, 19127270. Æ Labonte, M. et al. (2008). Effects of antioxidant supplements combined with resistance exercise on gains in fat-

free mass in healthy elderly subjects: a pilot study. JU Am Geriatr Soc,U 56(9), 1766-1768, 19166454. Æ Ledo, A. et al. (2009). Human milk enhances antioxidant defenses against hydroxyl radical aggression in preterm

infants. AmU J Clin Nutr,U 89(1), 210-215, 19056604. Æ Lee, C. Y. et al. (2009). Limited antioxidant effect after consumption of a single dose of tomato sauce by young

males, despite a rise in plasma lycopene. FreeU Radic Res,U 43(6), 622-628, 19437211. Æ Lin, J. et al. (2009). Vitamins C and E and beta carotene supplementation and cancer risk: a randomized

controlled trial. JU Natl Cancer Inst,U 101(1), 14-23, 19116389. Æ Mahdavi, R. et al. (2009). Evaluation of oxidative stress, antioxidant status and serum vitamin C levels in cancer

patients. BiolU Trace Elem Res,U 130(1), 1-6, 19148586. Æ Markart, P. et al. (2009). Alveolar oxidative stress is associated with elevated levels of nonenzymatic low- molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung

diseases. AntioxidU Redox Signal,U 11(2), 227-240, 18783310. Æ Michikawa, T. et al. (2009). Serum antioxidants and age-related macular degeneration among older Japanese.

AsiaU Pac J Clin Nutr,U 18(1), 1-7, 19329388. Æ Mier-Cabrera, J. et al. (2009). Women with endometriosis improved their peripheral antioxidant markers after the

application of a high antioxidant diet. ReprodU Biol Endocrinol,U 7, 54, 19476631. GVF-Update | Annual 2009 | 50

Æ Minelli, A. et al. (2009). Oxidative stress-related aging: A role for prostate cancer? BiochimU Biophys Acta,U 1795(2), 83-91, 19121370. Æ Mohammed, H. O. et al. (2008). The role of dietary antioxidant insufficiency on the permeability of the blood-

brain barrier. JU Neuropathol Exp Neurol,U 67(12), 1187-1193, 19018244. Æ Nadeem, A. et al. (2008). Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data

and possible therapeutic options. TherU Adv Respir Dis,U 2(4), 215-235, 19124374. Æ Nielsen, H. G. et al. (2008). Effect of antioxidant supplementation on leucocyte expression of reactive oxygen

species in athletes. ScandU J Clin Lab Invest,U 68(7), 526-533, 19378423. Æ Nourmohammadi, I. et al. (2008). Association of serum alpha-tocopherol, retinol and ascorbic acid with the risk of

cataract development. AnnU Nutr Metab,U 52(4), 296-298, 18663288. Æ Oresajo, C. et al. (2008). Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and

phloretin against ultraviolet-induced photodamage in human skin. JU Cosmet Dermatol,U 7(4), 290-297, 19146606. Æ Orhon, F. S. et al. (2009). The influence of maternal smoking on maternal and newborn oxidant and antioxidant

status. EurU J Pediatr,U 168(8), 975-981, 19034508. Æ Paran, E. et al. (2009). The effects of natural antioxidants from tomato extract in treated but uncontrolled

hypertensive patients. CardiovascU Drugs Ther,U 23(2), 145-151, 19052855.

Æ Patil, S. B. et al. (2008). Lipid peroxidation and antioxidant status in hypertensive pregnancies. ClinU Exp Obstet

Gynecol,U 35(4), 272-274, 19205442. Æ Pialoux, V. et al. (2009). Effects of the 'live high-train low' method on prooxidant/antioxidant balance on elite

athletes. EurU J Clin Nutr,U 63(6), 756-762, 18398420.

Æ Pratico, D. (2008). Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. TrendsU Pharmacol Sci,U 29(12), 609-615, 18838179.

Æ Ren, H. et al. (2008). Patients with sickle cell disease have reduced blood antioxidant protection. IntU J Vitam Nutr

Res,U 78(3), 139-147, 19003736. Æ Riccioni, G. et al. (2009). Relationship between plasma antioxidant concentrations and carotid intima-media

thickness: the Asymptomatic Carotid Atherosclerotic Disease In Manfredonia Study. EurU J Cardiovasc Prev

Rehabil,U 16(3), 351-357, 19384236.

Æ Ristow, M. et al. (2009). Antioxidants prevent health-promoting effects of physical exercise in humans. ProcU Natl

Acad Sci U S A,U 106(21), 8665-8670, 19433800.

Æ Serafini, M. et al. (2009). Antioxidant activity of blueberry fruit is impaired by association with milk. FreeU Radic

Biol Med,U 46(6), 769-774, 19135520. Æ Sezikli, M. et al. (2009). Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C

and E increase the eradication rate? HelicobacterU ,U 14(4), 280-285, 19674132.

Æ Shah, F. D. et al. (2009). Evaluation of plasma non-enzymatic antioxidants in breast cancer etiology. AsianU Pac J

Cancer Prev,U 10(1), 91-96, 19469632. Æ Sharif, M. A. et al. (2009). Effects of antioxidants on endothelial function in human saphenous vein in an ex vivo

model. AngiologyU ,U 60(4), 448-454, 18796454. Æ Sram, R. J. et al. (2009). Effect of vitamin levels on biomarkers of exposure and oxidative damage-the EXPAH

study. MutatU Res,U 672(2), 129-134, 19071228. Æ Srivatsan, R. et al. (2009). Antioxidants and lipid peroxidation status in diabetic patients with and without

complications. UArch Iran Med,U 12(2), 121-127, 19249880. Æ Sundl, I. et al. (2009). Antioxidant status of patients on peritoneal dialysis: associations with inflammation and

glycoxidative stress. PeritU Dial Int,U 29(1), 89-101, 19164258. Æ Suresh, D. R. et al. (2009). Total antioxidant capacity--a novel early bio-chemical marker of oxidative stress in HIV

infected individuals. JU Biomed Sci,U 16, 61, 19583866. Æ Taylor, K. et al. (2009). Effect of antioxidant supplementation of cryopreservation medium on post-thaw integrity

of human spermatozoa. ReprodU Biomed Online,U 18(2), 184-189, 19192337. GVF-Update | Annual 2009 | 51

Æ Thomson, M. J. et al. (2009). Antioxidant treatment for heart failure: friend or foe? QJMU ,U 102(5), 305-310, 19095676. Æ Tijerina-Saenz, A. et al. (2009). Antioxidant capacity of human milk and its association with vitamins A and E and

fatty acid composition. ActaU Paediatr,U 98(11), 1793-1798, 19807706. Æ van der Pols, J. C. et al. (2009). Serum antioxidants and skin cancer risk: an 8-year community-based follow-up

study. CancerU Epidemiol Biomarkers Prev,U 18(4), 1167-1173, 19336544. Æ Wang, Y. Z. et al. (2009). Concentrations of antioxidant vitamins in maternal and cord serum and their effect on

birth outcomes. JU Nutr Sci Vitaminol (Tokyo),U 55(1), 1-8, 19352057. Æ Wray, D. W. et al. (2009). Antioxidants and aging: NMR-based evidence of improved skeletal muscle perfusion

and energetics. AmU J Physiol Heart Circ Physiol,U 297(5), H1870-1875, 19767527.

Æ Yeum, K. J. et al. (2009). Synergistic interactions of antioxidant nutrients in a biological model system. NutritionU ,U 25(7-8), 839-846, 19398299. Æ Yong, L. C. et al. (2009). High dietary antioxidant intakes are associated with decreased chromosome

translocation frequency in airline pilots. AmU J Clin Nutr,U 90(5), 1402-1410, 19793852.

Æ Zadak, Z. et al. (2009). Antioxidants and vitamins in clinical conditions. PhysiolU Res,U 58 Suppl 1, S13-17, 19857031.

Æ Zwolinska, D. et al. (2009). Oxidative stress in children on peritoneal dialysis. PeritU Dial Int,U 29(2), 171-177, 19293354.

Carnitine4B

Æ Anil, M. et al. (2009). Serum and muscle carnitine levels in epileptic children receiving sodium valproate. JU Child

Neurol,U 24(1), 80-86, 19168820.

Æ Arduini, A. et al. (2008). Carnitine in metabolic disease: potential for pharmacological intervention. PharmacolU

Ther,U 120(2), 149-156, 18793670. Æ Azzollini, N. et al. (2008). Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney

transplantation. KidneyU Int,U 74(11), 1420-1428, 19008910. Æ Broad, E. M. et al. (2008). Carbohydrate, protein, and fat metabolism during exercise after oral carnitine

supplementation in humans. IntU J Sport Nutr Exerc Metab,U 18(6), 567-584, 19164828. Æ Cao, Y. et al. (2009). Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-

carnitine after single oral administration of L-carnitine in healthy volunteers. ClinU Invest Med,U 32(1), E13- 19, 19178874. Æ Cruciani, R. A. et al. (2009). L-carnitine supplementation in patients with advanced cancer and carnitine

deficiency: a double-blind, placebo-controlled study. JU Pain Symptom Manage,U 37(4), 622-631, 18809275. Æ El-Beshlawy, A. et al. (2008). Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine

therapy. PediatrU Hematol Oncol,U 25(8), 734-743, 19065439.

Æ Evans, J. D. et al. (2008). Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy. AnnU

Pharmacother,U 42(11), 1686-1691, 18940920. Æ Fingerhut, R. et al. (2009). Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter

deficiency. AnalU Chem,U 81(9), 3571-3575, 19323528. Æ Galvano, F. et al. (2009). Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and

apoprotein(a) in type 2 diabetes mellitus. ExpertU Opin Pharmacother,U 10(12), 1875-1882, 19618992. Æ Hirche, F. et al. (2009). Determination of carnitine, its short chain acyl esters and metabolic precursors

trimethyllysine and gamma-butyrobetaine by quasi-solid phase extraction and MS/MS detection. JU

Chromatogr B Analyt Technol Biomed Life Sci,U 877(22), 2158-2162, 19523885. GVF-Update | Annual 2009 | 52

Æ Hockenberry, M. J. et al. (2009). Carnitine plasma levels and fatigue in children/adolescents receiving cisplatin,

ifosfamide, or doxorubicin. JU Pediatr Hematol Oncol,U 31(9), 664-669, 19707160. Æ Janiri, L. et al. (2009). Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.

ClinU Neuropharmacol,U 32(1), 35-40, 18978503. Æ Keller, U. et al. (2009). Carnitine status of pregnant women: effect of carnitine supplementation and correlation

between iron status and plasma carnitine concentration. EurU J Clin Nutr,U 63(9), 1098-1105, 19491916.

Æ Malaguarnera, M. et al. (2008). Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. DigU Dis Sci,U 53(11), 3018-3025, 18357530. Æ Malaguarnera, M. et al. (2009). L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with

diabetes. AmU J Clin Nutr,U 89(1), 71-76, 19056606. Æ Malaguarnera, M. et al. (2009). Effect of L-carnitine on the size of low-density lipoprotein particles in type 2

diabetes mellitus patients treated with simvastatin. MetabolismU ,U 58(11), 1618-1623, 19604523. Æ Moselhy, S. S. & Demerdash, S. H. (2009). Serum free L-carnitine in association with myoglobin as a diagnostic

marker of acute myocardial infarction. ClinU Biochem,U 42(1-2), 78-82, 18930039.

Æ Nasser, M. et al. (2009). Carnitine supplementation for inborn errors of metabolism. CochraneU Database Syst

Rev,U (2), CD006659, 19370646. Æ Noland, R. C. et al. (2009). Carnitine insufficiency caused by aging and overnutrition compromises

mitochondrial performance and metabolic control. JU Biol Chem,U 284(34), 22840-22852, 19553674.

Æ Pescosolido, N. et al. (2008a). The aging eye and the role of L-carnitine and its derivatives. DrugsU R D,U 9 Suppl 1, 3-14, 19105587.

Æ Pescosolido, N. et al. (2008b). Inherited ocular disorders, ophthalmic procedures and carnitines. DrugsU R D,U 9 Suppl 1, 23-32, 19105589. Æ Pescosolido, N. et al. (2008c). Ocular disorders secondary to systemic disease and the potential role of

carnitines. DrugsU R D,U 9 Suppl 1, 15-22, 19105588.

Æ Pescosolido, N. et al. (2009). L-carnitine and short chain ester in tears from patients with dry eye. OptomU Vis Sci,U 86(2), E132-138, 19156017. Æ Reuter, S. E. et al. (2008). Determination of the reference range of endogenous plasma carnitines in healthy

adults. AnnU Clin Biochem,U 45(Pt 6), 585-592, 18782814. Æ Reuter, S. E. et al. (2009). Endogenous plasma carnitine pool composition and response to erythropoietin

treatment in chronic haemodialysis patients. NephrolU Dial Transplant,U 24(3), 990-996, 18987259. Æ Ruggenenti, P. et al. (2009). Ameliorating hypertension and insulin resistance in subjects at increased

cardiovascular risk: effects of acetyl-L-carnitine therapy. HypertensionU ,U 54(3), 567-574, 19620516. Æ Schoffski, P. et al. (2009). Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-

carnitine, in patients with unresectable advanced renal cell carcinoma. MarU Drugs,U 7(1), 57-70, 19370171. Æ Schulpis, K. H. et al. (2009). Evidence for the participation of the stimulated sympathetic nervous system in the

regulation of carnitine blood levels of soccer players during a game. MetabolismU ,U 58(8), 1080-1086, 19428035. Æ Shenk, J. C. et al. (2009). The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a

model of human Alzheimer's disease. JU Neurol Sci,U 283(1-2), 199-206, 19342064.

Æ Sitta, A. et al. (2009). L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. CellU Mol

Neurobiol,U 29(2), 211-218, 18814025. Æ Volek, J. S. et al. (2008). Effects of carnitine supplementation on flow-mediated dilation and vascular

inflammatory responses to a high-fat meal in healthy young adults. AmU J Cardiol,U 102(10), 1413-1417, 18993165. Æ Walter, J. H. et al. (2009). Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and

reference data from a large cohort study. JU Inherit Metab Dis,U 32(1), 95-101, 19191006.

GVF-Update | Annual 2009 | 53

Carotenoids5B

Æ Akbaraly, T. N. et al. (2009). Total plasma carotenoids and mortality in the elderly: results of the Epidemiology of

Vascular Ageing (EVA) study. BrU J Nutr,U 101(1), 86-92, 18507882. Æ Al-Wadei, H. A. & Schuller, H. M. (2009). Non-genomic inhibitory signaling of beta-carotene in squamous cell

carcinoma of the lungs. IntU J Oncol,U 34(4), 1093-1098, 19287967. Æ Albanes, D. (2009). Vitamin supplements and cancer prevention: where do randomized controlled trials stand?

JU Natl Cancer Inst,U 101(1), 2-4, 19116387. Æ Alipanah, N. et al. (2009). Low serum carotenoids are associated with a decline in walking speed in older

women. JU Nutr Health Aging,U 13(3), 170-175, 19262947. Æ Apel, W. & Bock, R. (2009). Enhancement of carotenoid biosynthesis in transplastomic tomatoes by induced

lycopene-to-provitamin A conversion. PlantU Physiol,U 151(1), 59-66, 19587100. Æ Arnlov, J. et al. (2009). Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of

Adult Men (ULSAM) study. DiabetologiaU ,U 52(1), 97-105, 18985315. Æ Aung, H. H. et al. (2009). Effects of dietary carotenoids on mouse lung genomic profiles and their modulatory

effects on short-term cigarette smoke exposures. GenesU Nutr,U 4(1), 23-39, 19104882. Æ Banerjee, S. et al. (2009). Trial of lycopene to prevent pre-eclampsia in healthy primigravidas: results show

some adverse effects. JU Obstet Gynaecol Res,U 35(3), 477-482, 19527386.

Æ Bayerl, C. (2008). Beta-carotene in dermatology: Does it help? ActaU Dermatovenerol Alp Panonica Adriat,U 17(4), 160-162, 164-166, 19104740. Æ Bernstein, P. S. et al. (2009). The value of measurement of macular carotenoid pigment optical densities and

distributions in age-related macular degeneration and other retinal disorders. VisionU Res,U 19854211. Æ Bhosale, P. et al. (2009). Purification and partial characterization of a lutein-binding protein from human retina.

BiochemistryU ,U 48(22), 4798-4807, 19402606. Æ Blume-Peytavi, U. et al. (2009). Cutaneous lycopene and beta-carotene levels measured by resonance Raman

spectroscopy: high reliability and sensitivity to oral lactolycopene deprivation and supplementation. EurU

J Pharm Biopharm,U 73(1), 187-194, 19442725. Æ Boon, C. S. et al. (2009). Role of iron and hydroperoxides in the degradation of lycopene in oil-in-water

emulsions. JU Agric Food Chem,U 57(7), 2993-2998, 19265448.

Æ Brazionis, L. et al. (2009). Plasma carotenoids and diabetic retinopathy. BrU J Nutr,U 101(2), 270-277, 18554424.

Æ Buajeeb, W. et al. (2008). Reduction of micronuclei in oral lichen planus supplemented with beta-carotene. JU

Oral Sci,U 50(4), 461-467, 19106475. Æ Bureyko, T. et al. (2009). Reduced growth and integrin expression of prostate cells cultured with lycopene,

vitamin E and fish oil in vitro. BrU J Nutr,U 101(7), 990-997, 18718045. Æ Burri, B. J. et al. (2009). Absorption estimates improve the validity of the relationship between dietary and

serum lycopene. NutritionU ,U 19819675. Æ Carpentier, S. et al. (2009). Associations between lutein, zeaxanthin, and age-related macular degeneration: an

overview. CritU Rev Food Sci Nutr,U 49(4), 313-326, 19234943. Æ Chan, C. M. et al. (2009). Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by

suppression of PI3K/Akt and MAPK pathways. BiochemU Biophys Res Commun,U 388(1), 172-176, 19664603. Æ Chung, H. Y. et al. (2009). Site-specific concentrations of carotenoids in adipose tissue: relations with dietary

and serum carotenoid concentrations in healthy adults. AmU J Clin Nutr,U 90(3), 533-539, 19587090.

Æ Coleman, H. R. et al. (2008). Age-related macular degeneration. LancetU ,U 372(9652), 1835-1845, 19027484. Æ Czeczuga-Semeniuk, E. & Wolczynski, S. (2008). Dietary carotenoids in normal and pathological tissues of

corpus uteri. FoliaU Histochem Cytobiol,U 46(3), 283-290, 19056531. GVF-Update | Annual 2009 | 54

Æ Darvin, M. E. et al. (2009). In vivo distribution of carotenoids in different anatomical locations of human skin:

comparative assessment with two different Raman spectroscopy methods. ExpU Dermatol,U 19650865. Æ Day, R. M. et al. (2009). Plasma levels of retinoids, carotenoids and tocopherols in patients with mild obstructive

sleep apnoea. RespirologyU ,U 19761534. Æ Del Rio, D. et al. (2009). Intervention study with a high or low antioxidant capacity diet: effects on circulating

beta-carotene. EurU J Clin Nutr,U 63(10), 1220-1225, 19536163. Æ Djuric, Z. et al. (2009). A Mediterranean dietary intervention in healthy American women changes plasma

carotenoids and fatty acids in distinct clusters. NutrU Res,U 29(3), 156-163, 19358929. Æ Dorjgochoo, T. et al. (2009). Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the

Shanghai Women Health Study (SWHS). BreastU Cancer Res Treat,U 117(2), 381-389, 19096929. Æ Ellinger, S. et al. (2009). [Tomatoes and lycopene in prevention and therapy--is there an evidence for prostate

diseases?]. AktuelleU Urol,U 40(1), 37-43, 19177320. Æ Farwell, W. R. et al. (2008). The relationship between total plasma carotenoids and risk factors for chronic

disease among middle-aged and older men. BrU J Nutr,U 100(4), 883-889, 18334043. Æ Fassett, R. G. et al. (2008). Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal

transplant patients (Xanthin): a randomised controlled trial. BMCU Nephrol,U 9, 17, 19091127. Æ Fassett, R. G. & Coombes, J. S. (2009). Astaxanthin, oxidative stress, inflammation and cardiovascular disease.

FutureU Cardiol,U 5(4), 333-342, 19656058. Æ Ferrucci, L. et al. (2009). Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects

circulating levels of carotenoids: a genome-wide association study. AmU J Hum Genet,U 84(2), 123-133, 19185284. Æ Forman, M. R. et al. (2009). Components of variation in serum carotenoid concentrations: the Polyp Prevention

Trial. EurU J Clin Nutr,U 63(6), 763-770, 18414504.

Æ Fornelli, F. et al. (2007). The influence of lycopene on the proliferation of human breast cell line (MCF-7). ToxicolU

In Vitro,U 21(2), 217-223, 17140762. Æ Granado-Lorencio, F. et al. (2009). Bioavailability of carotenoids and alpha-tocopherol from fruit juices in the

presence of absorption modifiers: in vitro and in vivo assessment. BrU J Nutr,U 101(4), 576-582, 18616839. Æ Granado-Lorencio, F. et al. (2008). Seasonal variation of serum alpha- and beta-cryptoxanthin and 25-OH-

vitamin D(3) in women with osteoporosis. OsteoporosU Int,U 19(5), 717-720, 17882465.

Æ Hammond, B. R., Jr. (2008). Possible role for dietary lutein and zeaxanthin in visual development. NutrU Rev,U 66(12), 695-702, 19019038. Æ Helmersson, J. et al. (2009). Low dietary intake of beta-carotene, alpha-tocopherol and ascorbic acid is

associated with increased inflammatory and oxidative stress status in a Swedish cohort. BrU J Nutr,U 101(12), 1775-1782, 19079838. Æ Hesterberg, K. et al. (2009). Raman spectroscopic analysis of the increase of the carotenoid antioxidant

concentration in human skin after a 1-week diet with ecological eggs. JU Biomed Opt,U 14(2), 024039, 19405767. Æ Hozawa, A. et al. (2009). Circulating carotenoid concentrations and incident hypertension: the Coronary Artery

Risk Development in Young Adults (CARDIA) study. JU Hypertens,U 27(2), 237-242, 19155781. Æ Hughes, K. J. et al. (2009). Plasma Carotenoids and Biomarkers of Oxidative Stress in Patients with prior Head

and Neck Cancer. BiomarkU Insights,U 4, 17-26, 19554200. Æ Jang, S. H. et al. (2009). Mechanism of beta-carotene-induced apoptosis of gastric cancer cells: involvement of

ataxia-telangiectasia-mutated. AnnU N Y Acad Sci,U 1171, 156-162, 19723050. Æ Kabat, G. C. et al. (2009). Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in

relation to breast cancer risk among postmenopausal women. AmU J Clin Nutr,U 90(1), 162-169, 19474140. Æ Kalariya, N. M. et al. (2009). Genotoxic effects of carotenoid breakdown products in human retinal pigment

epithelial cells. CurrU Eye Res,U 34(9), 737-747, 19839867. Æ Karppi, J. et al. (2009). Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor

(KIHD) study. AnnU Epidemiol,U 19(7), 512-518, 19443241. GVF-Update | Annual 2009 | 55

Æ Khachik, F. & Chang, A. N. (2009). Total synthesis of (3R,3'R,6'R)-lutein and its stereoisomers. JU Org Chem,U 74(10), 3875-3885, 19391613.

Æ Khoo, H. E. et al. (2008). Carotenoid content of underutilized tropical fruits. PlantU Foods Hum Nutr,U 63(4), 170- 175, 18810641. Æ Lauretani, F. et al. (2008). Low total plasma carotenoids are independent predictors of mortality among older

persons: the InCHIANTI study. EurU J Nutr,U 47(6), 335-340, 18709473. Æ Lee, J. E. et al. (2009). Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of

13 prospective studies. CancerU Epidemiol Biomarkers Prev,U 18(6), 1730-1739, 19505906. Æ Leung, W. C. et al. (2009). Two common single nucleotide polymorphisms in the gene encoding beta-carotene

15,15'-monoxygenase alter beta-carotene metabolism in female volunteers. FasebU J,U 23(4), 1041-1053, 19103647. Æ Li, L. et al. (2009). Supplementation with lutein or lutein plus green tea extracts does not change oxidative

stress in adequately nourished older adults. JU Nutr Biochem,U 19447020. Æ Liu, C. et al. (2009). Modulation of lung molecular biomarkers by beta-carotene in the Physicians' Health Study.

CancerU ,U 115(5), 1049-1058, 19142877. Æ Liu, X. & Osawa, T. (2009). Astaxanthin protects neuronal cells against oxidative damage and is a potent

candidate for brain food. ForumU Nutr,U 61, 129-135, 19367117. Æ Lorenzo, Y. et al. (2009). The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in

addition to acting as an antioxidant in human cells. CarcinogenesisU ,U 30(2), 308-314, 19056931. Æ Luo, M. et al. (2009). Prospective analysis of serum carotenoids, vitamin A, and tocopherols in adults with short

bowel syndrome undergoing intestinal rehabilitation. NutritionU ,U 25(4), 400-407, 19081706. Æ Ma, L. et al. (2009). A 12-week lutein supplementation improves visual function in Chinese people with long-

term computer display light exposure. BrU J Nutr,U 102(2), 186-190, 19586568. Æ Maiani, G. et al. (2009). Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and

their protective role in humans. MolU Nutr Food Res,U 53 Suppl 2, S194-218, 19035552. Æ Markovitch, D. et al. (2009). Lycopene supplementation (passata sauce) reduces apoptosis but does not affect

oxidant-responsive heme oxygenase-1 in human lymphocytes. NutritionU ,U 25(6), 668-675, 19121922. Æ Martin, H. D. et al. (2009). 3,3'-Dihydroxyisorenieratene, a natural carotenoid with superior antioxidant and

photoprotective properties. AngewU Chem Int Ed Engl,U 48(2), 400-403, 19034947.

Æ Mignone, L. I. et al. (2009). Dietary carotenoids and the risk of invasive breast cancer. IntU J Cancer,U 124(12), 2929-2937, 19330841. Æ Mikhak, B. et al. (2008). Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with

carotenoid levels and prostate cancer risk. CarcinogenesisU ,U 29(12), 2335-2340, 18784358.

Æ Miyashita, K. (2009). Function of marine carotenoids. ForumU Nutr,U 61, 136-146, 19367118. Æ Moeller, S. M. et al. (2009). Women's Health Initiative diet intervention did not increase macular pigment

optical density in an ancillary study of a subsample of the Women's Health Initiative. JU Nutr,U 139(9), 1692-1699, 19587126. Æ Musa-Veloso, K. et al. (2009). Influence of observational study design on the interpretation of cancer risk

reduction by carotenoids. NutrU Rev,U 67(9), 527-545, 19703260.

Æ Nagao, A. (2009). Absorption and function of dietary carotenoids. ForumU Nutr,U 61, 55-63, 19367110. Æ Nakagawa, K. et al. (2009). Antioxidant effect of lutein towards phospholipid hydroperoxidation in human

erythrocytes. BrU J Nutr,U 102(9), 1280-1284, 19622187. Æ Nakajima, Y. et al. (2008). Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-

vitro and in mice in-vivo. JU Pharm Pharmacol,U 60(10), 1365-1374, 18812030.

Æ Nakajima, Y. et al. (2009). Zeaxanthin, a retinal carotenoid, protects retinal cells against oxidative stress. CurrU

Eye Res,U 34(4), 311-318, 19373580. Æ Nakano, M. et al. (2008). Inhibitory effect of astraxanthin combined with Flavangenol on oxidative stress

biomarkers in streptozotocin-induced diabetic rats. IntU J Vitam Nutr Res,U 78(4-5), 175-182, 19326340. GVF-Update | Annual 2009 | 56

Æ Neuhouser, M. L. et al. (2009). Dietary supplement use and prostate cancer risk in the Carotene and Retinol

Efficacy Trial. CancerU Epidemiol Biomarkers Prev,U 18(8), 2202-2206, 19661078. Æ Okuda, M. et al. (2009). Carotenoid, tocopherol, and fatty acid biomarkers and dietary intake estimated by

using a brief self-administered diet history questionnaire for older Japanese children and adolescents. JU

Nutr Sci Vitaminol (Tokyo),U 55(3), 231-241, 19602831. Æ Olson, J. B. et al. (2008). Lycopene incorporation into egg yolk and effects on laying hen immune function.

PoultU Sci,U 87(12), 2573-2580, 19038813. Æ Palozza, P. et al. (2009). Effect of beta-carotene-rich tomato lycopene beta-cyclase ( tlcy-b) on cell growth

inhibition in HT-29 colon adenocarcinoma cells. BrU J Nutr,U 102(2), 207-214, 19105854. Æ Palozza, P. et al. (2009). Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in

human colon cancer cells. CancerU Lett,U 283(1), 108-117, 19423215. Æ Park, S. et al. (2009). Synergic effects of alpha-tocopherol and beta-carotene on tert-butylhydroperoxide-

induced HepG2 cell injury. ToxicolU Ind Health,U 25(4-5), 311-320, 19651802. Æ Pelucchi, C. et al. (2008). Dietary intake of carotenoids and retinol and endometrial cancer risk in an Italian case-

control study. CancerU Causes Control,U 19(10), 1209-1215, 18592384.

Æ Roberts, R. L. et al. (2009). Lutein and zeaxanthin in eye and skin health. ClinU Dermatol,U 27(2), 195-201, 19168000. Æ Ruhl, R. et al. (2008). Modulation of plasma all-trans retinoic acid concentrations by the consumption of

carotenoid-rich vegetables. NutritionU ,U 24(11-12), 1224-1226, 18653315. Æ Saedisomeolia, A. et al. (2009). Lycopene enrichment of cultured airway epithelial cells decreases the

inflammation induced by rhinovirus infection and lipopolysaccharide. JU Nutr Biochem,U 20(8), 577-585, 18824341. Æ Sahni, S. et al. (2009a). Inverse association of carotenoid intakes with 4-y change in bone mineral density in

elderly men and women: the Framingham Osteoporosis Study. AmU J Clin Nutr,U 89(1), 416-424, 19056581. Æ Sahni, S. et al. (2009b). Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-

year follow-up from the Framingham Osteoporosis Study. JU Bone Miner Res,U 24(6), 1086-1094, 19138129. Æ Satia, J. A. et al. (2009). Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung

cancer risk: results from the VITamins And Lifestyle (VITAL) study. AmU J Epidemiol,U 169(7), 815-828, 19208726. Æ Seo, J. Y. et al. (2009). Protective effect of lycopene on oxidative stress-induced cell death of pancreatic acinar

cells. AnnU N Y Acad Sci,U 1171, 570-575, 19723106. Æ Seren, S. et al. (2008). Potential role of lycopene in the treatment of hepatitis C and prevention of

hepatocellular carcinoma. NutrU Cancer,U 60(6), 729-735, 19005972.

Æ Shen, H. et al. (2009). Astaxanthin reduces ischemic brain injury in adult rats. FasebU J,U 23(6), 1958-1968, 19218497.

Æ Shen, Y. et al. (2009). Solid-phase extraction of carotenoids. JU Chromatogr A,U 1216(30), 5763-5768, 19539943. Æ Siems, W. et al. (2009). Beta-carotene degradation products - formation, toxicity and prevention of toxicity.

ForumU Nutr,U 61, 75-86, 19367112. Æ Sluijs, I. et al. (2009). Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in

middle-aged and elderly men. JU Nutr,U 139(5), 987-992, 19321578. Æ Srinivasan, M. et al. (2009). Lycopene: An antioxidant and radioprotector against gamma-radiation-induced

cellular damages in cultured human lymphocytes. ToxicologyU ,U 262(1), 43-49, 19450652. Æ Sugiura, M. et al. (2008). Associations of serum carotenoid concentrations with the metabolic syndrome:

interaction with smoking. BrU J Nutr,U 100(6), 1297-1306, 18445303. Æ Sujak, A. (2009). Interactions between canthaxanthin and lipid membranes--possible mechanisms of

canthaxanthin toxicity. CellU Mol Biol Lett,U 14(3), 395-410, 19214394.

Æ Tacken, K. J. et al. (2009). Loss of triglycerides and carotenoids in human milk after processing. ArchU Dis Child

Fetal Neonatal Ed,U 94(6), F447-450, 19416803. GVF-Update | Annual 2009 | 57

Æ Talegawkar, S. A. et al. (2008). Serum carotenoid and tocopherol concentrations vary by dietary pattern among

African Americans. JU Am Diet Assoc,U 108(12), 2013-2020, 19027404. Æ Tang, F. Y. et al. (2009). Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the

proliferation of human colon cancer cells. JU Nutr Biochem,U 20(6), 426-434, 18708285. Æ Tanumihardjo, S. A. et al. (2009). Serum alpha- and beta-carotene concentrations qualitatively respond to

sustained carrot feeding. ExpU Biol Med (Maywood),U 234(11), 1280-1286, 19657072. Æ Teodoro, A. J. et al. (2009). Lycopene isomerisation and storage in an in vitro model of murine hepatic stellate

cells. EurU J Nutr,U 48(5), 261-268, 19533199. Æ Thurnham, D. I. (2007). Macular zeaxanthins and lutein -- a review of dietary sources and bioavailability and

some relationships with macular pigment optical density and age-related macular disease. NutrU Res Rev,U 20(2), 163-179, 19079868. Æ Thurnham, D. I. et al. (2008). A supplementation study in human subjects with a combination of meso-

zeaxanthin, (3R,3'R)-zeaxanthin and (3R,3'R,6'R)-lutein. BrU J Nutr,U 100(6), 1307-1314, 18405400. Æ Valacchi, G. et al. (2009). Beta-carotene prevents ozone-induced proinflammatory markers in murine skin.

ToxicolU Ind Health,U 25(4-5), 241-247, 19651793. Æ van de Kraats, J. et al. (2008). Lutein and zeaxanthin measured separately in the living human retina with

fundus reflectometry. InvestU Ophthalmol Vis Sci,U 49(12), 5568-5573, 18676627.

Æ van der Veen, R. L. et al. (2009). Macular pigment optical density relates to foveal thickness. EurU J Ophthalmol,U 19(5), 836-841, 19787606. Æ van Helden, Y. G. et al. (2009). Beta-carotene metabolites enhance inflammation-induced oxidative DNA

damage in lung epithelial cells. FreeU Radic Biol Med,U 46(2), 299-304, 19026740.

Æ Veeramachaneni, S. & Wang, X. D. (2009). Carotenoids and lung cancer prevention. FrontU Biosci (Schol Ed),U 1, 258-274, 19482701. Æ Venugopalan, V. et al. (2009). 9-cis-canthaxanthin exhibits higher pro-apoptotic activity than all-trans-

canthaxanthin isomer in THP-1 macrophage cells. FreeU Radic Res,U 43(2), 100-105, 19148843. Æ Vieira, M. M. et al. (2008). Carotenoids, retinol, and intestinal barrier function in children from northeastern

Brazil. JU Pediatr Gastroenterol Nutr,U 47(5), 652-659, 18955868. Æ Ward, M. S. et al. (2008). Macular and serum carotenoid concentrations in patients with malabsorption

syndromes. JU Ocul Biol Dis Infor,U 1(1), 12-18, 19081745. Æ Yanagisawa, A. et al. (2009). Possible protective effect of serum beta-carotene levels on the association

between interleukin-1B C-31T polymorphism and hypertension in a Japanese population. ClinU Nutr,U 28(2), 198-202, 19249142. Æ Zefferino, R. et al. (2008). Mercury modulates interplay between IL-1beta, TNF-alpha, and gap junctional

intercellular communication in keratinocytes: mitigation by lycopene. JU Immunotoxicol,U 5(4), 353-360, 19404869. Æ Zeimer, M. et al. (2009). [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA

Study]. OphthalmologeU ,U 106(1), 29-36, 18551295.

Choline6B

Æ Konstantinova, S. V. et al. (2008). Dietary patterns, food groups, and nutrients as predictors of plasma choline and

betaine in middle-aged and elderly men and women. AmU J Clin Nutr,U 88(6), 1663-1669, 19064529.

GVF-Update | Annual 2009 | 58

CoQ107B

Æ Abdin, A. A. & Hamouda, H. E. (2008). Mechanism of the neuroprotective role of coenzyme Q10 with or without

L-dopa in rotenone-induced parkinsonism. NeuropharmacologyU ,U 55(8), 1340-1346, 18817789. Æ Adarsh, K. et al. (2008). Coenzyme Q10 (CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy

(HCM). BiofactorsU ,U 32(1-4), 145-149, 19096110.

Æ Belardinelli, R. et al. (2008). Oxidative stress, endothelial function and coenzyme Q10. BiofactorsU ,U 32(1-4), 129- 133, 19096108. Æ Bergamin, C. S. et al. (2008). Unusual occurrence of intestinal pseudo obstruction in a patient with maternally

inherited diabetes and deafness (MIDD) and favorable outcome with coenzyme Q10. ArqU Bras Endocrinol

Metabol,U 52(8), 1345-1349, 19169492. Æ Cooper, J. M. et al. (2008). Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of

vitamin E and coenzyme Q10 therapy. EurU J Neurol,U 15(12), 1371-1379, 19049556.

Æ Cordero, M. D. et al. (2009). Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. ClinU

Biochem,U 42(7-8), 732-735, 19133251.

Æ Crane, F. L. (2008). The evolution of coenzyme Q. BiofactorsU ,U 32(1-4), 5-11, 19096095. Æ El-ghoroury, E. A. et al. (2009). Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes

mellitus: correlation with glycemic control. BloodU Coagul Fibrinolysis,U 20(4), 248-251, 19530339. Æ Haas, D. et al. (2008). Plasma and thrombocyte levels of coenzyme Q10 in children with Smith-Lemli-Opitz

syndrome (SLOS) and the influence of HMG-CoA reductase inhibitors. BiofactorsU ,U 32(1-4), 191-197, 19096116. Æ Haas, D. et al. (2009). Coenzyme Q(10) is decreased in fibroblasts of patients with methylmalonic aciduria but not

in mevalonic aciduria. JU Inherit Metab Dis,U 32(4), 570-575, 19504350. Æ Hamilton, S. J. et al. (2009). Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic

patients. DiabetesU Care,U 32(5), 810-812, 19228872. Æ Hargreaves, I. P. et al. (2008). The coenzyme Q10 status of the brain regions of Parkinson's disease patients.

NeurosciU Lett,U 447(1), 17-19, 18840506.

Æ Hidaka, T. et al. (2008). Safety assessment of coenzyme Q10 (CoQ10). BiofactorsU ,U 32(1-4), 199-208, 19096117. Æ Inui, M. et al. (2008). Mechanisms of inhibitory effects of CoQ10 on UVB-induced wrinkle formation in vitro and in

vivo. BiofactorsU ,U 32(1-4), 237-243, 19096121.

Æ Kaufmann, P. et al. (2009). Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. AnnU

Neurol,U 66(2), 235-244, 19743457. Æ Kharaeva, Z. et al. (2009). Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium

supplementation to psoriasis patients. NutritionU ,U 25(3), 295-302, 19041224. Æ Kon, M. et al. (2008). Reducing exercise-induced muscular injury in kendo athletes with supplementation of

coenzyme Q10. BrU J Nutr,U 100(4), 903-909, 18284711. Æ Langsjoen, P. H. & Langsjoen, A. M. (2008). Supplemental ubiquinol in patients with advanced congestive heart

failure. BiofactorsU ,U 32(1-4), 119-128, 19096107. Æ Liang, W. C. et al. (2009). ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with

riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. NeuromusculU Disord,U 19(3), 212-216, 19249206. Æ Liu, Z. X. & Artmann, C. (2009). Relative bioavailability comparison of different coenzyme Q10 formulations with a

novel delivery system. AlternU Ther Health Med,U 15(2), 42-46, 19284181. Æ Lucangioli, S. et al. (2009). A capillary electrophoretic system based on a novel microemulsion for the analysis of

coenzyme Q10 in human plasma by electrokinetic chromatography. ElectrophoresisU ,U 30(11), 1899-1905, 19517432. Æ Makhija, N. et al. (2008). The role of oral coenzyme Q10 in patients undergoing coronary artery bypass graft

surgery. JU Cardiothorac Vasc Anesth,U 22(6), 832-839, 18834786. GVF-Update | Annual 2009 | 59

Æ Menke, T. et al. (2008). Antioxidant level and redox status of coenzyme Q10 in the plasma and blood cells of

children with diabetes mellitus type 1. PediatrU Diabetes,U 9(6), 540-545, 18694454.

Æ Molyneux, S. L. et al. (2008). Coenzyme Q10: an independent predictor of mortality in chronic heart failure. JU Am

Coll Cardiol,U 52(18), 1435-1441, 19017509. Æ Montero, R. et al. (2009). Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a

case report. ClinU Biochem,U 42(7-8), 742-745, 19094978. Æ Morre, D. M. et al. (2008). Supplementation with CoQ10 lowers age-related (ar) NOX levels in healthy subjects.

BiofactorsU ,U 32(1-4), 221-230, 19096119. Æ Plecita-Hlavata, L. et al. (2009). Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-

oxidant at retarded electron transport or proton pumping within Complex I. IntU J Biochem Cell Biol,U 41(8- 9), 1697-1707, 19433311. Æ Prahl, S. et al. (2008). Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care.

BiofactorsU ,U 32(1-4), 245-255, 19096122. Æ Premkumar, V. G. et al. (2008). Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA

repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. BrU J Nutr,U 100(6), 1179-1182, 18377693.

Æ Qu, J. et al. (2009). Coenzyme Q10 in the human retina. InvestU Ophthalmol Vis Sci,U 50(4), 1814-1818, 19060288.

Æ Quinzii, C. M. et al. (2008). Human CoQ10 deficiencies. BiofactorsU ,U 32(1-4), 113-118, 19096106. Æ Saito, Y. et al. (2009). Characterization of cellular uptake and distribution of coenzyme Q10 and vitamin E in PC12

cells. JU Nutr Biochem,U 20(5), 350-357, 18602819.

Æ Schmelzer, C. et al. (2008). Functions of coenzyme Q10 in inflammation and gene expression. BiofactorsU ,U 32(1-4), 179-183, 19096114. Æ Schmelzer, C. et al. (2007). Influence of Coenzyme Q_(Adolphe, Whiting, & Dahl) on release of pro-inflammatory

chemokines in the human monocytic cell line THP-1. BiofactorsU ,U 31(3-4), 211-217, 18997284. Æ Tauler, P. et al. (2008). Supplementation with an antioxidant cocktail containing coenzyme Q prevents plasma

oxidative damage induced by soccer. EurU J Appl Physiol,U 104(5), 777-785, 18665388.

Æ Teran, E. et al. (2008). Coenzyme Q10 levels in women with preeclampsia living at different altitudes. BiofactorsU ,U 32(1-4), 185-190, 19096115.

Æ Teran, E. et al. (2009). Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. IntU J

Gynaecol Obstet,U 105(1), 43-45, 19154996. Æ Tiano, L. et al. (2008). Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical

aspects. BiofactorsU ,U 32(1-4), 161-167, 19096112. Æ Yuvaraj, S. et al. (2009). Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal

breast cancer women with special reference to blood chemistry profiles. BreastU Cancer Res Treat,U 114(2), 377-384, 18427979. Æ Zheng, A. & Moritani, T. (2008). Influence of CoQ10 on autonomic nervous activity and energy metabolism

during exercise in healthy subjects. JU Nutr Sci Vitaminol (Tokyo),U 54(4), 286-290, 18797149.

Glucosamine8B

Æ Fox, B. A. & Stephens, M. M. (2009). Glucosamine/chondroitin/primorine combination therapy for osteoarthritis.

DrugsU Today (Barc),U 45(1), 21-31, 19271029.

GVF-Update | Annual 2009 | 60

Inositol9B

Æ Brown, L. D. et al. (2009). Inositol and mannose utilization rates in term and late-preterm infants exceed

nutritional intakes. JU Nutr,U 139(9), 1648-1652, 19494026. Æ Costantino, D. et al. (2009). Metabolic and hormonal effects of myo-inositol in women with polycystic ovary

syndrome: a double-blind trial. EurU Rev Med Pharmacol Sci,U 13(2), 105-110, 19499845. Æ Siger, M. et al. (2009). Regional myo-inositol concentration in mild cognitive impairment Using 1H magnetic

resonance spectroscopic imaging. AlzheimerU Dis Assoc Disord,U 23(1), 57-62, 18725861.

Alpha10B Lipoic Acid

Æ Amenta, F. et al. (2008). Pharmacokinetics of different formulations of tioctic (alpha-lipoic) acid in healthy

volunteers. ClinU Exp Hypertens,U 30(8), 767-775, 19021026.

Æ Burekovic, A. et al. (2008). The role of alpha-lipoic acid in diabetic polyneuropathy treatment. BosnU J Basic Med

Sci,U 8(4), 341-345, 19125705. Æ Carbone, M. et al. (2009). Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind,

randomized, placebo-controlled study. EurU J Pain,U 13(5), 492-496, 18675569. Æ Cavalcanti, D. R. & da Silveira, F. R. (2009). Alpha lipoic acid in burning mouth syndrome--a randomized double-

blind placebo-controlled trial. JU Oral Pathol Med,U 38(3), 254-261, 19175713.

Æ Chng, H. T. et al. (2009). Distribution study of orally administered lipoic acid in rat brain tissues. BrainU Res,U 1251, 80-86, 19046949.

Æ Choi, S. Y. et al. (2009). Mechanism of alpha-lipoic acid-induced apoptosis of lung cancer cells. AnnU N Y Acad Sci,U 1171, 149-155, 19723049.

Æ Di Geronimo, G. et al. (2009). Treatment of carpal tunnel syndrome with alpha-lipoic acid. EurU Rev Med

Pharmacol Sci,U 13(2), 133-139, 19499849. Æ Du, X. et al. (2008). Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1

diabetes. DiabetologiaU ,U 51(10), 1930-1932, 18663426.

Æ Ibrahim, S. F. et al. (2008). A study of the antioxidant effect of alpha lipoic acids on sperm quality. ClinicsU (Sao

Paulo),U 63(4), 545-550, 18719769. Æ Jia, L. et al. (2009). Protective effect of lipoic acid against acrolein-induced cytotoxicity in IMR-90 human

fibroblasts. JU Nutr Sci Vitaminol (Tokyo),U 55(2), 126-130, 19436138. Æ Maczurek, A. et al. (2008). Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's

disease. AdvU Drug Deliv Rev,U 60(13-14), 1463-1470, 18655815. Æ Martins, V. D. et al. (2009). Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and

sickle cell patients. ClinU Nutr,U 28(2), 192-197, 19231043. Æ Moore, R. M. et al. (2009). Alpha-lipoic acid inhibits tumor necrosis factor-induced remodeling and weakening of

human fetal membranes. BiolU Reprod,U 80(4), 781-787, 19109223. Æ Ruessmann, H. J. (2009). Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other

analgesics in painful diabetic neuropathy: a real-world study in outpatients. JU Diabetes Complications,U 23(3), 174-177, 18403218. Æ Ruktanonchai, U. et al. (2009). Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid

nanoparticulate formulations of alpha-lipoic acid. AAPSU PharmSciTech,U 10(1), 227-234, 19280350.

Æ Singh, U. & Jialal, I. (2008). Alpha-lipoic acid supplementation and diabetes. NutrU Rev,U 66(11), 646-657, 19019027.

Æ Steele, J. C. et al. (2008). Alpha-lipoic acid treatment of 31 patients with sore, burning mouth. OralU Dis,U 14(6), 529- 532, 18266840. GVF-Update | Annual 2009 | 61

Æ Xiang, G. D. et al. (2008). The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute

hyperglycaemia during OGTT in impaired glucose tolerance. ClinU Endocrinol (Oxf),U 68(5), 716-723, 18070144.

Æ Yamasaki, M. et al. (2009). Dihydro-alpha-lipoic acid has more potent cytotoxicity than alpha-lipoic acid. InU Vitro

Cell Dev Biol Anim,U 45(5-6), 275-280, 19118438. Æ Zembron-Lacny, A. et al. (2009). Assessment of the antioxidant effectiveness of alpha-lipoic acid in healthy men

exposed to muscle-damaging exercise. JU Physiol Pharmacol,U 60(2), 139-143, 19617657. Æ Zulkhairi, A. et al. (2008). Alpha lipoic acid possess dual antioxidant and lipid lowering properties in

atherosclerotic-induced New Zealand White rabbit. BiomedU Pharmacother,U 62(10), 716-722, 18538528.

Miscellaneous1B

Æ Aasheim, E. T. et al. (2009). Vitamin status after bariatric surgery: a randomized study of gastric bypass and

duodenal switch. AmU J Clin Nutr,U 90(1), 15-22, 19439456.

Æ Adolphe, J. L. et al. (2009). Vitamin fortification of pureed foods for long-term care residents. CanU J Diet Pract Res,U 70(3), 143-150, 19709470.

Æ Aerenhouts, D. et al. (2008). Nutritional habits of Flemish adolescent sprint athletes. IntU J Sport Nutr Exerc Metab,U 18(5), 509-523, 19033612.

Æ Baker, P. N. et al. (2009). A prospective study of micronutrient status in adolescent pregnancy. AmU J Clin Nutr,U 89(4), 1114-1124, 19244368. Æ Bartlett, H. E. & Eperjesi, F. (2008). Nutritional supplementation for type 2 diabetes: a systematic review.

OphthalmicU Physiol Opt,U 28(6), 503-523, 19076553.

Æ Bluck, L. J. (2009). Recent progress in stable isotope methods for assessing vitamin metabolism. CurrU Opin Clin

Nutr Metab Care,U 12(5), 495-500, 19571745.

Æ Braun, H. et al. (2009). Dietary supplement use among elite young German athletes. IntU J Sport Nutr Exerc Metab,U 19(1), 97-109, 19403956.

Æ Calder, P. C. et al. (2009). Inflammatory disease processes and interactions with nutrition. BrU J Nutr,U 101 Suppl 1, S1-45, 19586558.

Æ Cerf-Bensussan, N. (2009). Autoimmunity and diet. NestleU Nutr Workshop Ser Pediatr Program,U 64, 91-99; discussion 99-104, 251-107, 19710517.

Æ Christensen, E. I. et al. (2009). Receptor-mediated endocytosis in renal proximal tubule. PflugersU Arch,U 458(6), 1039-1048, 19499243.

Æ Craig, W. J. & Mangels, A. R. (2009). Position of the American Dietetic Association: vegetarian diets. JU Am Diet

Assoc,U 109(7), 1266-1282, 19562864. Æ Deryabin, P. G. et al. (2008). Effects of a nutrient mixture on infectious properties of the highly pathogenic strain

of avian influenza virus A/H5N1. BiofactorsU ,U 33(2), 85-97, 19346584.

Æ Edgar, K. S. et al. (2008). Thiol and cardiovascular risk factor status in a male northern Irish population. IntU J Vitam

Nutr Res,U 78(4-5), 208-216, 19326344. Æ Elemraid, M. A. et al. (2009). Nutritional factors in the pathogenesis of ear disease in children: a systematic review.

AnnU Trop Paediatr,U 29(2), 85-99, 19460262.

Æ Elmadfa, I. & Freisling, H. (2009). Nutritional status in Europe: methods and results. NutrU Rev,U 67 Suppl 1, S130- 134, 19453667.

Æ Forte, A. et al. (2008). Dietary chemoprevention of colorectal cancer. AnnU Ital Chir,U 79(4), 261-267, 19093628.

Æ Garcia, O. P. et al. (2009). Impact of micronutrient deficiencies on obesity. NutrU Rev,U 67(10), 559-572, 19785688. Æ Gewa, C. A. et al. (2009). Dietary micronutrients are associated with higher cognitive function gains among

primary school children in rural Kenya. BrU J Nutr,U 101(9), 1378-1387, 18826659. GVF-Update | Annual 2009 | 62

Æ Goldman, R. D. et al. (2009). Potential vitamin-drug interactions in children: at a pediatric emergency

department. PaediatrU Drugs,U 11(4), 251-257, 19566109. Æ Golnik, A. E. & Ireland, M. (2009). Complementary alternative medicine for children with autism: a physician

survey. JU Autism Dev Disord,U 39(7), 996-1005, 19280328. Æ Gonzalez-Gross, M. et al. (2008). Sampling and processing of fresh blood samples within a European multicenter

nutritional study: evaluation of biomarker stability during transport and storage. IntU J Obes (Lond),U 32 Suppl 5, S66-75, 19011656. Æ Head, K. A. & Kelly, G. S. (2009). Nutrients and botanicals for treatment of stress: adrenal fatigue, neurotransmitter

imbalance, anxiety, and restless sleep. AlternU Med Rev,U 14(2), 114-140, 19594222.

Æ Holick, M. F. (2008). Diabetes and the vitamin d connection. CurrU Diab Rep,U 8(5), 393-398, 18778589. Æ Hornick, B. A. et al. (2008). Menu modeling with MyPyramid food patterns: incremental dietary changes lead to

dramatic improvements in diet quality of menus. JU Am Diet Assoc,U 108(12), 2077-2083, 19027412.

Æ Itsiopoulos, C. et al. (2009). Can the Mediterranean diet prevent prostate cancer? MolU Nutr Food Res,U 53(2), 227- 239, 19051189. Æ Jia, X. et al. (2008). Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A

systematic review of randomized controlled trials. JU Hum Nutr Diet,U 21(4), 317-336, 18721399.

Æ Johnson, C. S. & Begum, M. N. (2008). Adequacy of nutrient intake among elderly persons receiving home care. JU

Nutr Elder,U 27(1-2), 65-82, 18928191. Æ Jonsson, T. et al. (2009). Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a

randomized cross-over pilot study. CardiovascU Diabetol,U 8, 35, 19604407.

Æ Kilpinen-Loisa, P. et al. (2009). Insufficient energy and nutrient intake in children with motor disability. ActaU

Paediatr,U 98(8), 1329-1333, 19432830. Æ Kleiser, C. et al. (2009). HuSKY: a healthy nutrition score based on food intake of children and adolescents in

Germany. BrU J Nutr,U 102(4), 610-618, 19203423. Æ Kloosterman, J. et al. (2007). Safe addition of vitamins and minerals to foods: setting maximum levels for

fortification in the Netherlands. EurU J Nutr,U 46(4), 220-229, 17479209. Æ Lammes, E. et al. (2009). Nutrient density and variation in nutrient intake with changing energy intake in

multimorbid nursing home residents. JU Hum Nutr Diet,U 22(3), 210-218, 19226354. Æ Landin, J. et al. (2008). Use of alternative therapies in patients with dementia and mild cognitive impairment: a

prospective, controlled study. IntU J Geriatr Psychiatry,U 23(11), 1163-1165, 18512256.

Æ Lane, J. S. et al. (2008). Nutrition impacts the prevalence of peripheral arterial disease in the United States. JU Vasc

Surg,U 48(4), 897-904, 18586439. Æ Lee, J. S. & Kim, J. (2009). Factors affecting the use of dietary supplements by Korean adults: data from the Korean

National Health and Nutrition Examination Survey III. JU Am Diet Assoc,U 109(9), 1599-1605, 19699841. Æ Maillot, M. et al. (2009). To meet nutrient recommendations, most French adults need to expand their habitual

food repertoire. JU Nutr,U 139(9), 1721-1727, 19625703. Æ Manios, Y. et al. (2009). Changes in biochemical indices of bone metabolism in post-menopausal women

following a dietary intervention with fortified dairy products. JU Hum Nutr Diet,U 22(2), 156-165, 19226352.

Æ Marian, M. & Sacks, G. (2009). Micronutrients and older adults. NutrU Clin Pract,U 24(2), 179-195, 19321892. Æ Mariscal-Arcas, M. et al. (2009). Evaluation of the Mediterranean Diet Quality Index (KIDMED) in children and

adolescents in Southern Spain. PublicU Health Nutr,U 12(9), 1408-1412, 19087384.

Æ Martinez, M. E. et al. (2008). Diet and cancer prevention: the roles of observation and experimentation. NatU Rev

Cancer,U 8(9), 694-703, 19143054.

Æ McGill, A. T. (2008). Malnutritive obesity ('malnubesity'): is it driven by human brain evolution? MetabU Syndr Relat

Disord,U 6(4), 241-246, 19067526.

Æ McKeever, T. M. et al. (2008). A multivariate analysis of serum nutrient levels and lung function. RespirU Res,U 9, 67, 18823528. GVF-Update | Annual 2009 | 63

Æ Mente, A. et al. (2009). A systematic review of the evidence supporting a causal link between dietary factors and

coronary heart disease. ArchU Intern Med,U 169(7), 659-669, 19364995.

Æ Miller, P. et al. (2008). Dietary supplement use among elderly, long-term cancer survivors. JU Cancer Surviv,U 2(3), 138-148, 18792788. Æ Montenegro-Bethancourt, G. et al. (2009). Ready-to-eat cereals are key sources of selected micronutrients among

schoolchildren from public and private elementary schools in Quetzaltenango, Guatemala. NutrU Res,U 29(5), 335-342, 19555815. Æ Papaleo, E. et al. (2009). Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A

prospective, controlled, randomized trial. FertilU Steril,U 91(5), 1750-1754, 18462730.

Æ Park, S. et al. (2008). Vitamin and mineral supplements: barriers and challenges for older adults. JU Nutr Elder,U 27(3- 4), 297-317, 19042577. Æ Pinheiro, M. M. et al. (2009). Nutrient intakes related to osteoporotic fractures in men and women--the Brazilian

Osteoporosis Study (BRAZOS). NutrU J,U 8, 6, 19178745. Æ Polidori, M. C. et al. (2009). Plasma micronutrient status is improved after a 3-month dietary intervention with 5

daily portions of fruits and vegetables: implications for optimal antioxidant levels. NutrU J,U 8, 10, 19208246. Æ Pournaras, D. J. & le Roux, C. W. (2009). After bariatric surgery, what vitamins should be measured and what

supplements should be given? ClinU Endocrinol (Oxf),U 71(3), 322-325, 19250264. Æ Rajamanickam, S. & Agarwal, R. (2008). Natural products and colon cancer: current status and future prospects.

DrugU Dev Res,U 69(7), 460-471, 19884979. Æ Raniga, A. & Elder, M. J. (2009). Dietary supplement use in the prevention of age-related macular degeneration

progression. NU Z Med J,U 122(1299), 32-38, 19684645. Æ Rees, G. A. et al. (2008). Food and nutrient intakes of primary school children: a comparison of school meals and

packed lunches. JU Hum Nutr Diet,U 21(5), 420-427, 18631283.

Æ Rivers, J. K. (2008). The role of cosmeceuticals in antiaging therapy. SkinU Therapy Lett,U 13(8), 5-9, 19145383. Æ Robitaille, J. et al. (2009). Maternal nutrient intake and risks for transverse and longitudinal limb deficiencies: data

from the National Birth Defects Prevention Study, 1997-2003. BirthU Defects Res A Clin Mol Teratol,U 85(9), 773-779, 19350655. Æ Rodriguez, N. R. et al. (2009). American College of Sports Medicine position stand. Nutrition and athletic

performance. MedU Sci Sports Exerc,U 41(3), 709-731, 19225360.

Æ Rucklidge, J. J. et al. (2009). Nutrient supplementation approaches in the treatment of ADHD. ExpertU Rev

Neurother,U 9(4), 461-476, 19344299. Æ Rumawas, M. E. et al. (2009). The development of the Mediterranean-style dietary pattern score and its

application to the American diet in the Framingham Offspring Cohort. JU Nutr,U 139(6), 1150-1156, 19357215.

Æ Russell, R. M. (2008). Current framework for DRI development: what are the pros and cons? NutrU Rev,U 66(8), 455- 458, 18667006. Æ Sanchez-Moreno, C. et al. (2008). Effect of a blueberry nutritional supplement on macronutrients, food group

intake, and plasma vitamin E and vitamin C in US athletes. IntU J Food Sci Nutr,U 59(4), 327-338, 17852477.

Æ Saura-Calixto, F. & Goni, I. (2009). Definition of the Mediterranean diet based on bioactive compounds. CritU Rev

Food Sci Nutr,U 49(2), 145-152, 18989833. Æ Schweitzer, D. H. & Posthuma, E. F. (2008). Prevention of vitamin and mineral deficiencies after bariatric surgery:

evidence and algorithms. ObesU Surg,U 18(11), 1485-1488, 18369680.

Æ Serra-Majem, L. et al. (2009). Dietary patterns and nutritional adequacy in a Mediterranean country. BrU J Nutr,U 101 Suppl 2, S21-28, 19594961. Æ Shah, P. S. & Ohlsson, A. (2009). Effects of prenatal multimicronutrient supplementation on pregnancy outcomes:

a meta-analysis. CmajU ,U 180(12), E99-108, 19506270. Æ Sriram, K. & Lonchyna, V. A. (2009). Micronutrient supplementation in adult nutrition therapy: practical

considerations. JPENU J Parenter Enteral Nutr,U 33(5), 548-562, 19454751. GVF-Update | Annual 2009 | 64

Æ Stull, A. J. et al. (2009). Effects of acute pinitol supplementation on plasma pinitol concentration, whole body

glucose tolerance, and activation of the skeletal muscle insulin receptor in older humans. HormU Metab

Res,U 41(5), 381-386, 19221977. Æ Sumanen, M. et al. (2009). Use of vitamins, trace elements, or herbal products does not differ between cancer

patients and population in general. EurU J Gen Pract,U 15(2), 112-115, 19606399. Æ Tabacchi, G. et al. (2009). How is the adequacy of micronutrient intake assessed across Europe? A systematic

literature review. BrU J Nutr,U 101 Suppl 2, S29-36, 19594962. Æ Tilburt, J. C. et al. (2008). Does the evidence make a difference in consumer behavior? Sales of supplements

before and after publication of negative research results. JU Gen Intern Med,U 23(9), 1495-1498, 18618194.

Æ Toft, U. et al. (2008). Relative validity of a food frequency questionnaire used in the Inter99 study. EurU J Clin Nutr,U 62(8), 1038-1046, 17538538. Æ Townsend, M. S. et al. (2009). Less-energy-dense diets of low-income women in California are associated with

higher energy-adjusted diet costs. AmU J Clin Nutr,U 89(4), 1220-1226, 19225114. Æ Tyson, J. et al. (2009). Inter-individual variation in nucleotide excision repair in young adults: effects of age,

adiposity, micronutrient supplementation and genotype. BrU J Nutr,U 101(9), 1316-1323, 18838045. Æ Vercambre, M. N. et al. (2009). Long-term association of food and nutrient intakes with cognitive and functional

decline: a 13-year follow-up study of elderly French women. BrU J Nutr,U 102(3), 419-427, 19203415. Æ Wang, C. et al. (2009). No evidence of association between breast cancer risk and dietary carotenoids, retinols,

vitamin C and tocopherols in Southwestern Hispanic and non-Hispanic White women. BreastU Cancer Res

Treat,U 114(1), 137-145, 18670874. Æ Watson, P. E. & McDonald, B. W. (2009). The association of maternal diet and dietary supplement intake in

pregnant New Zealand women with infant birthweight. EurU J Clin Nutr,U 19920847.

Æ Xu, J. et al. (2009). Immunonutrition in surgical patients. CurrU Drug Targets,U 10(8), 771-777, 19702523. Æ Zeisel, S. H. (2009). Is maternal diet supplementation beneficial? Optimal development of infant depends on

mother's diet. AmU J Clin Nutr,U 89(2), 685S-687S, 19116319. Æ Zimmermann, M. B. & Aeberli, I. (2008). Dietary determinants of subclinical inflammation, dyslipidemia and

components of the metabolic syndrome in overweight children: a review. IntU J Obes (Lond),U 32 Suppl 6, S11-18, 19079275. Æ Zoellner, J. et al. (2009). Meaningful Messages: Adults in the Lower Mississippi Delta Provide Cultural Insight into

Strategies for Promoting the MyPyramid. JU Nutr Educ Behav,U 19910255. Æ Zwart, S. R. et al. (2009). Assessment of nutrient stability in foods from the space food system after long-duration

spaceflight on the ISS. JU Food Sci,U 74(7), H209-217, 19895472.

Minerals12B

Æ Allen, N. E. et al. (2008). Plasma selenium concentration and prostate cancer risk: results from the European

Prospective Investigation into Cancer and Nutrition (EPIC). AmU J Clin Nutr,U 88(6), 1567-1575, 19064517. Æ Bauman, W. A. et al. (2009). Acute suppression of bone turnover with calcium infusion in persons with spinal cord

injury. JU Spinal Cord Med,U 32(4), 398-403, 19777860.

Æ Beard, J. & Han, O. (2009). Systemic iron status. BiochimU Biophys Acta,U 1790(7), 584-588, 18930117. Æ Bhatla, N. et al. (2009). Comparison of effect of daily versus weekly iron supplementation during pregnancy on

lipid peroxidation. JU Obstet Gynaecol Res,U 35(3), 438-445, 19527380. Æ Christian, P. et al. (2009). Antenatal and postnatal iron supplementation and childhood mortality in rural Nepal: a

prospective follow-up in a randomized, controlled community trial. AmU J Epidemiol,U 170(9), 1127-1136, 19778983. GVF-Update | Annual 2009 | 65

Æ Deb, S. et al. (2009). Modulation of intracellular iron levels by oxidative stress implicates a novel role for iron in

signal transduction. BiometalsU ,U 22(5), 855-862, 19190985. Æ Dickstein, D. P. et al. (2009). Randomized double-blind placebo-controlled trial of lithium in youths with severe

mood dysregulation. JU Child Adolesc Psychopharmacol,U 19(1), 61-73, 19232024.

Æ Evenepoel, P. et al. (2009). Calcium metabolism in the early posttransplantation period. ClinU J Am Soc Nephrol,U 4(3), 665-672, 19261823. Æ Fallahi, E. et al. (2007). Effect of zinc and iron supplementation on indicators of iron, zinc and vitamin A status of

primary school children. PakU J Biol Sci,U 10(7), 1088-1092, 19070056. Æ Fukumoto, S. et al. (2008). Causes and differential diagnosis of hypocalcemia--recommendation proposed by

expert panel supported by ministry of health, labour and welfare, Japan. EndocrU J,U 55(5), 787-794, 18490837.

Æ Gonzalez, A. et al. (2009). Zinc intake from supplements and diet and prostate cancer. NutrU Cancer,U 61(2), 206- 215, 19235036. Æ Intorre, F. et al. (2008). Effect of zinc supplementation on vitamin status of middle-aged and older European

adults: the ZENITH study. EurU J Clin Nutr,U 62(10), 1215-1223, 17622255. Æ Katko, M. et al. (2008). Relationship between serum nickel and homocysteine concentration in hemodialysis

patients. BiolU Trace Elem Res,U 124(3), 195-205, 18465090. Æ Koehler, K. et al. (2009). Serum testosterone and urinary excretion of steroid hormone metabolites after

administration of a high-dose zinc supplement. EurU J Clin Nutr,U 63(1), 65-70, 17882141. Æ Mocchegiani, E. et al. (2008). Zinc, metallothioneins and longevity: interrelationships with niacin and selenium.

CurrU Pharm Des,U 14(26), 2719-2732, 18991691. Æ Nemec, A. A. et al. (2009). Nickel mobilizes intracellular zinc to induce metallothionein in human airway epithelial

cells. AmU J Respir Cell Mol Biol,U 41(1), 69-75, 19097988.

Æ Ozturk, S. & Cillier, A. E. (2006). Magnesium supplementation in the treatment of dementia patients. MedU

Hypotheses,U 67(5), 1223-1225, 16790324. Æ Pentti, K. et al. (2009). Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old

women: The Kuopio Osteoporosis Risk Factor and Prevention Study. MaturitasU ,U 63(1), 73-78, 19394167.

Æ Peris Roig, B. et al. (2009). [Iodine deficiency and pregnancy. Current situation]. EndocrinolU Nutr,U 56(1), 9-12, 19627703.

Æ Quarles, L. D. (2008). Endocrine functions of bone in mineral metabolism regulation. JU Clin Invest,U 118(12), 3820- 3828, 19033649.

Æ Reid, I. R. et al. (2008). Effect of calcium supplementation on hip fractures. OsteoporosU Int,U 19(8), 1119-1123, 18286218. Æ Risonar, M. G. et al. (2009). Effectiveness of a redesigned iron supplementation delivery system for pregnant

women in Negros Occidental, Philippines. PublicU Health Nutr,U 12(7), 932-940, 18752691.

Æ Ruz, M. et al. (2009). Iron absorption and iron status are reduced after Roux-en-Y gastric bypass. AmU J Clin Nutr,U 90(3), 527-532, 19625680. Æ Sampath, V. et al. (2008). Calcium supplementation does not alter lipid oxidation or lipolysis in overweight/obese

women. ObesityU (Silver Spring)U, 16(11), 2400-2404, 18719672. Æ Soliman, A. et al. (2008). Calcium homeostasis in 40 adolescents with beta-thalassemia major: a case-control

study of the effects of intramuscular injection of a megadose of cholecalciferol. PediatrU Endocrinol Rev,U 6 Suppl 1, 149-154, 19337170.

Æ Song, Y. et al. (2009). Dietary zinc restriction and repletion affects DNA integrity in healthy men. AmU J Clin Nutr,U 90(2), 321-328, 19515738. Æ Tantawy, A. A. et al. (2008). Bone mineral density and calcium metabolism in adolescents with beta-thalassemia

major. PediatrU Endocrinol Rev,U 6 Suppl 1, 132-135, 19337166.

Æ Titan, S. M. et al. (2009). Acute renal failure and hypercalcemia in an athletic young man. ClinU Nephrol,U 71(4), 445- 447, 19356379. GVF-Update | Annual 2009 | 66

Æ Troesch, B. et al. (2009). Optimization of a phytase-containing micronutrient powder with low amounts of highly

bioavailable iron for in-home fortification of complementary foods. AmU J Clin Nutr,U 89(2), 539-544, 19106242. Æ van den Heuvel, E. G. et al. (2009). Short-chain fructo-oligosaccharides improve magnesium absorption in

adolescent girls with a low calcium intake. NutrU Res,U 29(4), 229-237, 19410973. Æ van der Hee, R. M. et al. (2009). Calcium absorption from fortified ice cream formulations compared with calcium

absorption from milk. JU Am Diet Assoc,U 109(5), 830-835, 19394469.

Æ von Drygalski, A. & Andris, D. A. (2009). Anemia after bariatric surgery: more than just iron deficiency. NutrU Clin

Pract,U 24(2), 217-226, 19321896. Æ Waters, R. S. et al. (2008). Intravenous magnesium sulfate with and without EDTA as a magnesium load test-is

magnesium deficiency widespread? BiolU Trace Elem Res,U 124(3), 243-250, 18665335.

Polyphenols13B

Æ Baumeister, P. et al. (2009). Epigallocatechin-3-gallate reduces DNA damage induced by benzo[a]pyrene diol

epoxide and cigarette smoke condensate in human mucosa tissue cultures. EurU J Cancer Prev,U 18(3), 230-235, 19491610.

Æ Cicerale, S. et al. (2009). Chemistry and health of olive oil phenolics. CritU Rev Food Sci Nutr,U 49(3), 218-236, 19093267. Æ Corona, G. et al. (2009). Extra virgin olive oil phenolics: absorption, metabolism, and biological activities in the

GI tract. ToxicolU Ind Health,U 25(4-5), 285-293, 19651799. Æ Crescente, M. et al. (2009). Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet

cyclooxygenase-1 level. Functional and modelling studies. ThrombU Haemost,U 102(2), 336-346, 19652885. Æ Forester, S. C. & Waterhouse, A. L. (2009). Metabolites are key to understanding health effects of wine

polyphenolics. JU Nutr,U 139(9), 1824S-1831S, 19640966. Æ Gomikawa, S. et al. (2008). Effect of ground green tea drinking for 2 weeks on the susceptibility of plasma and

LDL to the oxidation ex vivo in healthy volunteers. KobeU J Med Sci,U 54(1), E62-72, 18772610.

Æ Huang, G. et al. (2008). Effects of genistein on oxidative injury in endothelial cells. JU Nutr Sci Vitaminol (Tokyo),U 54(5), 402-408, 19001773. Æ Jones, P. J. & AbuMweis, S. S. (2009). Phytosterols as functional food ingredients: linkages to cardiovascular

disease and cancer. CurrU Opin Clin Nutr Metab Care,U 12(2), 147-151, 19209468.

Æ Nardini, M. et al. (2009). White wine phenolics are absorbed and extensively metabolized in humans. JU Agric

Food Chem,U 57(7), 2711-2718, 19334754. Æ Papandreou, M. A. et al. (2009). Effect of a polyphenol-rich wild blueberry extract on cognitive performance of

mice, brain antioxidant markers and acetylcholinesterase activity. BehavU Brain Res,U 198(2), 352-358, 19056430. Æ Roche, M. et al. (2009). Olive phenols efficiently inhibit the oxidation of serum albumin-bound linoleic acid and

butyrylcholine esterase. BiochimU Biophys Acta,U 19364484.

Æ Selma, M. V. et al. (2009). Interaction between phenolics and gut microbiota: role in human health. JU Agric Food

Chem,U 57(15), 6485-6501, 19580283.

Æ Sun, A. Y. et al. (2008). Botanical phenolics and brain health. NeuromolecularU Med,U 10(4), 259-274, 19191039.

Æ Tang, N. P. et al. (2009). Flavonoids intake and risk of lung cancer: a meta-analysis. JpnU J Clin Oncol,U 39(6), 352- 359, 19351659.

Æ Visioli, F. et al. (2009). Olive Phenolics Increase Glutathione Levels in Healthy Volunteers. JU Agric Food Chem,U 19219997.

GVF-Update | Annual 2009 | 67

Probiotics14B

Æ Kirpich, I. A. et al. (2008). Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced

liver injury: a pilot study. AlcoholU ,U 42(8), 675-682, 19038698.

PUFAs15B

Æ Abbatecola, A. M. et al. (2009). Plasma polyunsaturated fatty acids and age-related physical performance

decline. RejuvenationU Res,U 12(1), 25-32, 19196012. Æ Abu, E. O. & Oluwatowoju, I. (2009). Omega-3 index determined by gas chromatography with electron impact

mass spectrometry. ProstaglandinsU Leukot Essent Fatty Acids,U 80(4), 189-194, 19376692.

Æ Agostoni, C. (2008). Role of long-chain polyunsaturated fatty acids in the first year of life. JU Pediatr

Gastroenterol Nutr,U 47 Suppl 2, S41-44, 18931599. Æ Agostoni, C. et al. (2009). Docosahexaenoic acid supplementation and time at achievement of gross motor

milestones in healthy infants: a randomized, prospective, double-blind, placebo-controlled trial. AmU J

Clin Nutr,U 89(1), 64-70, 19056592. Æ Ahren, B. et al. (2009). Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin

secretion and estimated insulin sensitivity in men. EurU J Clin Nutr,U 63(6), 778-786, 18772894. Æ Albanese, E. et al. (2009). Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66

Dementia Research Group population-based study. AmU J Clin Nutr,U 90(2), 392-400, 19553298. Æ Aldamiz-Echevarria, L. et al. (2008). Fatty acid deficiency profile in children with food allergy managed with

elimination diets. ActaU Paediatr,U 97(11), 1572-1576, 18671692. Æ Anandan, C. et al. (2009). Omega 3 and 6 oils for primary prevention of allergic disease: systematic review and

meta-analysis. AllergyU ,U 64(6), 840-848, 19392990. Æ Anderson, S. G. et al. (2009). Plasma fatty acid composition as a predictor of arterial stiffness and mortality.

HypertensionU ,U 53(5), 839-845, 19307467. Æ Angela Liou, Y. & Innis, S. M. (2009). Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-gamma-linolenic and eicosapentaenoic acid in plasma of adult

men. ProstaglandinsU Leukot Essent Fatty Acids,U 80(4), 201-206, 19356914.

Æ Antypa, N. et al. (2009). Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. JU

Psychopharmacol,U 23(7), 831-840, 18583436. Æ Arai, Y. et al. (2008). Effect of dietary Lorenzo's oil and docosahexaenoic acid treatment for Zellweger

syndrome. CongenitU Anom (Kyoto),U 48(4), 180-182, 18983586. Æ Astorg, P. et al. (2008). Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a

cross-sectional study within a cohort of middle-aged French men and women. EurU J Clin Nutr,U 62(10), 1155-1161, 17622261. Æ Ayer, J. G. et al. (2009). Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: effects

on blood pressure and arterial structure and function at age 8 y. AmU J Clin Nutr,U 90(2), 438-446, 19515739. Æ Azevedo-Martins, A. K. & Curi, R. (2008). Fatty acids decrease catalase activity in human leukaemia cell lines.

CellU Biochem Funct,U 26(1), 87-94, 17566139. Æ Baddini Feitoza, A. et al. (2009). Conjugated linoleic acid (CLA): effect modulation of body composition and

lipid profile. NutrU Hosp,U 24(4), 422-428, 19721921. Æ Bakker, E. C. et al. (2009). Relationship between long-chain polyunsaturated fatty acids at birth and motor

function at 7 years of age. EurU J Clin Nutr,U 63(4), 499-504, 18091766. GVF-Update | Annual 2009 | 68

Æ Barden, A. E. et al. (2009). Flaxseed oil supplementation increases plasma F1-phytoprostanes in healthy men. JU

Nutr,U 139(10), 1890-1895, 19675101. Æ Bays, H. E. et al. (2009). The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of

treatment for very high triglyceride levels. PostgradU Med,U 121(5), 145-150, 19820283. Æ Bell, S. et al. (2009). Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range

proteinuria. AtherosclerosisU ,U 205(1), 296-301, 19150063.

Æ Berger, M. M. et al. (2008). Fish oil after abdominal aorta aneurysm surgery. EurU J Clin Nutr,U 62(9), 1116-1122, 17538537. Æ Berr, C. et al. (2009). Increased selenium intake in elderly high fish consumers may account for health benefits

previously ascribed to omega-3 fatty acids. JU Nutr Health Aging,U 13(1), 14-18, 19151902. Æ Biondo, P. D. et al. (2008). The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids

during chemotherapy. JU Nutr Biochem,U 19(12), 787-796, 18602809. Æ Block, R. C. et al. (2008). Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary

syndromes? AmU Heart J,U 156(6), 1117-1123, 19033007. Æ Boland, L. M. & Drzewiecki, M. M. (2008). Polyunsaturated fatty acid modulation of voltage-gated ion channels.

CellU Biochem Biophys,U 52(2), 59-84, 18830821. Æ Boland, L. M. et al. (2009). Inhibitory effects of polyunsaturated fatty acids on Kv4/KChIP potassium channels.

AmU J Physiol Cell Physiol,U 296(5), C1003-1014, 19261906. Æ Bountziouka, V. et al. (2009). Long-term fish intake is associated with less severe depressive symptoms among

elderly men and women: the MEDIS (MEDiterranean ISlands Elderly) epidemiological study. JU Aging

Health,U 21(6), 864-880, 19587361. Æ Bourre, J. M. & Paquotte, P. M. (2008). Contributions (in 2005) of marine and fresh water products (finfish and shellfish, seafood, wild and farmed) to the French dietary intakes of vitamins D and B12, selenium, iodine

and docosahexaenoic acid: impact on public health. IntU J Food Sci Nutr,U 59(6), 491-501, 18686110. Æ Bouwens, M. et al. (2009). Fish-oil supplementation induces antiinflammatory gene expression profiles in

human blood mononuclear cells. AmU J Clin Nutr,U 90(2), 415-424, 19515734. Æ Bowden, R. G. et al. (2009). Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal

disease patients. JU Ren Nutr,U 19(4), 259-266, 19539180. Æ Bowden, R. G. et al. (2009). Fish oil supplementation lowers C-reactive protein levels independent of

triglyceride reduction in patients with end-stage renal disease. NutrU Clin Pract,U 24(4), 508-512, 19461006. Æ Bretillon, L. et al. (2008). Lipid and fatty acid profile of the retina, retinal pigment epithelium/choroid, and the

lacrimal gland, and associations with adipose tissue fatty acids in human subjects. ExpU Eye Res,U 87(6), 521-528, 18801361. Æ Brouwer, I. A. et al. (2009). Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with

implantable cardioverter defibrillators. EurU Heart J,U 30(7), 820-826, 19196720. Æ Brownawell, A. M. et al. (2009). Assessing the environment for regulatory change for eicosapentaenoic acid and

docosahexaenoic acid nutrition labeling. NutrU Rev,U 67(7), 391-397, 19566599. Æ Brunborg, L. A. et al. (2008). Effects of short-term oral administration of dietary marine oils in patients with

inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil. ClinU Nutr,U 27(4), 614-622, 18374458. Æ Butler, L. M. et al. (2009). Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in

Singapore Chinese: a prospective study. IntU J Cancer,U 124(3), 678-686, 18973226. Æ Calandria, J. M. et al. (2009). Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial

cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1. JU Biol Chem,U 284(26), 17877-17882, 19403949. Æ Calder, P. C. (2008). Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on

'Nutrition and autoimmune disease' PUFA, inflammatory processes and rheumatoid arthritis. ProcU Nutr

Soc,U 67(4), 409-418, 18847518. GVF-Update | Annual 2009 | 69

Æ Calder, P. C. (2009a). Early life programming of immune and lung function: can we now exclude a role of

arachidonic acid exposure? BrU J Nutr,U 102(3), 331-333, 19166631. Æ Calder, P. C. (2009b). Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale.

BiochimieU ,U 91(6), 791-795, 19455748. Æ Calder, P. C. & Yaqoob, P. (2009). Omega-3 polyunsaturated fatty acids and human health outcomes.

BiofactorsU ,U 35(3), 266-272, 19391122.

Æ Carlson, S. E. (2009). Docosahexaenoic acid supplementation in pregnancy and lactation. AmU J Clin Nutr,U 89(2), 678S-684S, 19116324. Æ Carney, R. M. et al. (2009). Omega-3 augmentation of sertraline in treatment of depression in patients with

coronary heart disease: a randomized controlled trial. JamaU ,U 302(15), 1651-1657, 19843899. Æ Caron-Dorval, D. et al. (2008). Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk

factor in response to n-3 polyunsaturated fatty acids. JU Nutrigenet Nutrigenomics,U 1(4), 205-212, 19776627.

Æ Cetin, I. et al. (2009). Long chain fatty acids and dietary fats in fetal nutrition. JU Physiol,U 587(Pt 14), 3441-3451, 19528253.

Æ Chan, E. J. & Cho, L. (2009). What can we expect from omega-3 fatty acids? CleveU Clin J Med,U 76(4), 245-251, 19339640. Æ Chavarro, J. E. et al. (2008). A 22-y prospective study of fish intake in relation to prostate cancer incidence and

mortality. AmU J Clin Nutr,U 88(5), 1297-1303, 18996866.

Æ Cheng, J. W. & Santoni, F. (2008). Omega-3 fatty acid: a role in the management of cardiac arrhythmias? JU Altern

Complement Med,U 14(8), 965-974, 18928392. Æ Chiu, C. J. et al. (2009). Does eating particular diets alter the risk of age-related macular degeneration in users of

the Age-Related Eye Disease Study supplements? BrU J Ophthalmol,U 93(9), 1241-1246, 19508997.

Æ Chong, E. W. et al. (2009). Fat consumption and its association with age-related macular degeneration. ArchU

Ophthalmol,U 127(5), 674-680, 19433719. Æ Chung, H. et al. (2008). Frequency and type of seafood consumed influence plasma (n-3) fatty acid

concentrations. JU Nutr,U 138(12), 2422-2427, 19022967. Æ Cicero, A. F. et al. (2009). Omega-3 polyunsaturated fatty acids: their potential role in blood pressure

prevention and management. CurrU Vasc Pharmacol,U 7(3), 330-337, 19601857. Æ Clayton, E. H. et al. (2009). Reduced mania and depression in juvenile bipolar disorder associated with long-

chain omega-3 polyunsaturated fatty acid supplementation. EurU J Clin Nutr,U 63(8), 1037-1040, 19156158. Æ Coates, A. M. et al. (2009). Regular consumption of n-3 fatty acid-enriched pork modifies cardiovascular risk

factors. BrU J Nutr,U 101(4), 592-597, 18590592. Æ Colangelo, L. A. et al. (2009). Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is

inversely associated with depressive symptoms in women. NutritionU ,U 25(10), 1011-1019, 19195841. Æ Condray, R. et al. (2008). Semantic memory in schizophrenia: association with cell membrane essential fatty

acids. SchizophrU Res,U 106(1), 13-28, 18929465. Æ Cooper, J. A. et al. (2009). Effects of dietary fatty acid composition on 24-h energy expenditure and chronic

disease risk factors in men. AmU J Clin Nutr,U 89(5), 1350-1356, 19321562. Æ Cornish, S. M. et al. (2009). Conjugated linoleic acid combined with creatine monohydrate and whey protein

supplementation during strength training. IntU J Sport Nutr Exerc Metab,U 19(1), 79-96, 19403955. Æ Courville, A. B. et al. (2009). Plasma or red blood cell phospholipids can be used to assess docosahexaenoic acid

status in women during pregnancy. NutrU Res,U 29(3), 151-155, 19358928. Æ Crowe, F. L. et al. (2008). Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-

control analysis nested within the European Prospective Investigation into Cancer and Nutrition. UAm J

Clin Nutr,U 88(5), 1353-1363, 18996872. Æ Cussons, A. J. et al. (2009). Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary

syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. JU Clin

Endocrinol Metab,U 94(10), 3842-3848, 19622617. GVF-Update | Annual 2009 | 70

Æ da Silva, T. M. et al. (2008). Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled

pilot study of omega-3 fatty-acid supplementation. JU Affect Disord,U 111(2-3), 351-359, 18485485. Æ Dall, T. L. & Bays, H. (2009). Addressing lipid treatment targets beyond cholesterol: a role for prescription

omega-3 fatty acid therapy. SouthU Med J,U 102(4), 390-396, 19279539. Æ Dangour, A. D. et al. (2009). Fish consumption and cognitive function among older people in the UK: baseline

data from the OPAL study. JU Nutr Health Aging,U 13(3), 198-202, 19262951. Æ Das, U. N. (2008). Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory,

cytoprotective, and cardioprotective molecules. LipidsU Health Dis,U 7, 37, 18922179. Æ Davis, W. et al. (2009). Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in

asymptomatic adults. AmU J Ther,U 16(4), 326-332, 19092644. Æ De Groote, G. et al. (2008). Improvement in the plasma omega-3 index by the use of a fish oil-enriched spread.

AnnU Nutr Metab,U 53(1), 23-28, 18772586. Æ De Luis, D. A. et al. (2009). Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2

diabetes mellitus and hypertriglyceridemia: an open study. EurU Rev Med Pharmacol Sci,U 13(1), 51-55, 19364085. Æ de Meijer, V. E. et al. (2009). Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated

liver disease: the Boston experience. JPENU J Parenter Enteral Nutr,U 33(5), 541-547, 19571170. Æ De Spirt, S. et al. (2009). Intervention with flaxseed and borage oil supplements modulates skin condition in

women. BrU J Nutr,U 101(3), 440-445, 18761778.

Æ Decsi, T. (2009). Effects of supplementing LCPUFA to the diet of pregnant women: data from RCT. AdvU Exp Med

Biol,U 646, 65-69, 19536664. Æ Derosa, G. et al. (2009). Effects of long chain omega-3 fatty acids on metalloproteinases and their inhibitors in

combined dyslipidemia patients. ExpertU Opin Pharmacother,U 10(8), 1239-1247, 19397392.

Æ Devore, E. E. et al. (2009). Dietary fat intake and cognitive decline in women with type 2 diabetes. DiabetesU

Care,U 32(4), 635-640, 19336640. Æ di Giuseppe, R. et al. (2009). Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and

women from 3 European populations. AmU J Clin Nutr,U 89(1), 354-362, 19056552. Æ Diamond, I. R. et al. (2009). What is the current role for parenteral lipid emulsions containing omega-3 fatty

acids in infants with short bowel syndrome? MinervaU Pediatr,U 61(3), 263-272, 19461570. Æ Diekman, C. & Malcolm, K. (2009). Consumer perception and insights on fats and fatty acids: knowledge on the

quality of diet fat. AnnU Nutr Metab,U 54 Suppl 1, 25-32, 19641347. Æ Dimitrow, P. P. & Jawien, M. (2009). Pleiotropic, cardioprotective effects of omega-3 polyunsaturated fatty

acids. MiniU Rev Med Chem,U 9(9), 1030-1039, 19689400. Æ Dirix, C. E. et al. (2009). Prenatal arachidonic acid exposure and selected immune-related variables in

childhood. BrU J Nutr,U 102(3), 387-397, 19173768. Æ Dirix, C. E. et al. (2009). Fetal learning and memory: weak associations with the early essential polyunsaturated

fatty acid status. ProstaglandinsU Leukot Essent Fatty Acids,U 80(4), 207-212, 19303277. Æ Drouillet, P. et al. (2009). Maternal fatty acid intake and fetal growth: evidence for an association in overweight women. The 'EDEN mother-child' cohort (study of pre- and early postnatal determinants of the child's

development and health). BrU J Nutr,U 101(4), 583-591, 18631416. Æ Duda, M. K. et al. (2009). omega-3 polyunsaturated fatty acid supplementation for the treatment of heart

failure: mechanisms and clinical potential. CardiovascU Res,U 84(1), 33-41, 19474179.

Æ Dyall, S. C. & Michael-Titus, A. T. (2008). Neurological benefits of omega-3 fatty acids. NeuromolecularU Med,U 10(4), 219-235, 18543124. Æ Egert, S. et al. (2008). Effects of dietary alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on

parameters of glucose metabolism in healthy volunteers. AnnU Nutr Metab,U 53(3-4), 182-187, 19011281. GVF-Update | Annual 2009 | 71

Æ Egert, S. et al. (2009). Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid

composition but similar effects on serum lipid profiles in normolipidemic humans. JU Nutr,U 139(5), 861- 868, 19261730. Æ El-khayat, H. et al. (2007). Cognitive functions in protein-energy malnutrition: in relation to long chain-

polyunsaturated fatty acids. PakU J Biol Sci,U 10(11), 1773-1781, 19086537.

Æ Elmadfa, I. & Kornsteiner, M. (2009). Dietary fat intake--a global perspective. AnnU Nutr Metab,U 54 Suppl 1, 8-14, 19641345. Æ Emsley, R. et al. (2008). Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients:

results from a randomized, placebo-controlled trial. PsychiatryU Res,U 161(3), 284-291, 18962989.

Æ Enke, U. et al. (2008). Impact of PUFA on early immune and fetal development. BrU J Nutr,U 100(6), 1158-1168, 18590581. Æ Eriksson, S. et al. (2009). Fatty acid pattern in serum is associated with bone mineralisation in healthy 8-year-old

children. BrU J Nutr,U 102(3), 407-412, 19175947. Æ Erkkila, A. T. et al. (2008). Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart

disease using multiple medications. EurU J Nutr,U 47(6), 319-328, 18665413. Æ Eskelinen, M. H. et al. (2008). Fat intake at midlife and cognitive impairment later in life: a population-based

CAIDE study. IntU J Geriatr Psychiatry,U 23(7), 741-747, 18188871. Æ Falasca, K. et al. (2009). Severe HIV-associated hypertriglyceridaemia treated with rosuvastatin plus omega-3

fatty acids. IntU J STD AIDS,U 20(8), 580-581, 19625595. Æ Fekete, K. et al. (2009). Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a

systematic review. AmU J Clin Nutr,U 89(6), 2070S-2084S, 19420097. Æ Fetterman, J. W., Jr. & Zdanowicz, M. M. (2009). Therapeutic potential of n-3 polyunsaturated fatty acids in

disease. AmU J Health Syst Pharm,U 66(13), 1169-1179, 19535655. Æ Field, C. J. et al. (2008). Feeding a formula supplemented with long chain polyunsaturated fatty acids modifies

the "ex vivo" cytokine responses to food proteins in infants at low risk for allergy. PediatrU Res,U 64(4), 411- 417, 18552712. Æ Flachs, P. et al. (2009). Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue

biology and metabolism. ClinU Sci (Lond),U 116(1), 1-16, 19037880.

Æ Floel, A. et al. (2008). Lifestyle and memory in the elderly. NeuroepidemiologyU ,U 31(1), 39-47, 18535399.

Æ Florent-Bechard, S. et al. (2009). The essential role of lipids in Alzheimer's disease. BiochimieU ,U 91(6), 804-809, 19303044. Æ Fonolla, J. et al. (2009). Milk enriched with "healthy fatty acids" improves cardiovascular risk markers and

nutritional status in human volunteers. NutritionU ,U 25(4), 408-414, 19084376. Æ Fotuhi, M. et al. (2009). Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or

Alzheimer disease: a complex association. NatU Clin Pract Neurol,U 5(3), 140-152, 19262590. Æ Fradet, V. et al. (2009). Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive

prostate cancer risk. ClinU Cancer Res,U 15(7), 2559-2566, 19318492. Æ Freije, A. (2009). Fatty acid profile of the erythrocyte membranes of healthy Bahraini citizens in comparison

with coronary heart disease patients. JU Oleo Sci,U 58(7), 379-388, 19491533. Æ Freund-Levi, Y. et al. (2009). Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and

plasma in Alzheimer's disease: the OmegAD study. DementU Geriatr Cogn Disord,U 27(5), 481-490, 19439966. Æ Friedman, A. N. et al. (2008). Feasibility study of erythrocyte long-chain omega-3 polyunsaturated fatty acid

content and mortality risk in hemodialysis patients. JU Ren Nutr,U 18(6), 509-512, 18940654. Æ Friesecke, S. et al. (2008). Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a

randomised controlled trial. IntensiveU Care Med,U 34(8), 1411-1420, 18357434. Æ Furuhjelm, C. et al. (2009). Fish oil supplementation in pregnancy and lactation may decrease the risk of infant

allergy. ActaU Paediatr,U 98(9), 1461-1467, 19489765. GVF-Update | Annual 2009 | 72

Æ Ghosh, A. (2009). Obesity measures, metabolic profiles and dietary fatty acids in lean and obese

postmenopausal diabetic Asian Indian women. AnthropolU Anz,U 67(1), 83-93, 19462679. Æ Golding, J. et al. (2009). High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake

from fish. EpidemiologyU ,U 20(4), 598-603, 19289957. Æ Gosai, P. et al. (2008). Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of

rosuvastatin in healthy adults. ExpertU Opin Pharmacother,U 9(17), 2947-2953, 19006471. Æ Guebre-Egziabher, F. et al. (2008). Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases

adiponectin concentration and fatty acid oxidation in healthy subjects. EurU J Clin Nutr,U 62(11), 1287- 1293, 17700650. Æ Guerreiro, C. S. et al. (2009). Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in

Crohn's disease. AmU J Gastroenterol,U 104(9), 2241-2249, 19550417. Æ Guillot, N. et al. (2009). Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet

functions and redox status in healthy men. FasebU J,U 23(9), 2909-2916, 19443612. Æ Habbel, P. et al. (2009). Docosahexaenoic acid suppresses arachidonic acid-induced proliferation of LS-174T

human colon carcinoma cells. WorldU J Gastroenterol,U 15(9), 1079-1084, 19266600. Æ Hall, W. L. (2009). Dietary saturated and unsaturated fats as determinants of blood pressure and vascular

function. NutrU Res Rev,U 22(1), 18-38, 19243668. Æ Hamazaki, K. et al. (2008). The effects of docosahexaenoic acid-rich fish oil on behavior, school attendance rate and malaria infection in school children--a double-blind, randomized, placebo-controlled trial in

Lampung, Indonesia. AsiaU Pac J Clin Nutr,U 17(2), 258-263, 18586645.

Æ Hanebutt, F. L. et al. (2008). Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. ClinU

Nutr,U 27(5), 685-693, 18639956. Æ Hanwell, H. E. et al. (2009). Acute fish oil and soy isoflavone supplementation increase postprandial serum (n-3) polyunsaturated fatty acids and isoflavones but do not affect triacylglycerols or biomarkers of oxidative

stress in overweight and obese hypertriglyceridemic men. JU Nutr,U 139(6), 1128-1134, 19339704. Æ Harris, W. S. et al. (2008). Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from

coronary heart disease in healthy adults. CurrU Atheroscler Rep,U 10(6), 503-509, 18937898. Æ Harris, W. S. et al. (2009). Towards establishing dietary reference intakes for eicosapentaenoic and

docosahexaenoic acids. JU Nutr,U 139(4), 804S-819S, 19244379.

Æ Hassan-Zadeh, A. et al. (2008). Optimization of the omega-3 extraction as a functional food from flaxseed. IntU J

Food Sci Nutr,U 59(6), 526-534, 18651294. Æ He, K. (2009). Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease--

eat fish or take fish oil supplement? ProgU Cardiovasc Dis,U 52(2), 95-114, 19732603. Æ He, K. et al. (2009). Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers

of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). UAm J

Cardiol,U 103(9), 1238-1243, 19406265.

Æ Heinen, M. M. et al. (2009). Meat and fat intake and pancreatic cancer risk in the Netherlands Cohort Study. IntU J

Cancer,U 125(5), 1118-1126, 19452526. Æ Hengstermann, S. et al. (2008). Altered status of antioxidant vitamins and fatty acids in patients with inactive

inflammatory bowel disease. ClinU Nutr,U 27(4), 571-578, 18316141. Æ Higashihara, E. et al. (2008). The effect of eicosapentaenoic acid on renal function and volume in patients with

ADPKD. NephrolU Dial Transplant,U 23(9), 2847-2852, 18372389. Æ Homsi, J. et al. (2009). Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and

mucosal metastatic melanoma patients. MelanomaU Res,U 19(4), 238-242, 19521262. Æ Hoy, S. M. & Keating, G. M. (2009). Omega-3 ethylester concentrate: a review of its use in secondary prevention

post-myocardial infarction and the treatment of hypertriglyceridaemia. DrugsU ,U 69(8), 1077-1105, 19496632.

Æ Hu, F. B. (2009). Diet and lifestyle influences on risk of coronary heart disease. CurrU Atheroscler Rep,U 11(4), 257- 263, 19500488. GVF-Update | Annual 2009 | 73

Æ Huwiler, A. & Pfeilschifter, J. (2009). Lipids as targets for novel anti-inflammatory therapies. PharmacolU Ther,U 124(1), 96-112, 19576246. Æ Ian Givens, D. & Gibbs, R. A. (2008). Current intakes of EPA and DHA in European populations and the potential

of animal-derived foods to increase them. ProcU Nutr Soc,U 67(3), 273-280, 18498671.

Æ Ibiebele, T. I. et al. (2009). Dietary fat intake and risk of skin cancer: a prospective study in Australian adults. IntU J

Cancer,U 125(7), 1678-1684, 19462452. Æ Innis, S. M. (2009). Omega-3 Fatty acids and neural development to 2 years of age: do we know enough for

dietary recommendations? JU Pediatr Gastroenterol Nutr,U 48 Suppl 1, S16-24, 19214053. Æ Janovska, P. & Kopecky, J. (2009). Adipose tissue-muscle interactions and the metabolic effects of n-3 LCPUFA -

implications for programming effects of early diet. AdvU Exp Med Biol,U 646, 149-157, 19536674. Æ Jenkins, D. J. et al. (2008). Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids

in restenosis, secondary prevention and ventricular arrhythmias. JU Am Coll Nutr,U 27(3), 367-378, 18838524. Æ Jimenez-Gomez, Y. et al. (2009). Olive oil and walnut breakfasts reduce the postprandial inflammatory

response in mononuclear cells compared with a butter breakfast in healthy men. AtherosclerosisU ,U 204(2), e70-76, 18952211.

Æ Jirapinyo, P. et al. (2008). Fatty acid composition in breast milk from 4 regions of Thailand. UJ Med Assoc Thai,U 91(12), 1833-1837, 19133517. Æ Johnson, E. J. et al. (2008). Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein

supplementation in older women. NutrU Neurosci,U 11(2), 75-83, 18510807. Æ Johnson, M. et al. (2009). Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a

randomized placebo-controlled trial in children and adolescents. JU Atten Disord,U 12(5), 394-401, 18448859.

Æ Josse, A. R. et al. (2008). Nutritional determinants of the metabolic syndrome. UJ Nutrigenet Nutrigenomics,U 1(3), 109-117, 19776620.

Æ Kang, J. X. & Weylandt, K. H. (2008). Modulation of inflammatory cytokines by omega-3 fatty acids. SubcellU

Biochem,U 49, 133-143, 18751910.

Æ Kannass, K. N. et al. (2009). Maternal DHA levels and toddler free-play attention. DevU Neuropsychol,U 34(2), 159- 174, 19267293. Æ Kaushik, M. et al. (2009). Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus.

AmU J Clin Nutr,U 90(3), 613-620, 19625683. Æ Kohro, T. & Yamazaki, T. (2009). Eicosapentaenoic acid (EPA) in reducing secondary cardiovascular events in

hypercholesterolemic Japanese patients. CircU J,U 73(7), 1197-1198, 19556699. Æ Koletzko, B. et al. (2008). The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and

infancy: review of current knowledge and consensus recommendations. UJ Perinat Med,U 36(1), 5-14, 18184094. Æ Koletzko, B. et al. (2009). Omega-3 LC-PUFA supply and neurological outcomes in children with

phenylketonuria (PKU). JU Pediatr Gastroenterol Nutr,U 48 Suppl 1, S2-7, 19214054. Æ Koyama, N. et al. (2009). Effects of safflower seed extract supplementation on oxidation and cardiovascular risk

markers in healthy human volunteers. BrU J Nutr,U 101(4), 568-575, 18590590. Æ Kralova Lesna, I. et al. (2008). Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol

transport. JU Lipid Res,U 49(11), 2414-2418, 18614815. Æ Laasonen, M. et al. (2009). Project DyAdd: Fatty acids and cognition in adults with dyslexia, ADHD, or both.

ProstaglandinsU Leukot Essent Fatty Acids,U 81(1), 79-88, 19464861.

Æ Lands, B. (2008). A critique of paradoxes in current advice on dietary lipids. ProgU Lipid Res,U 47(2), 77-106, 18177743. Æ Lankinen, M. et al. (2009). Fatty fish intake decreases lipids related to inflammation and insulin signaling--a

lipidomics approach. PLoSU One,U 4(4), e5258, 19390588. GVF-Update | Annual 2009 | 74

Æ Larson, M. K. et al. (2008). Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on

platelet function in healthy subjects. ThrombU Haemost,U 100(4), 634-641, 18841286. Æ Larsson, S. C. et al. (2009). Conjugated linoleic acid intake and breast cancer risk in a prospective cohort of

Swedish women. AmU J Clin Nutr,U 90(3), 556-560, 19491389.

Æ Lauritzen, L. et al. (2008). The effect of fish oil supplementation on heart rate in healthy Danish infants. PediatrU

Res,U 64(6), 610-614, 18679165.

Æ Lavie, C. J. et al. (2009). Omega-3 polyunsaturated fatty acids and cardiovascular diseases. JU Am Coll Cardiol,U 54(7), 585-594, 19660687. Æ Lazzarin, N. et al. (2009). Low-dose aspirin and omega-3 fatty acids improve uterine artery blood flow velocity

in women with recurrent miscarriage due to impaired uterine perfusion. FertilU Steril,U 92(1), 296-300, 18692841.

Æ Leon, H. et al. (2008). Effect of fish oil on arrhythmias and mortality: systematic review. BmjU ,U 337, a2931, 19106137. Æ Levitan, E. B. et al. (2009). Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a

population-based prospective study of middle-aged and elderly men. EurU Heart J,U 30(12), 1495-1500, 19383731. Æ Lien, V. W. & Clandinin, M. T. (2009). Dietary assessment of arachidonic acid and docosahexaenoic acid intake in

4-7 year-old children. JU Am Coll Nutr,U 28(1), 7-15, 19571154. Æ Lucas, M. et al. (2009). Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized

clinical trial. MenopauseU ,U 16(2), 357-366, 19034052.

Æ Lucas, M. et al. (2009). Plasma omega-3 and psychological distress among Nunavik Inuit (Canada). PsychiatryU

Res,U 167(3), 266-278, 19394089.

Æ Lucenteforte, E. et al. (2009). Macronutrients, fatty acids and cholesterol intake and stomach cancer risk. AnnU

Oncol,U 20(8), 1434-1438, 19465424.

Æ Lukiw, W. J. & Bazan, N. G. (2008). Docosahexaenoic acid and the aging brain. JU Nutr,U 138(12), 2510-2514, 19022980. Æ Magnusardottir, A. R. et al. (2009). Red blood cell n-3 polyunsaturated fatty acids in first trimester of pregnancy

are inversely associated with placental weight. ActaU Obstet Gynecol Scand,U 88(1), 91-97, 19140046. Æ Makrides, M. et al. (2009). Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic

acid: a randomized controlled trial. JamaU ,U 301(2), 175-182, 19141765.

Æ Mangat, I. (2009). Do vegetarians have to eat fish for optimal cardiovascular protection? AmU J Clin Nutr,U 89(5), 1597S-1601S, 19321560. Æ Marchioli, R. et al. (2009). Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart

failure: results of the GISSI-HF trial. ExpertU Rev Cardiovasc Ther,U 7(7), 735-748, 19589110. Æ Marosvolgyi, T. et al. (2009). Trans isomeric and LCPUFA are inversely correlated in erythrocyte membrane

lipids at mid-gestation. AdvU Exp Med Biol,U 646, 159-163, 19536675.

Æ Martin de Santa Olalla, L. et al. (2009). N-3 fatty acids in glucose metabolism and insulin sensitivity. NutrU Hosp,U 24(2), 113-127, 19593479.

Æ Martin, L. et al. (2008). Food products as vehicles for n-3 fatty acid supplementation. CanU J Diet Pract Res,U 69(4), 203-207, 19063811. Æ Matsuzaki, M. et al. (2009). Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-

treated patients with coronary artery disease. CircU J,U 73(7), 1283-1290, 19423946. Æ Metherel, A. H. et al. (2009). Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil

supplementation and washout in men and women. ProstaglandinsU Leukot Essent Fatty Acids,U 81(1), 23- 29, 19515545. Æ Methy, N. et al. (2008). Dietary fatty acids and recurrence of colorectal adenomas in a European intervention

trial. NutrU Cancer,U 60(5), 560-567, 18791918.

Æ Meves, H. (2008). Arachidonic acid and ion channels: an update. BrU J Pharmacol,U 155(1), 4-16, 18552881. GVF-Update | Annual 2009 | 75

Æ Micallef, M. A. & Garg, M. L. (2009). Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty

acids and plant sterols in hyperlipidemic individuals. AtherosclerosisU ,U 204(2), 476-482, 18977480. Æ Micallef, M. A. et al. (2009). An inverse relationship between plasma n-3 fatty acids and C-reactive protein in

healthy individuals. EurU J Clin Nutr,U 63(9), 1154-1156, 19352379. Æ Micha, R. & Mozaffarian, D. (2009). Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes.

NatU Rev Endocrinol,U 5(6), 335-344, 19399016. Æ Michalski, M. C. et al. (2008). Oxidation products of polyunsaturated fatty acids in infant formulas compared to

human milk--a preliminary study. MolU Nutr Food Res,U 52(12), 1478-1485, 18792926. Æ Mickleborough, T. D. et al. (2009). Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic

alveolar macrophage cells. ClinU Nutr,U 28(1), 71-77, 19054597.

Æ Middleton, L. E. & Yaffe, K. (2009). Promising strategies for the prevention of dementia. ArchU Neurol,U 66(10), 1210-1215, 19822776. Æ Miller, E. R., 3rd et al. (2009). The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine

protein excretion and kidney function: meta-analysis of clinical trials. AmU J Clin Nutr,U 89(6), 1937-1945, 19403630. Æ Milte, C. M. et al. (2009). Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression,

and Alzheimer's disease: towards an omega-3 index for mental health? NutrU Rev,U 67(10), 573-590, 19785689. Æ Mischoulon, D. et al. (2008). A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major

depressive disorder. EurU Neuropsychopharmacol,U 18(9), 639-645, 18539007.

Æ Mittal, A. et al. (2009). Status of fatty acids as skin penetration enhancers-a review. CurrU Drug Deliv,U 6(3), 274- 279, 19604141. Æ Mogos, T. & Dondoi, C. (2008). Which dose of omega-3 fatty acids must be taken in different cases of

hypertriglyceridemia? RomU J Intern Med,U 46(1), 81-86, 19157275. Æ Moodley, T. et al. (2009). Arachidonic and docosahexaenoic acid deficits in preterm neonatal mononuclear cell

membranes. Implications for the immune response at birth. NutrU Health,U 20(2), 167-185, 19835110. Æ Morris, C. R. & Agin, M. C. (2009). Syndrome of allergy, apraxia, and malabsorption: characterization of a

neurodevelopmental phenotype that responds to omega 3 and vitamin E supplementation. AlternU Ther

Health Med,U 15(4), 34-43, 19623831. Æ Munakata, M. et al. (2009). The nutrient formula containing eicosapentaenoic acid and docosahexaenoic acid

benefits the fatty acid status of patients receiving long-term enteral nutrition. TohokuU J Exp Med,U 217(1), 23-28, 19155604. Æ Murff, H. J. et al. (2009). A prospective study of dietary polyunsaturated fatty acids and colorectal cancer risk in

Chinese women. CancerU Epidemiol Biomarkers Prev,U 18(8), 2283-2291, 19661088. Æ Muthayya, S. et al. (2009). The effect of fish and omega-3 LCPUFA intake on low birth weight in Indian pregnant

women. EurU J Clin Nutr,U 63(3), 340-346, 17957193. Æ Muthayya, S. et al. (2009). Effect of fortification with multiple micronutrients and n-3 fatty acids on growth and cognitive performance in Indian schoolchildren: the CHAMPION (Children's Health and Mental

Performance Influenced by Optimal Nutrition) Study. AmU J Clin Nutr,U 89(6), 1766-1775, 19369376. Æ Navas-Carretero, S. et al. (2009). An oily fish diet increases insulin sensitivity compared to a red meat diet in

young iron-deficient women. BrU J Nutr,U 102(4), 546-553, 19210857.

Æ Netsu, S. et al. (2008). Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis. FertilU

Steril,U 90(4 Suppl), 1496-1502, 18054352. Æ Niederdeppe, J. & Frosch, D. L. (2009). News coverage and sales of products with trans fat: effects before and

after changes in federal labeling policy. AmU J Prev Med,U 36(5), 395-401, 19269126. Æ Norris, L. E. et al. (2009). Comparison of dietary conjugated linoleic acid with safflower oil on body composition

in obese postmenopausal women with type 2 diabetes mellitus. AmU J Clin Nutr,U 90(3), 468-476, 19535429. GVF-Update | Annual 2009 | 76

Æ O'Connor, N. R. (2009). Infant formula. AmU Fam Physician,U 79(7), 565-570, 19378873. Æ Ohman, M. et al. (2008). Biochemical effects of consumption of eggs containing omega-3 polyunsaturated fatty

acids. UpsU J Med Sci,U 113(3), 315-323, 18991244. Æ Overgaard, J. et al. (2008). Postprandial lipid responses of butter blend containing fish oil in a single-meal study

in humans. MolU Nutr Food Res,U 52(10), 1140-1146, 18646005. Æ Panza, F. et al. (2009). Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia

syndromes and Alzheimer's disease: a review. ScientificWorldJournalU ,U 9, 373-389, 19468660. Æ Panza, F. et al. (2009). Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated

fatty acids in predementia syndromes and Alzheimer's disease. JU Alzheimers Dis,U 16(3), 467-470, 19276539. Æ Parekh, N. et al. (2009). Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health

Initiative. ArchU Ophthalmol,U 127(11), 1483-1493, 19901214. Æ Park, Y. et al. (2009). Correlation of erythrocyte fatty acid composition and dietary intakes with markers of

atherosclerosis in patients with myocardial infarction. NutrU Res,U 29(6), 391-396, 19628105. Æ Parra, D. et al. (2008). A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese

volunteers during weight loss. AppetiteU ,U 51(3), 676-680, 18602429. Æ Patenaude, A. et al. (2009). Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of

the subject. EurU J Clin Nutr,U 63(9), 1123-1129, 19584895. Æ Paulo, M. C. et al. (2008). Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as

biomarkers of cardiovascular risk in young healthy subjects. NutrU Metab Cardiovasc Dis,U 18(10), 664-670, 18420395. Æ Pauwels, E. K. et al. (2009). Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of

mice, men and fish. DrugU News Perspect,U 22(4), 205-213, 19536365.

Æ Peoples, G. E. et al. (2008). Fish oil reduces heart rate and oxygen consumption during exercise. JU Cardiovasc

Pharmacol,U 52(6), 540-547, 19034030. Æ Peters, B. D. et al. (2009). Polyunsaturated fatty acids and brain white matter anisotropy in recent-onset

schizophrenia: a preliminary study. ProstaglandinsU Leukot Essent Fatty Acids,U 81(1), 61-63, 19477108.

Æ Picone, O. et al. (2009). [Effects of omega 3 supplementation in pregnant women]. JU Gynecol Obstet Biol

Reprod (Paris),U 38(2), 117-124, 18947942. Æ Pieniak, Z. et al. (2008). Fish consumption and its motives in households with versus without self-reported

medical history of CVD: a consumer survey from five European countries. BMCU Public Health,U 8, 306, 18783593. Æ Pignier, C. et al. (2007). Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against

activation of cardiac late sodium current: a mechanism for ischemia selectivity. BasicU Res Cardiol,U 102(6), 553-564, 17891522. Æ Pivik, R. T. et al. (2009). Early infant diet and the omega 3 fatty acid DHA: effects on resting cardiovascular

activity and behavioral development during the first half-year of life. DevU Neuropsychol,U 34(2), 139-158, 19267292. Æ Pratt, C. M. et al. (2009). Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of

recurrent symptomatic atrial fibrillation: a prospective study. AmU Heart J,U 158(2), 163-169 e161-163, 19619690. Æ Priante, G. et al. (2009). EPA and DHA suppress AngII- and arachidonic acid-induced expression of profibrotic

genes in human mesangial cells. JU Nephrol,U 22(1), 137-143, 19229829. Æ Proudman, S. M. et al. (2008). Dietary omega-3 fats for treatment of inflammatory joint disease: efficacy and

utility. RheumU Dis Clin North Am,U 34(2), 469-479, 18638687. Æ Raatz, S. K. et al. (2009). Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated

fish oil. JU Am Diet Assoc,U 109(6), 1076-1081, 19465191. GVF-Update | Annual 2009 | 77

Æ Rajaram, S. et al. (2009). Walnuts and fatty fish influence different serum lipid fractions in normal to mildly

hyperlipidemic individuals: a randomized controlled study. AmU J Clin Nutr,U 89(5), 1657S-1663S, 19339404.

Æ Rapoport, S. I. (2008). Arachidonic acid and the brain. JU Nutr,U 138(12), 2515-2520, 19022981. Æ Rasmussen, J. G. et al. (2009). Adiponectin and marine n-3 fatty acids in patients referred for coronary

angiography. IntU J Cardiol,U 135(2), 248-250, 18579237. Æ Raz, R. & Gabis, L. (2009). Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review.

DevU Med Child Neurol,U 51(8), 580-592, 19549202. Æ Rein, P. et al. (2009). Omega-3 fatty acids significantly reduce postprandial triglyceridemia in male smokers: a

pilot study. NutrU Metab Cardiovasc Dis,U 19(2), e3-4, 19073364. Æ Ribeiro, M. et al. (2008). Fatty acid profile of human milk of Portuguese lactating women: prospective study

from the 1st to the 16th week of lactation. AnnU Nutr Metab,U 53(1), 50-56, 18802330.

Æ Richard, D. et al. (2009). Polyunsaturated fatty acids and cardiovascular disease. CellU Mol Life Sci,U 66(20), 3277- 3288, 19590823. Æ Richard, D. et al. (2009). Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling

pathway. BiochemU Biophys Res Commun,U 389(3), 516-522, 19737538. Æ Romaguera, D. et al. (2009). Adherence to the Mediterranean diet is associated with lower abdominal adiposity

in European men and women. JU Nutr,U 139(9), 1728-1737, 19571036. Æ Romieu, I. et al. (2008). The effect of supplementation with omega-3 polyunsaturated fatty acids on markers of

oxidative stress in elderly exposed to PM(2.5). EnvironU Health Perspect,U 116(9), 1237-1242, 18795169. Æ Rousseau, J. H. et al. (2009). Self-reported dietary intake of omega-3 fatty acids and association with bone and

lower extremity function. JU Am Geriatr Soc,U 57(10), 1781-1788, 18759757. Æ Ryan, A. S. et al. (2009). Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other

cardiovascular risk factors. AmU J Ther,U 16(2), 183-192, 19145206. Æ Sabel, K. G. et al. (2009). Fatty acid patterns early after premature birth, simultaneously analysed in mothers'

food, breast milk and serum phospholipids of mothers and infants. LipidsU Health Dis,U 8, 20, 19515230. Æ Sadovsky, R. & Kris-Etherton, P. (2009). Prescription omega-3-acid ethyl esters for the treatment of very high

triglycerides. PostgradU Med,U 121(4), 145-153, 19641280. Æ Safarinejad, M. R. (2009). Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: A

prospective, randomized, double-blind placebo-controlled study. JU Sex Med,U 6(6), 1743-1754, 19453924.

Æ Sahin, N. et al. (2006). Human milk fat substitutes containing omega-3 fatty acids. JU Agric Food Chem,U 54(10), 3717-3722, 19127750.

Æ Schmitz, G. & Ecker, J. (2008). The opposing effects of n-3 and n-6 fatty acids. ProgU Lipid Res,U 47(2), 147-155, 18198131. Æ Scholtens, S. et al. (2009). Long-chain polyunsaturated fatty acids in breast milk and early weight gain in breast-

fed infants. BrU J Nutr,U 101(1), 116-121, 18492299. Æ Senapati, S. et al. (2008). Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled

trial. IndianU J Dermatol Venereol Leprol,U 74(5), 447-452, 19052401. Æ Shapira, N. (2009). Modified egg as a nutritional supplement during peak brain development: a new target for

fortification. NutrU Health,U 20(2), 107-118, 19835107. Æ Sharma, A. et al. (2009). Effects of omega-3 fatty acids on components of the transforming growth factor beta-1

pathway: implication for dietary modification and prevention in ovarian cancer. AmU J Obstet Gynecol,U 200(5), 516 e511-516, 19268879.

Æ Shoji, H. et al. (2009). Effect of docosahexaenoic acid on oxidative stress in placental trophoblast cells. EarlyU

Hum Dev,U 85(7), 433-437, 19327919. Æ Sichert-Hellert, W. et al. (2009). Age and time trends in fish consumption pattern of children and adolescents,

and consequences for the intake of long-chain n-3 polyunsaturated fatty acids. EurU J Clin Nutr,U 63(9), 1071-1075, 19536160. GVF-Update | Annual 2009 | 78

Æ Signorello, M. G. et al. (2009). The arachidonic acid effect on platelet nitric oxide level. BiochimU Biophys Acta,U 1791(11), 1084-1092, 19615463. Æ Simon, J. A. et al. (2009). The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review

and meta-analysis. AmU J Clin Nutr,U 89(5), 1558S-1564S, 19321563. Æ Singer, P. et al. (2008). Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms

and an integrative perspective. IntensiveU Care Med,U 34(9), 1580-1592, 18461305. Æ Sinikovic, D. S. et al. (2009). Women's awareness of the importance of long-chain omega-3 polyunsaturated fatty acid consumption during pregnancy: knowledge of risks, benefits and information accessibility.

PublicU Health Nutr,U 12(4), 562-569, 18507886. Æ Sioen, I. et al. (2008). Fish consumption is a safe solution to increase the intake of long-chain n-3 fatty acids.

PublicU Health Nutr,U 11(11), 1107-1116, 18167167.

Æ Sioen, I. et al. (2009). Effect of ALA-enriched food supply on cardiovascular risk factors in males. LipidsU ,U 44(7), 603-611, 19452183. Æ Smith, K. M. et al. (2009). Relationship between fish intake, n-3 fatty acids, mercury and risk markers of CHD

(National Health and Nutrition Examination Survey 1999-2002). PublicU Health Nutr,U 12(8), 1261-1269, 18986590. Æ Smith, P. J. et al. (2009). Association between n-3 fatty acid consumption and ventricular ectopy after

myocardial infarction. AmU J Clin Nutr,U 89(5), 1315-1320, 19321564.

Æ Solfrizzi, V. et al. (2009). Dietary fatty acids and predementia syndromes. ScientificWorldJournalU ,U 9, 792-810, 19705039.

Æ Soltan, S. S. & Gibson, R. A. (2008). Levels of Omega 3 fatty acids in Australian seafood. AsiaU Pac J Clin Nutr,U 17(3), 385-390, 18818157.

Æ Spencer, L. et al. (2009). The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. EurU

J Cancer,U 45(12), 2077-2086, 19493674. Æ Spiekerkoetter, U. et al. (2009). Treatment recommendations in long-chain fatty acid oxidation defects:

consensus from a workshop. JU Inherit Metab Dis,U 32(4), 498-505, 19452263. Æ Stanke-Labesque, F. et al. (2008). Effect of dietary supplementation with increasing doses of docosahexaenoic

acid on neutrophil lipid composition and leukotriene production in human healthy volunteers. BrU J Nutr,U 100(4), 829-833, 18304388. Æ Strain, J. J. et al. (2008). Associations of maternal long-chain polyunsaturated fatty acids, methyl mercury, and

infant development in the Seychelles Child Development Nutrition Study. NeurotoxicologyU ,U 29(5), 776- 782, 18590765. Æ Streppel, M. T. et al. (2008). Long-term fish consumption and n-3 fatty acid intake in relation to (sudden)

coronary heart disease death: the Zutphen study. EurU Heart J,U 29(16), 2024-2030, 18641046. Æ Strychar, I. et al. (2009). Effects of a diet higher in carbohydrate/lower in fat versus lower in carbohydrate/higher in monounsaturated fat on postmeal triglyceride concentrations and other

cardiovascular risk factors in type 1 diabetes. DiabetesU Care,U 32(9), 1597-1599, 19542011. Æ Suresh, Y. & Das, U. N. (2006). Differential effect of saturated, monounsaturated, and polyunsaturated fatty

acids on alloxan-induced diabetes mellitus. ProstaglandinsU Leukot Essent Fatty Acids,U 74(3), 199-213, 16412622. Æ Svensson, M. et al. (2008). The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with

chronic haemodialysis: a randomized placebo-controlled intervention study. NephrolU Dial Transplant,U 23(9), 2918-2924, 18436564. Æ Szabo, E. et al. (2009). Long-chain polyunsaturated fatty acids in a diabetic teenager during and after nine

repeated episodes of diabetic ketoacidosis. PediatrU Diabetes,U 10(3), 209-212, 19076300. Æ Tan, J. S. et al. (2009). Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the

Blue Mountains Eye Study. ArchU Ophthalmol,U 127(5), 656-665, 19433717. Æ Tanaka, T. et al. (2009). Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI

Study. PLoSU Genet,U 5(1), e1000338, 19148276. GVF-Update | Annual 2009 | 79

Æ Tang, F. Y. et al. (2009). Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the

proliferation of human colon cancer cells. JU Nutr Biochem,U 20(6), 426-434, 18708285. Æ Tapsell, L. C. et al. (2009). Long-term effects of increased dietary polyunsaturated fat from walnuts on

metabolic parameters in type II diabetes. EurU J Clin Nutr,U 63(8), 1008-1015, 19352378. Æ Tartibian, B. et al. (2009). The effects of ingestion of omega-3 fatty acids on perceived pain and external

symptoms of delayed onset muscle soreness in untrained men. ClinU J Sport Med,U 19(2), 115-119, 19451765. Æ Tavazzi, L. et al. (2008). Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-

HF trial): a randomised, double-blind, placebo-controlled trial. LancetU ,U 372(9645), 1223-1230, 18757090. Æ Teraoka, N. et al. (2009). Oral supplementation with dihomo-gamma-linolenic acid-enriched oil altered serum

fatty acids in healthy men. BiosciU Biotechnol Biochem,U 73(6), 1453-1455, 19502748. Æ Thiebaut, A. C. et al. (2009). Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of

breast cancer. IntU J Cancer,U 124(4), 924-931, 19035453.

Æ Thiebaut, A. C. et al. (2009). Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. JU

Natl Cancer Inst,U 101(14), 1001-1011, 19561318. Æ Tinoco, S. M. et al. (2009). n-3 polyunsaturated fatty acids in milk is associate to weight gain and growth in

premature infants. LipidsU Health Dis,U 8, 23, 19558659. Æ Torres, A. G. & Trugo, N. M. (2009). Evidence of inadequate docosahexaenoic acid status in Brazilian pregnant

and lactating women. RevU Saude Publica,U 43(2), 359-368, 19287877. Æ Troseid, M. et al. (2009). Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in

elderly high-risk men. MetabolismU ,U 58(11), 1543-1549, 19595382. Æ Tull, S. P. et al. (2009). Omega-3 Fatty acids and inflammation: novel interactions reveal a new step in

neutrophil recruitment. PLoSU Biol,U 7(8), e1000177, 19707265. Æ Tuller, E. R. et al. (2009). Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible

factor-2alpha signaling. MolU Pharmacol,U 76(3), 588-595, 19528198. Æ Tuo, J. et al. (2009). A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular

degeneration. AmU J Pathol,U 175(2), 799-807, 19608872. Æ Turnbull, T. et al. (2008). Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms:

a systematic review. ArchU Psychiatr Nurs,U 22(5), 305-311, 18809123.

Æ Tziomalos, K. et al. (2008). Omega-3 fatty acids: how can they be used in secondary prevention? UCurr

Atheroscler Rep,U 10(6), 510-517, 18937899. Æ Ueeda, M. et al. (2008). Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary

plaques and calcifications in patients with acute myocardial infarction. CircU J,U 72(11), 1836-1843, 18812674. Æ van de Rest, O. et al. (2009). Effect of fish oil supplementation on quality of life in a general population of older

Dutch subjects: a randomized, double-blind, placebo-controlled trial. JU Am Geriatr Soc,U 57(8), 1481-1486, 19549020. Æ van Eijsden, M. et al. (2009). Ethnic differences in early pregnancy maternal n-3 and n-6 fatty acid

concentrations: an explorative analysis. BrU J Nutr,U 101(12), 1761-1768, 18983717. Æ van Goor, S. A. et al. (2008). Milk of women with lifetime consumption of the recommended daily intake of fish

fatty acids should constitute the basis for the DHA contents of infant formula. JU Perinat Med,U 36(6), 548- 549, 18673085.

Æ Virtanen, J. K. et al. (2008). Fish consumption and risk of major chronic disease in men. AmU J Clin Nutr,U 88(6), 1618-1625, 19064523. Æ Waitzberg, D. L. & Torrinhas, R. S. (2009). Fish oil lipid emulsions and immune response: what clinicians need to

know. NutrU Clin Pract,U 24(4), 487-499, 19605803.

Æ Wandall, B. (2008). The controversy over trans fatty acids: effects early in life. FoodU Chem Toxicol,U 46(12), 3571- 3579, 18790712. GVF-Update | Annual 2009 | 80

Æ Warstedt, K. et al. (2009). The effects of omega-3 fatty acid supplementation in pregnancy on maternal

eicosanoid, cytokine, and chemokine secretion. PediatrU Res,U 66(2), 212-217, 19390480. Æ Watson, P. D. et al. (2009). Comparison of bleeding complications with omega-3 fatty acids + aspirin +

clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease. AmU J Cardiol,U 104(8), 1052-1054, 19801023.

Æ Wertz, P. W. (2009). Essential fatty acids and dietary stress. ToxicolU Ind Health,U 25(4-5), 279-283, 19651798. Æ Weseler, A. R. et al. (2008). Dietary arachidonic acid dose-dependently increases the arachidonic acid

concentration in human milk. JU Nutr,U 138(11), 2190-2197, 18936218.

Æ Whelan, J. (2008). (n-6) and (n-3) Polyunsaturated fatty acids and the aging brain: food for thought. JU Nutr,U 138(12), 2521-2522, 19022982. Æ Willis, L. M. et al. (2009). Modulation of cognition and behavior in aged animals: role for antioxidant- and

essential fatty acid-rich plant foods. AmU J Clin Nutr,U 89(5), 1602S-1606S, 19339395. Æ Witte, K. K. & Clark, A. L. (2009). Marine polyunsaturated fatty acids in heart failure. Are the theoretical benefits

matched by the clinical data? PolU Arch Med Wewn,U 119(3), 162-169, 19514646.

Æ Woodside, J. V. et al. (2008). Saturated and trans fatty acids and coronary heart disease. CurrU Atheroscler Rep,U 10(6), 460-466, 18937892. Æ Woodward, M. et al. (2009). Association between both lipid and protein oxidation and the risk of fatal or non-

fatal coronary heart disease in a human population. ClinU Sci (Lond),U 116(1), 53-60, 18507534. Æ Wooten, J. S. et al. (2009). Responses of LDL and HDL particle size and distribution to omega-3 fatty acid

supplementation and aerobic exercise. JU Appl Physiol,U 107(3), 794-800, 19589957. Æ Yamagami, T. et al. (2009). Docosahexaenoic acid induces dose dependent cell death in an early

undifferentiated subtype of acute myeloid leukemia cell line. CancerU Biol Ther,U 8(4), 331-337, 19197149. Æ Yashodhara, B. M. et al. (2009). Omega-3 fatty acids: a comprehensive review of their role in health and disease.

PostgradU Med J,U 85(1000), 84-90, 19329703.

Æ Yasui, T. et al. (2008). Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis. UUrol

Int,U 81(2), 135-138, 18758209. Æ Zeisel, S. H. (2009). Is maternal diet supplementation beneficial? Optimal development of infant depends on

mother's diet. AmU J Clin Nutr,U 89(2), 685S-687S, 19116319. Æ Zhang, X. H. et al. (2009). Increasing dietary fish intake has contributed to decreasing mortality from CHD

among the older population in Hong Kong. PublicU Health Nutr,U 12(8), 1248-1253, 18838028. Æ Zhao, W. S. et al. (2009). Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril

in Chinese patients with obesity-related hypertension. AmU J Hypertens,U 22(6), 680-686, 19300423. Æ Zhao, Y. T. et al. (2009). Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary

heart disease: a meta-analysis of randomized controlled trials. AnnU Med,U 41(4), 301-310, 19148838.

Reservatrol16B

Æ Karuppagounder, S. S. et al. (2009). Dietary supplementation with resveratrol reduces plaque pathology in a

transgenic model of Alzheimer's disease. NeurochemU Int,U 54(2), 111-118, 19041676. Æ Tan, Y. & Lim, L. H. (2008). trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and

degranulation. BrU J Pharmacol,U 155(7), 995-1004, 18776917.

GVF-Geschäftsstelle Institut für Ernährungswissenschaft Universität Potsdam Arthur-Scheunert-Allee 114-116 D-14558 Nuthetal (Potsdam-Rehbrücke)

Tel.: +49 (0)33 200 88-550 Fax: +49 (0)33 200 88-573

E-Mail: [email protected] Internet: www.vitaminforschung.org